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ADE Adverse drug event 




CI Confidence interval 
CPPS Community pharmacy pilot study 
DRG Diagnosis related group remuneration system for hospitalisation 
DRP Drug related problem 
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FIP International Pharmaceutical Federation 
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GP General practitioner 
hCRF Hospital case report form 
HL Health literacy 
IQR Interquartile range 
KSB Kantonsspital Baden AG 
LOS Lenth of hospital stay 
MC Medication chart 
MED Internal medicine ward 
MedRec Medication reconciliation 
MMS Mini-Mental-Status-Test 
MP Medikationsplan 
MRC Medical Research Council  
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OTC Over the counter medication, available without prescription 
P Patient 
pCRF Pharmacy case report form 
PI Pharmaceutical intervention, pharmazeutische Intervention 
POMMES Pharmazeutische Optimierung des Medikamenten Managements nach Entlassung 
aus dem Spital, Pharmaceutical Optimisation of the Medication Management after 
dischargE from hoSpital 
PPS Procedural pilot study 
R Resident 
RCT Randomised controlled trial 
RPZ Risikoprioritätszahl 
RR Relative risk 
Rx Prescription 
SD Standard deviation 
SP Senior physician 
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In Swiss ambulatory care, a patient’s medication is usually prescribed by the family general 
practitioner (GP) and dispensed by the community pharmacy. In the canton of Aargau (AG), GP and 
pharmacy density is lower than the Swiss average, and self-dispensing by physicians is not allowed. 
This canton is of interest in this thesis, as most of the projects were performed there.  
Inpatient care is provided by 267 hospitals in Switzerland. They are differentiated according to size, 
location and teaching responsibilities. The Cantonal Hospital of Baden (Kantonsspital Baden AG, 
KSB) is located in AG and is the study site of most of the projects presented in this thesis. Upon 
admission of a patient to hospital, a best possible medication history has to be taken. Information 
may be obtained from many different sources such as GPs, the patients themselves or the patients’ 
community pharmacies. At admission, a significant portion of medication lists are incomplete or 
contain mistakes. Medication reconciliation (MedRec) is a structured but time-consuming approach 
to obtain the correct information. Upon hospital discharge, the medication list has to be updated 
once again. MedRec helps to identify intentional medication changes and to define a good, reliable 
discharge medication list. This approach may take some time, and its quality is often lacking due to 
the spontaneous nature of many discharges.  
The ward resident physician is responsible for discharge documents and patient counselling. The 
discharge summary is the most complete document, and usually contains information about 
medication, clinical situations and follow-up. The summaries are often sent directly to the patient’s 
GP by postal or electronic delivery. GPs in Switzerland and abroad complain about the quality of 
these summaries. Also, the late transfer of summaries is a problem. In the KSB, only a short 
discharge summary is given to the patients. The patients could transfer it to their GP or community 
pharmacy, if they wanted to.  
The hospital provides the discharge prescription to obtain new medication supply, and sometimes a 
medication chart (MC) to the patient. In the canton AG, discharge medication can only be obtained 
in a public community pharmacy with a prescription. That is why this system was studied in this 
thesis. The medication charts given to patients are often designed by health care professionals and 
usually have a tabular design with some surrounding information. It is known that comprehensibility 
is crucial to benefit of these MCs. Patients with low health literacy are especially susceptible to 
misunderstanding. Furthermore, it is important that the documentation meets the patients’ needs 
with respect to content and design. A first step should be to gain an overview of existing charts to 
see all possibilities of design and content. However, there is no systematic comparison of existing 
MCs.  
Counselling upon discharge may be of low quality and impaired by time constraints. It is clear that 
counselling and its effect depend to a high degree on the counsellor’s personal priorities, 
experience, and also the patient’s need and understanding. Patients and relatives complain about 
the low amounts of information obtained at discharge.  
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When filling the discharge prescription, community pharmacists reconcile the prescription with the 
patient’s history in the pharmacy software. Drug related problems (DRPs), that affect many patients, 
may be detected this way. Through talking with the patient or their relatives, pharmacists also detect 
handling difficulties, inadequate package sizes, or nonadherence. Clarifications to solve DPRs are 
often needed, but, as physicians are often difficult to contact, community pharmacists may lack 
information to care appropriately for the discharged patient. To bridge this gap, different strategies 
have been evaluated. The hospital may provide better information, e.g. on a handover form or on the 
prescription. Furthermore, a liaison pharmacist could provide information on request from the 
pharmacies. A third option is to counsel patients extensively while they are still in hospital. With 
improving their own knowledge, they may later be a valuable information source.  
Irrespective of the methodology chosen to optimise discharge, some important aspects have to be 
kept in mind. Firstly, good discharge processes are a combination of discharge coordination, 
information content and information transfer. All three aspects have to be addressed when discharge 
processes are to be changed successfully. Secondly, many studies use extensive resources for their 
optimisation strategies. As resources are often limited in health care and evidence on cost-
effectiveness is rare, their later implementation is often impaired. Thirdly, also regarding future 
implementation of a service, the difference between explanatory and pragmatic approaches should 
be distinguished. They use different study designs, different structures and provide different results. 
Pragmatic trials use existing processes, resources and experiences, to estimate the effect of a 
service in daily practice.  
Goal of this thesis 
The overall goal of this thesis was to develop a service to optimise care of discharged patients by a 
pragmatic in-hospital service. Three different aims helped to reach the goal.  
 
1. The first aim was to assess the views of discharged patients (Project A1). Views should be 
obtained about the challenges they face upon discharge. In particular, the comprehensibility 
of MCs should be evaluated. Furthermore, experiences of discharge counselling and supply 
problems should be evaluated (A2.1 and A2.2). It was an aim to ask patients if they see any 
optimisation strategies for discharge problems (A2.3).  
2. The second aim targeted in Project B was to assess the community pharmacist’s views of 
hospital discharge. In this population as well, problems and possible optimisation strategies 
should be assessed.  
3. With all of this background information, we aimed to develop a service to optimise hospital 
discharge (Project C). The most important aspect was information transfer from the hospital 




Projects with results 
In Project A1, different MCs from hospitals, pharmacies or projects were compared. All contained 
brand name, strength, dosage form and a dosing scheme. In many plans, the first column contained 
the name of the active ingredient. However, of the 45 patients from internal medicine, surgical and 
dialysis ward of the KSB who were interviewed, mostly preferred brand names in first position. There 
was a trend that “eMediplan” was the patients’ favourite MC, but the “AMTS-Apothekenplan” was 
judged as the clearest MC. Also, health care professionals preferred the “eMediplan”. Patients were 
then asked to interpret standard dosing instructions in a MC. The abbreviation „Mo“ for the german 
word for morning (“Morgen”) was misinterpreted by 24.4% as Monday. 55.6% interpreted the 
abbreviation „Na“ (night, german = “Nacht”) correctly as before going to bed, while 24.4% would take 
the medication during the night or in the afternoon instead (“Nachmittag”). Electronic patient records 
in hospitals may generate abbreviated dosing instructions. The maximum daily dose for the dosing 
instructions „3x/d 1 tablet“ was correctly interpreted by 82.2% of all participants. 42.2% understood 
correctly the dosing instructions „max. 2 tablets max. 4x/24h“. Of 45 interviewees, 36 interpreted the 
expression „on empty stomach“ (the german word means the same as sober) as medication intake 
without food.  
In Project A2, telephone interviews were conducted with 100 patients from the surgical and internal 





discharge to ask about their medication knowledge (Project A2.1). A combination of oral and written 
instruction was the most preferred method of delivery (69% of all patients), but only 55% received it 
that way. According to five physicians, to whom these results were presented, and who were 
interviewed, all patients should have received oral and written instructions. However, the patients 
had overall good knowledge about medication indications and the latest changes. It should also be 
taken into account that they reported this knowledge themselves. Asked about when they filled their 
discharge prescription (A2.2), 75 patients had filled the prescription within two days of discharge, 
and 73 had obtained all medications. There were some patients experiencing supply problems, such 
as unavailable medication. But of these 14 patients, there were only four patients with therapy gaps. 
Patients discharged from internal medicine wards or with polymedication experienced most supply 
problems. Interviewed physicians stated that therapy gaps seemed unexpectedly low, although the 
proportion of patients experiencing supply problems was higher than acceptable. Patients were 
further asked how hospital discharge could be optimised (A2.3). Most patients (88%) were satisfied 
with the general discharge process, although there was room for optimisation. Asked if 
communication between hospital and the community pharmacy could be a strategy, 21% agreed, 
but other ideas, such as bridging supply, were also suggested. The five physicians were undecided 
about the advantages of improved information transfer.  
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The Project B aimed to assess the community pharmacists’ views about hospital discharge. A 
mixed method approach was chosen, with a focus group of six pharmacists and a nationwide online-
questionnaire sent to 1348 Swiss pharmacies. All pharmacists reported a general lack of 
information. Medication changes, allergies, specifications for “off-label” medication use or contact 
information were reported as often unavailable. This led, presumably often, to therapy gaps. Focus 
group participants reported extensive workload with discharge prescriptions in order to enable good 
and continuous patient treatment. In the focus group and the questionnaire, pharmacists 
emphasised the importance of more extensive information transfer. This applied especially to 
medication changes, unclear prescriptions, and information about a patient's care. They stated that 
information should be delivered in a structured way, but no clear preference for one particular 
transfer method was found.  
The aim of Project C was to develop a pragmatic in-hospital service to optimise discharge. Within 
Project C1, the study design should be tested and the success of a later intervention study should 
be estimated. The service in the study should target information transfer from the hospital to 
community pharmacies, and should use the usual prescription as transfer method. The aim should 
be to reduce the community pharmacies’ workload and enhance patient safety. Based on a model 
for evaluation of complex interventions, important uncertainties and criteria were sampled which 
could influence quality, feasibility and efficiency of the study. The uncertainties were then assessed 
with the help of different piloting procedures. In the hospital, patient screening was tested with 
different inclusion and exclusion criteria, which were continuously specified according to the 
previous findings. With three screenings, good knowledge about the eligible population was gained. 
The recruitment tests revealed that many patients were missed, and the procedure was therefore 
adapted. Collaboration with the community pharmacies and their data recording proved to be 
feasible after some adaptations. For the community pharmacists, time constraints were a major 
barrier in filling out the case report form, but the pharmacies found the research question interesting.  
Based on the previous findings, a pragmatic in-hospital service was studied in Project C2, a 
randomised controlled trial (RCT). The service was tested on adult internal medicine patients who 
were discharged to home. They were included if the patients gave informed consent and if their 
pharmacy agreed to participate. Patients were randomised and control group patients received usual 
care. In the intervention group, the prepared prescription was checked by a clinical pharmacist. 
Flaws were discussed with the physician and corrected or specified on the usual prescription. When 
the patient filled their prescription in the pharmacy, the staff documented the pharmaceutical 
interventions (PIs), the established contacts, the time needed to fill the prescription and their 
satisfaction level. In each group, 76 patients were included in the final evaluation and their 
characteristics did not differ significantly. In an adjusted Poisson regression analysis, the 
intervention group had a relative risk of 0.78 (95% CI 0.62-0.99, p=0.04) for the number of PIs 
increasing by one, compared to the control group. The comparison of the PIs showed that the 
pattern was different between the groups. There were less clinically significant PIs performed, but 
more economically significant ones in the intervention group. The number of contacts with hospital 
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physicians by the community pharmacies was lower. The time that was needed to fill the prescription 
was 10 minutes in both groups and was therefore not influenced by the service. However, the 
community pharmacy staff was statistically significantly more satisfied with the quality of the 
prescriptions. The pragmatic service in the hospital took 6 minutes per patient. 
A qualitative study (Project C3) was conducted after Project C2 to learn from experiences and to 
complement the quantitative outcomes. Five involved resident physicians and five community 
pharmacists from the RCT were interviewed about their general impression, the methodology and 
effects. Also wishes for further services were evaluated. It proved that both professional groups were 
positive about the involvement of the hospital pharmacy in the discharge process. The interviewees 
stated that patient safety was increased. Physicians were aware of the problems at transitions of 
care and some reported having changed their behaviour. A topic most prominently discussed during 
the interviews were medication changes. Both groups stated that it was appropriate to communicate 
through the prescription. However, pharmacists reported that the standardised addition of a 
medication chart would be enormously helpful. For the future, both groups would benefit from a 
continuation of the studied service. It would ensure that every prescription is checked by two 
persons and it would enhance patient safety. Residents appreciated the wider presence of the 




To conclude, this thesis showed the following: 
Patients’ views of hospital discharge 
- MCs differ significantly in their design and content. The preference for the best chart differed 
between the hospital staff and the patients, indicating that people that design charts should 
be aware of this. 
- MCs do not meet the patients’ needs in all aspects, and patients wish for other information 
items, or the same items in another order, for example brand names. 
- Dosing instructions, which are commonly used in the hospitals and are therefore also 
prescribed at discharge, were not well understood. This may impair patient outcomes. All 
written dosing instructions should be accompanied by proper counselling. 
- Discharged patients get less instruction than they expect. Counselling at hospital discharge 
was unsatisfying according to the patients, and a quarter stated that they have neither been 
counselled orally, nor in written form. A combination of oral and written instruction was most 
preferred by the patients.  
- Patients reported rather good knowledge on their medication, which is in contrast to the 
unsatisfying counselling. However, there was no control on the correctness of the patients’ 
responses.  
- Discharge prescriptions are filled later than expected, and a relevant portion of patients had 
not filled their prescriptions until the 2
nd
 day post discharge. Therapy gaps were infrequent, 
but can be cumbersome and should be prevented. 
- Patients were satisfied with the general discharge process. They suggested that a bridging 
supply would be helpful. Transfer of information to their community pharmacy was not 
clearly welcomed by the interviewed patients and physicians, although literature shows 
promising approaches. 
Community pharmacists’ views of discharge 
- Swiss community pharmacists rarely received sufficient information along with discharge 
prescriptions. They complained that many information items are unavailable, although 
useful. Community pharmacists estimate also that through the lacking information, they are 
faced with extensive workload and patients experience therapy gaps. 
- To transfer information from hospital to the pharmacy, pharmacists would prefer a structured 
method of transfer. But no clear trend for electronic over paper based transfer was found.  
- Not only patient-specific information transfer, but also general collaboration was very 
welcome. Community pharmacists stated a wish for more exchange with the hospital 
personnel, either shared courses, or practical information as contact information, about 




Optimising discharge by a pragmatic in-hospital service 
- An optimisation of hospital discharge should be tested by a RCT. The previous feasibility 
testing helped to identify and assess uncertainties and criteria, which may possibly influence 
the study success.  
- The primary outcome, the total number of PIs performed in the pharmacy, was reduced in 
the intervention group compared to the controls. This was also true particularly for the 
clinically significant ones. There were more PIs with economic significance, indicating that 
costs could be lowered by the pharmacies of patients who underwent the service.  
- In the community pharmacy, the time needed for prescription filling was not influenced, but 
pharmacy staff were significantly more satisfied with the prescription quality.  
- The pragmatic in-hospital prescription check and the transfer of information to the 
community pharmacy proved to be feasible and resource-saving. This would help later 
implementation. 
- The physicians were highly aware of the problems at transition of care and of medication 
changes. They reported that their behaviour had changed. The physicians appreciated 
involvement of hospital pharmacists in patient care.  
- Community pharmacists appreciated the hospital’s efforts to optimise patient discharge. 
Their processes did not change. The service should be continued in the pharmacists’ 
opinion. In addition to the prescription, the pharmacists desire the medication chart for 






Due to an ongoing specialisation in the health care, patients are often treated by different health 
care professionals. Patients are transferred to specialists and hospitals, then back to their family 
practitioner. It is often difficult to ensure that these transitions of care are seamless, and that all 
information about a patient is transferred to all involved professionals. As most hospitalised patients 
are treated with medication, special caution has to be exercised to prevent and solve DRPs.  
In this thesis, the focus lays on hospital discharge, where patients and professionals face many 
barriers for real seamless care. In our study group, we understand seamless care as processes to 
optimise efficiency, quality, and safety of medication management at transitions, in order to establish 
a continuum of care. “Continuum of care” exists as a MeSH-Term since 1991 and is defined as 
“health care provided on a continuing basis from the initial contact, following the patient through all 
phases of medical care” [1]. Hospital discharge has various aspects (best possible 
pharmacotherapy, patient counselling, professional communication). As hospital discharge is 
influenced by the processes that happen before and after discharge, the broader context is 
highlighted in this introduction.  
5.1 Ambulatory care 
The Swiss ambulatory care is delivered by specialists and GPs. Overall, Switzerland has a high 
density of GPs (83 per 100’000 residents), whilst in the canton (administrative region) of Aargau 
there are only 64 [2]. This region is of special interest in this thesis, as most of the research projects 
were performed there. In Europe, only Austria has a higher GP density. This indicates that patients 
in Switzerland can make use of a good ambulatory care, but it is costly. It amounted to a third of the 
Swiss health care costs in 2016, which is higher than in many countries [3]. There might be a 
correlation between the number of GPs and the costs.  
In 16 of 26 cantons, so called “self-dispensing” allows physicians to dispense prescribed medicine 
directly to their patients [2]. In 8 cantons, including the AG, self-dispensing is not allowed and 
medication selling is only possible by public or mail order pharmacies. The remaining two cantons 
have a mixed system [4]. GPs dispensed 22% of all sold packages in Switzerland in 2016, while 
pharmacies dispensed 65% [3]. With 22 pharmacies per 100’000 residents, Switzerland has a 
relatively low density of pharmacies compared to other countries which have up to 87 pharmacies 
per 100’000 residents [5]. However, density varies significantly between the cantons. In AG, there 
are 17.6 pharmacies for 100’000 residents [6, 7]. Many patients have a family GP, and three-
quarters also regularly visit the same pharmacy [8]. With high continuity in primary care, hospital 
admissions were prevented [9]. The processes a patient runs through in ambulatory care are shown 
in Figure 1.  In the case of “pharmacy hopping”, continuity of care is sometimes difficult if no 
medication history is available in the pharmacy’s computer system. A shared electronic health 
record (EPD) would possibly assure continuity of care via seamless communication between health 
care providers. In 2017 the law on shared electronic health records (Bundesgesetz über das 
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elektronische Patientendossier, EPDG) came into force. This compels primary care providers and 
hospitals to offer shared electronic health records in near future. In Swiss ambulatory care, 
electronic patient records are less common than in other countries and also less common than in 
hospitals [2].  
 
 
Figure 1: Health processes in this thesis. The context in which this thesis is embedded and the processes a 
patient runs through. The blue areas show the ambulatory and hospital care with traditional patient, 
document and information flow. GP = General Practicioner, Rx = Prescription 
 
The population’s confidence in pharmacists is very high, the highest after GPs and specialised 
physicians [5]. Pharmaceutical care provided by Swiss community pharmacists has been shown to 
be above the European average [10]. Pharmacists provide direct patient care like health screenings, 
patient monitoring or health promotion. They may also provide medication charts. Medication charts 
(syn. dosing schedule, treatment plan) list all medication a patient uses, or should use, in a tabular 
form. Data from Germany showed that 57.5-80% of all ambulatory patients possessed one [11, 12]. 
But to design and fill in such medication charts, electronic tools or even shared electronic health 
records are favourable. Their prevalence in Switzerland, as discussed previously, is not very high. 
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5.2 Hospital admission 
Ambulatory care is of increasing importance, as the number of acute hospital beds in Switzerland is 
lowering [2]. There is an increasing trend that smaller and low-risk interventions (for example hand 
surgery) are conducted in ambulatory setting. But in case of severe health issues, patients are 
admitted to one of 267 Swiss hospitals [13]. In Switzerland, 1.4 Million patients are admitted to 
hospitals every year [13]. In 2015, there were five university hospitals (level 1 hospitals of tertiary 
care, Figure 2) in Switzerland. The  KSB, the study site of all locally performed projects, is one of 35 
larger hospitals (level 2, tertiary care).  
 
Figure 2: Hospital typology in Switzerland [13]. The Cantonal Hospital of Baden belongs to the Level 2 of 
tertiary medical care. 
 
On admission, a best possible medication history is of utmost importance. Blozik et al. analysed 
claims data of a large health insurer with patients admitted to a private hospital group in different 
parts of Switzerland [14]. The patients had a mean of 5.6 different medications (based on ATC-
Code). It is often difficult to get all patient information needed for the anamnesis to assure seamless 
health care during hospitalisation. Different sources may be of help: patient interviews, medication 
charts or brown bag analysis. If patients bring their own medication, this enables higher accuracy of 
admission orders [15]. Also, contact with a GP or community pharmacy may contribute to the 
completeness of information [16]. Swiss community pharmacists judged their records’ completeness 
as rather good [17]. In cantons with no self-dispensing, records were stated to be the most 
complete. However, 90% of interviewed Swiss pharmacists were rarely or never contacted by 
hospitals [17].  
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There are many studies about the completeness of medication history at admission: It was shown 
that between 25% and 80% of medication lists had mistakes, depending on country, population and 
methodology [18-21]. With lower experience of the health care professional performing ananmesis 
and higher number of medicines, there was an increasing risk for discrepancies [21]. However, 
many discrepancies were not judged as harmful and the total number of discrepancies is therefore 
not a valid indicator for harm [18]. MedRec is a systematic procedure to collect and compare 
information on all medications a patient uses, especially at transitions of care.  
If the hospital contacts the community pharmacists in order to complete medication lists, the lists 
showed higher completeness scores than without this contact [22]. In a survey about clinical 
pharmacy in Switzerland, 13 of 44 hospitals reported regular MedRec activities at admission [23]. 
Pharmacists are suitable to perform admission activities, as they achieved better medication 
histories than surgeons and anesthesists [24]. It can also be delegated to pharmacy technicians, 
who have proved to gain more complete medication histories than physicians [25]. A computerised 
physician order entry or a well defined algorithm may help to reduce discrepancies [21, 26]. It was 
also shown that MedRec at admission had an impact on discrepancies at discharge [27]. This may 
therefore be a promising strategy to optimise care more sustainably, however it can be time-
consuming [18]. 
5.3 Hospital stay 
After the admission procedures, the patient’s pre-existing medication usually has to be adapted to 
the hospital’s formulary. Switching of medication is inherently error-prone [24]. Whether the changes 
and their reasons are documented within the patients’ records is dependent on the staff involved. In 
a pilot study on the orthopaedic ward of the KSB, changes due to hospital formulary were supported 
and documented. It enabled cost-effective therapy and higher nurse satisfaction [28]. Interestingly, in 
cantons without self-dispensing, changes during hospitalisation were less likely [14]. If the patient 
uses their own medication, switching is not needed and this ensures medication continuity and cost 
savings for the hospital [15]. However, hospitals should not rely on patients’ own medication, as they 
are remunerated for complete patient care, and as their use may also result in duplication if 
additionally administred by the staff and taken by the patient [29]. 
If patients are transferred to other wards (in-hospital transitions), information transfer is important. It 
was shown that much of this information was handed over by telephone [30]. But telephone calls, or 
other oral communication, leads to information loss. Furthermore, written handovers showed 
significant differences in their information content [31]. But when more information was available, in-




Many health care professionals are involved in patient care on the wards. Of the hospitals that offer 
at least some clinical pharmacy services (75%), most conduct weekly ward rounds [23]. 
Interestingly, clinical pharmacy was more widely implemented in cantons without self-dispensing. 
Medication reviews are performed in half of surveyed hospitals [23]. It was shown that medication 
reviews helped to identify and reduce DRPs (see page 26) [32, 33]. In a French study, clinical 
pharmacists analysed medications and aimed to identify DRPs and solve them with a PI [34]. In 100 
analysed medications, a mean of 4.66 PIs were needed.  
5.4 Hospital discharge  
Discharge planning 
In acute care settings in Switzerland, patients were discharged after an average of 5.6 days [13]. 
After introduction of diagnosis related group remuneration regulations (DRG), hospitals are thought 
to have an interest to limit the length of stay (LOS) and shift more treatments to the ambulatory 
setting. In fact, the LOS has been lowering since introduction of DRG, but the Swiss Health 
Observatory found no clear causality [35].  
Discharge has to be planned in advance, this responsibility falling to the resident ward physician. In 
the KSB, physicians are supported by care managers [36]. They focus on high-risk patients and 
organise rehabilitation, follow-up GP visits or medication supply by the patient’s pharmacy. Internal 
hospital processes do sometimes not allow timely planning of discharge dates and patients are 
frequently discharged quite spontaneously. Some checklists were designed to help early and 
structured discharge planning, for example in the USA [37]. 
Discharge documents 
Short summaries, the prescription and sometimes a medication chart are provided when the patient 
is discharged. Discharge information is written by the resident physician, who is supported and 
supervised by a senior ward physician. The detailed discharge summaries are directly provided to 
the GP by electronic or postal delivery when the patient is back at home. At present, due to data 
safety concerns, discharge summaries are only provided to GPs in Switzerland. They are not sent to 
home care nurses or pharmacists.  
A literature review showed that the summaries were not available within a reasonable timeframe 
[38]. This unavailability affected 12-34% of the patient’s first GP visit after discharge. Furthermore, in 
2-40% of the transferred documents, information about discharge medication was missing [38]. The 
importance of information content in addition to timely transfer, has been known for some time [39]. 
However, in a recent study performed in Zurich, GPs continue to complain about the low quality of 
discharge summaries [40]. In AG, new platforms allow immediate transfer of discharge documents 
between the hospital and GP practice [41]. But it depends on in-house standard procedures as to 
how fast these documents are uploaded. 
A MC can be provided to patients to enable a good overview of their updated treament regimen. 
These MCs are designed by health care professionals, and patients are rarely involved. They are 
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most often simple tabular MCs or are sometimes illustrated. Individual MCs have been tested for 
their comprehensibility and for the patients’ satisfaction with design and content [11, 42, 43]. MCs 
with illustrations may enhance understanding for patients with low health literacy [42]. Health literacy 
(HL, german Gesundheitskompetenz, GK) is defined as the competence to retreive, understand and 
apply health-related information [44]. To our knowledge, there are no studies so far generally 
evaluating the design and content of charts in comparison to each other. Furthermore, the 
comprehensibility of dosing instructions used in Swiss hospitals is unknown.  
The prescription allows the patient to obtain needed medicines in the community pharmacy. Writing 
the prescription is the responsibility of the ward resident physician. MedRec between the best 
possible medication history from admission and the updated medication list during the hospital stay 
is very important to write correct and reliable prescriptions. A study from the Netherlands showed 
that 31 of 223 discrepancies occurring within 30 days of a hospital stay had their origin in discharge 
documents [45]. Discrepancies between discharge documents (summary, prescription and 
medication list) were a problem in 73% of discharges. Through MedRec, discrepancies can be 
reduced [46]. Kwan et al. suggested, however, that MedRec is not sufficient to protect patients from 
poor health outcomes, as most of the discrepancies were not significant [47]. This is supported by a 
literature review that found no impact of MedRec on health care utilisation [48]. But when only 
focusing on medication-related readmissions and emergency department visits instead of general 
health care utilisation, an effect could be seen [49]. Furthermore, potentially preventable adverse 
drug events (ADEs) were reduced [48, 50]. Irrespective of patient harm, economic benefits also 
drive actions in medicine. A study team simulated a MedRec model to obtain knowledge of its 
economic value [51]. They found that MedRec can have a net economic value, even higher if the 
service focussed on high risk patients only.  
Counselling 
Together with handing over the documents at discharge, physicians usually counsel patients and/or 
their relatives. The quality of this counselling session depend on different standard procedures, 
individual priorities and time constraints. In a paper called “Seamless care? Just a list would have 
helped! […]”, Knight et al. found that many patients and relatives complained about poor counselling 
quality [52]. They experienced a lack of competent staff, or any staff at all to counsel them. Patients 
felt dismissed from hospital without any good information about how to proceed further, or which 
treatments to take. It was found that patients need basic information about medication, indications or 
alternative treatments [53]. Information about side effects was desired at discharge, but moreso 
when patients were already back home [54]. 73% of patients knew the indication of their medicines 
after discharge, but many were found to be unaware of side effects or the correct medication 
regimens [55]. There were different findings about the correlation of this knowledge with age or 
education [55, 56]. Knowledge was, however, clearly influenced by previous counselling at 
discharge: Counselling (combined with or without other services) at discharge has shown an 
increase in knowledge, especially in elderly polymedicated patients [56, 57]. Medication adherence 
of counselled patients was enhanced [58]. Interestingly, non-adherent patients benefitted more 
  
25 
through counselling with respect to their later health care utilisation than adherent patients [59]. 
Adherent patients who were counselled used more health care facilities due to side-effects than their 
non-counselled controls.  
Counselling seemed to have an effect in reducing ADEs and readmissions [60]. The rate of patients, 
affected by preventable ADEs within 30 days after discharge, could be reduced through counselling 
from 11% to 1% [50]. Health care utilisation (hospital readmission and visits to the emergency 
department) was reduced in several studies: There were studies showing an effect in high-risk 
patients, e.g. with low literacy, in the elderly or polymedicated patients [57, 58, 61, 62]. Many authors 
sequentially combined services such as counselling, MCs, supply, MedRec or follow-up calls [61-
64]. It therefore seems obvious that many studies used extensive pharmacist ressources for their 
services. It is questionable if these services are cost-effective. A study showed no overall cost 
savings through discharge counselling [65]. But a more in-depth analysis was able to prove that in 
high-risk patients, this service could save money overall. It is therefore important to carefully select 
patients.  
It is not known how counselling in Swiss hospitals is performed at discharge, and if the counselling 
meets the patients’ needs. It is unclear if this counselling is sufficient to ensure patients’ knowledge 
about indications and medication changes.  
5.5 At the community pharmacy 
Counselling 
When patients fill their prescription in the community pharmacy, counselling can be performed there 
[60]. There is not as broad evidence for this, as compared to counselling performed by clinical or 
hospital pharmacists before discharge. One study evaluated counselling by community pharmacists 
at patients’ homes [66]. It was seen that through home counselling, the pharmacist was able to 
dispose of redundant medication packages, and the costs for mediacations were reduced. Standard 
counselling in Swiss community pharmacies was evaluated by an observational study, but not 
explicitly for recently discharged patients [67]. Of all encounters observed, 66% of patients were 
counselled on approximatly three subjects. There was a trend that new prescriptions and unknown 
or elderly clients were counselled more. This was also the case when carers obtained medication. 
However, high variability of the counselling effort was found between individual staff and also 
between pharmacies.  
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Discharge prescription filling 
It may be that a hospital has its own public pharmacy. In this case, patients can obtain medication 
directly after discharge. In a study of cardiovascular patients in the USA, 9.4% of all discharge 
prescriptions were not filled [68]. Risk factors associated with low filling rates were living alone, 
having  more than 10 medicines or a having a low income. If patients wish to fill their prescription 
immediately after discharge, availability of needed products depends on pharmacy stock and 
delivery modalities. A survey in the USA found that many parents failed to fill their child’s 
prescription within 24 or 48 hours post-discharge [69]. Even lower filling percentages were reached if 
compounding products have been prescribed [69]. This can lead to gaps of medical treatment. 
Depending on the indication, therapy gaps should be avoided, especially in the case of antiinfective 
or antithrombotic treatment. A study in newly stented patients showed that late filling of clopidogrel 
prescriptions correlated with harmful outcomes [70]. It is unclear how much of the adult Swiss 
population experiences supply problems or therapy gaps after discharge. 
Drug related problems 
"A Drug-Related Problem is an event or circumstance involving drug therapy that actually or 
potentially interferes with desired health outcomes" [71]. The prevalence range of DRPs identified by 
community pharmacists when filling discharge prescriptions was 18.4% to 63.7% [72-77]. It has to 
be considered that different definitions of DRPs, as well as different methodologies and settings, 
may have influenced these numbers. In one study, interestingly, the availability of MCs was 
associated with a higher detection rate of DRPs [77]. Unfortunately, 69% of patients received a MC, 
but did not bring it to their community pharmacy. In the KSB, internal medicine wards provide MCs to 
all discharged patients, however, in surgical wards, for example, no charts are distributed.  
A good method to detect DRPs in ambulatory care are medication reviews. According to the 
Pharmaceutical Care Network Europe statement, review types 1, 2A, 2B and 3 are applicable [78]. 
The type of review depends on the available information and can therefore reveal different DRPs 
(Table 1). In Swiss pharmacies, there seems to exist relevant barriers to conduct reviews [79]. 
Although the polymedication check is payed by health insurers if a patient has taken more than 4 








Needed information Revealed DRPs 
Simple  
(Type 1) 
Medication history in the pharmacy Drug interactions, some side-effects, unusual 
dosages, some adherence issues 
Intermediate  
(Type 2A) 
Additionally to type 1: patient 
information 
Additionally to type 1: other side-effects and 
adherence issues, drug-food interactions, 
effectiveness issues, side effects, problems 
with over the counter drugs (OTC) 
Intermediate  
(Type 2B) 
Additionally to type 1: medical 
information, e.g. from the GP or 
hospital 
Additionally to type 1: adherence issues, 
drug-food interactions, effectiveness issues, 




All combined information from types 
1, 2A and 2B 
All combined DRPs from types 1, 2A and 2B 
 
DRPs can be categorised to estimate their prevalence and the quality of care provided. Different 
tools for this categorisation are available, the GSASA-Tool for the Swiss inpatient setting [81] or the 
pharmDISC tool for Swiss community pharmacies [82]. The two latter systems are intervention-
oriented tools, as significant DRPs are followed by a PI. PIs may be any sort of action that the health 
care professional takes to solve the DRP. Calculated per prescribed item, 6.4% to 20% of items 
were associated with a DRP and required a PI [83, 84]. To assess the significance of these PIs for 
the patient or health care system, other tools are available, e.g. the CLEOde system which classifies 
clinical, economical and organisational significance [85].  
In a Swiss study, clinical reasons were responsible for 56.3% of all PIs [67]. Technical (bureaucratic, 
supply, funding) reasons caused 43.7% of PIs. A study from New Zealand confirmed that technical 
causes are important, as these PIs needed the most time spent by community pharmacy staff [84]. 
To solve these DRPs, a contact to the prescriber often has to be established. However, these 
numbers differ significantly. In a European study, a contact had to be established in 26.2% of cases 
[75], whilst in a study from the French speaking part of Switzerland, there were even 4.8 DRPs per 
patient needing a contact [18]. In a observational study in the general population in German 
speaking Switzerland, only 0.9 physician contacts per prescription were counted [67]. These 
differences might be due to population, methods, as well as due to differing discharge processes.  
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Undetected or unsolved DRPs may result in ADE. As not all DRPs result in such an event, they are 
sometimes classified as potential DRPs. An ADE may be an inefficacy of a treatment due to an 
interaction or handling problems, or side effects through a overdose. These ADEs are possibly 
preventable. To detect DRPs, perform PIs and establish contact to the prescriber, a lot of time is 
needed. It is, to date, unknown if Swiss community pharmacists are satisfied with the processes at 
discharge, and how much time they invest to care for their patients. Furthermore, it is unknown what 
role pharmacists fulfill. The International Pharmaceutical Federation (FIP) and the World Health 
Organisation (WHO) together defined roles of a community pharmacist in the Guidelines on Good 
Pharmacy Practice (Table 2) [86]. They suggest in Role 2 that the community pharmacist should 
manage a patient’s therapy. It would be interesting to know if Swiss pharmacists accomplish these 
roles satisfyingly. This has to be put in context within the costly, presumably good health care 
system and the low density of pharmacies in Switzerland. 
 
Table 2: Roles of a community pharmacist. The roles of a community pharmacist defined by the Guideline 
on Good Pharmacy Practice, adapted from [86] 
Role 1: Prepare, obtain, store, secure, distribute, administer, dispense and dispose of medical products  
Role 2: Provide effective medication therapy management (distinct service or group of services that optimise 
therapeutic outcomes for individual patients. Medication therapy management services are independent of, but 
can occur in conjunction with, the provision of a medication product) 
Role 3: Maintain and improve professional performance 
Role 4: Contribute to improve effectiveness of the health-care system and public health 
 
Discharge communication to community pharmacists 
As discussed previously, MedRec, detection of DRPs and counselling make up a big part of the 
pharmacist’s work. Community pharmacists are obliged by law to counsel patients and check 
prescriptions. But checking, for example, the suitable dosage of a renally excreted medication is 
impossible without knowing the patient’s current renal function. To fulfill all these roles, the 
pharmacist needs information about the discharged patient and their medication [86]. In a survey in 
the United Kingdom (UK), 32.5% of pharmacists stated that they have never seen a discharge 
summary [87]. Pharmacists lacked the information needed to counsel and dispense to recently 
discharged patients, and complained especially about inconsistent practices [88, 89]. Patients for 
whom the most information was available were those with dosing aids [89]. 55.8% of interviewed 
English pharmacists and 83.3% of interviewed Belgian pharmacists stated that enhanced 
information transfer would enable continuity of care [57, 90]. These information needs were very 
comparable to the needs of GPs in a study in the UK [39]. However, this could have changed since 
the publication of the paper (1997). Desired information items were primarily updated medication 
lists, special patient needs, medication at admission, clinical problems, or relevant laboratory data 
[87]. Also new and discontinued medication, with reasons for therapy changes, were desired [39, 
91]. These details allow health care professionals to continue the care which was started at the 
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hospital. However, if these details are not present in the documents, and if patients are not aware of 
the changes in their treatment, they are at risk for medication errors and therefore at risk for further 
health impairment.  
There have been different strategies to overcome this information defecit. Studies tested 
collaboration between pharmacists, or the provision of handovers. Communication between 
hospital/clinical and community pharmacists could optimise information transfer after discharge, as a 
Dutch study proved [92]. Pharmacists had many problems in reaching the prescriber for questions 
about the prescription. Within the hospital, it seems easier to reach intern colleagues than it is for 
external professionals. Furthermore, hospital pharmacists sometimes have access to electronic 
patient records to answer the questions themselves.  
In an Irish study, a hospital-based liaison pharmacist listed all medication changes and faxed this 
document to the GP and to the patient’s community pharmacy [19]. Discrepancies in the patients’ 
medication were reduced. In a comparable study in the UK, an updated medication sheet was faxed 
to the same health care professionals [93]. The usefulness of this intervention was approved by 80% 
of GPs and 100% of community pharmacists. Further initiatives were tested for hemodialysis 
patients, where the hospital sent a lot of background information about medication to avoid, correct 
antibiotic dosage or an updated medication list [94]. This service showed very high acceptance 
among GPs and pharmacists. But this extensive information transfer seems unfeasible in daily 
practice for a more general population. This was confirmed in a broad population with at least one 
medication change during hospitalisation, where writing of a discharge form by the pharmacist in a 
project setting already required 25 minutes [90]. One-third of pharmacists agreed that early 
information transfer could help to order all required medication. In the case of late transfer, 
medication ordering and the counselling of patients can be impaired.  
The information transfer in many projects was done by fax [19, 93, 94]. In a prospective study 
evaluating different transfer methods to GPs, email was the most successful (73.9% reached the 
GP) [95]. Fax was also successful (69.4%) and was the most preferred method for GPs. Postal 
delivery and patient hand delivery were insufficient. In Swiss community pharmacies, electronic 
communication is not well established [2], and the fax is still an important communication method, so 
these results may be applied to this setting.  
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5.6 Optimisation of hospital discharge 
There are several strategies to optimise discharge, as the literature overview so far demonstrated. 
But more generally, different aspects of an optimisation strategy have to be taken into account. 
- First, Hesselink et al. proposed to combine 1) well-coordinated care, 2) discharge 
information (content), and 3) communication of discharge information, to successfully 
optimise hospital discharge [96]. The third point “communication” is divided into time point 
and transfer. The well-coordinated care was already studied and implemented in the KSB by 
a care management study [36], leaving the information and communication as a focus.  
- A second strategy can be that optimisation focuses rather on process measures than clinical 
outcomes to evaluate improvement [97]. Many studies use these measures, for example 
number and type of medication discrepancies [60]. They are more independent of the 
patient’s health status and are useful to evaluate discharge processes.  
- A third important strategy is to decide between studies assessing efficacy or effectiveness. A 
more scientific approach with a highly selected population, well-educated staff and strict 
procedures can be chosen [98, 99]. In this sort of studies, the efficacy of a service in an 
ideal setting is evaluated. In contrast, a pragmatic approach is appropriate if the 
effectiveness of a service should be shown. These trials can prove if a service works in 
practice, where a broader population is targeted, procedures are flexible and the patient is 
treated under real-life conditions. These types of studies estimate what effect can be 
expected after the implementation of a service. If an intervention study is planned, it is 




- The Medical Research Council (MRC) updated its guidance on the development and 
evaluation of complex interventions in 2008 [100]. The guidance suggests to follow four key 
elements to develop and evaluate services (interventions) in a circular way. They are 
development, feasibility and piloting, evaluation, implementation (Figure 3). In the 
development phase, evidence should be gained on the topic, and the processes and 
outcomes of the service should be modelled to have a preliminary study design. The 
feasibility “should examine the key uncertainties” that exist in this design [100]. Criteria can 
be defined to judge if the feasibility needs are met. With the gained knowledge, the service 
can further be evaluated for effectiveness and may later be implemented. 
 
 
Figure 3: Development and evaluation of complex interventions. The Medical Research Council guidance 
suggests to develop and evaluate interventions with this circular model, adapted from [100] 
 
- A similar approach was also described by Reinertsen et al. (Figure 4) [101]. The authors 
suggest not just to design a service in the conference rooms, but to test and modify the 
ideas very early and repetitively. 
 
 




5.7 Thesis approach 
Research gaps 
To summarise, the following research gaps exist: In Switzerland, it is not known what adult patients 
experience at hospital discharge concerning their medication. Studies from other countries indicate 
that there are insufficiencies in supply. Furthermore, it is unknown if counselling (given instructions) 
meets the patients’ needs in terms of quantity and quality. It was shown in international studies that 
the use of MCs helps patients to understand their therapy and adhere to the prescribed dosing 
regimens. It was also shown that for patients with low health literacy, the use of illustrated MCs in 
very easy language is favourable. It does remain unknown if standard MCs meet the patients’ 
needs, and whether they understand them. 
The second research gap concerns community pharmacists. As the Swiss health care system, partly 
with self-dispensing by GPs, is very different to other countries, and international data cannot be 
transferred. It is unknown if Swiss community pharmacists encounter the same obstacles described 
in international literature, and if information needs are comparable.  
As discussed before, there are already studies trying to optimise information transfer from hospital to 
community pharmacies. They showed promising results on different outcomes, but there are still 
some conflicting findings. Irrespective of the outcome, many studies use extensive pharmacist 
resources. We therefore doubt that such services, many with only slight benefit, will ever be 
implemented.  
 
Goal and aims 
The overall goal of this thesis was to optimise care of discharged patients by a newly developed 
pragmatic in-hospital service at discharge. Three different aims helped to reach the goal: 
- Aim A: To assess views of discharged patients about challenges and optimisation strategies 
- Aim B: To assess views of community pharmacists about challenges and optimisation 
strategies 
- Aim C: To develop, and assess the feasibility and effectiveness of a pragmatic in-hospital 





In Figure 5, the health care context in which the Projects A, B and C take place and the processes 
targeted by these projects are shown.   
 
 
Figure 5: Targeted health processes in this thesis. The health care context of the thesis with the targeted 





To reach the goal and the three aims of this thesis, we chose to follow the MRC approach with the 
four step approach development, feasibility and piloting, evaluation, and implementation [100]. The 
approach was adapted to our project and is presented in Figure 6. We started with the development 
of a preliminary study design (blue arrow). The final step, however, the implementation was not one 
of our aims.  
 
Figure 6: Methodical approach used in this thesis. The approach starts with the blue arrow and follows the 





In the following boxes, the Projects A, B and C are shortly described with the according publications 
or work reports.  
 
Project A: Patients’ views of hospital discharge 
In Project A, we aimed to evaluate problems that evolve from patients’ viewpoints when they are 
discharged from hospital, to gain evidence for the development for a discharge service. Discharge 
counselling may be done with the help of a medication chart. We focused on this document in 
Project A1 and assessed its comprehensibility. Furthermore, it was of interest whether the charts 
met the patients’ needs by means of design and content. As a second more general focus for 
Project A2, we aimed to investigate the instructions given at discharge and what knowledge 
patients have (A2.1). After patients are discharged, they have to fill their discharge prescription in a 
community pharmacy. Therefore, we additionally aimed to investigate what problems they 
encounter when obtaining the prescribed discharge medication (A2.2). As a last Project (A2.3), 
patients’ views about the discharge process were evaluated and possible optimisation strategies 
were discussed.  
A1: Comprehensibility and Presentation of Medication Charts: Considering Patients’ Views 
Original research publication, in German 
Brühwiler LD, Schönenberg ST, Hersberger KE, Lutters M. Praxis 2016; 105 (21): 1249–1254 
A2: A2. Observational study on patient problems regarding medication instruction and 
supply after hospital discharge 
Work report  
A2.1 Medication instruction 
A2.2 Medication supply  
A2.3 Discharge process optimisation  
 
Project B: Community pharmacists’ views of hospital discharge 
As a comparison to the patients’ views, it was an aim to assess views of community pharmacists. 
They fill discharge prescriptions and are often the first health care professionals encountered by the 
discharged patient. This Project B added knowledge to Project A, in order to gain knowledge on 
how to develop a discharge service. 
B: Hospital discharge – What are the problems, information needs and objectives of 
community pharmacists? A mixed method approach 





KE, Lutters M. Pharmacy Practice 2017 Jul-Sep;15(3):1046. 
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Project C: Optimising hospital discharge by the POMMES service 
Based on the evidence obtained in Project A and B, a preliminary study design for a service to 
optimise hospital discharge was developed. After the development, a three step approach was 
chosen: First, a list of key uncertainties and criteria for the preliminary study design was completed, 
which helped to test the feasibility (C1). The results of the feasbility testing were evaluated and the 
preliminary study design was adapted according to gained knowledge. The final study design of the 
POMMES study (Pharmazeutische Optimierung des Medikamenten Managements nach 
Entlassung aus dem Spital, engl. Pharmaceutical Optimisation of the Medication Management after 
dischargE from hoSpital) was developed. The pragmatic in-hospital service was tested in a RCT for 
feasibility and effectiveness (C2). As a third step after the study, interviews were conducted with 
samples of involved resident physicians and pharmacists. Within the interviews it was aimed to 
evaluate the study success and collect ideas for further optimisation (C3).  
C1: Development and feasibility testing of a preliminary POMMES study design 
Work report 
C2: A RCT evaluating a pragmatic in-hospital service to increase the quality of discharge 
prescriptions 
Original research report 
Brühwiler LD , Beeler PE, Böni F, Giger R, Wiedemeier PG, Hersberger KE, Lutters M 
Submitted to the International Journal for Quality in Health Care, january 2018 
C3: Evaluation of the POMMES-Study through interviews with resident physicians and 
community pharmacists involved 






In Project A, the patient’s views of hospital discharge were assessed. Combined with the findings of 
Project B, the results helped to develop a preliminary study design (Figure 7). 
 
 
Figure 7: Overview of thesis approach, Project A 
 
  
A. Patients’ views of hospital discharge 
38 
A1. Comprehensibility and presentation of medication charts: 
Considering patient’s views? 
 
Verständlichkeit und Darstellung von Medikationsplänen:  
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9.1.2 Study development flow chart  
9.1.3 Systematic comparison of different medication charts 
9.1.4 Literature search results: Screening tool for health literacy 
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9.1.6 Script focus group 
9.1.7 Interview guide 
 
Kernaussagen 
- In Medikationsplänen genutzte Abkürzungen wie "Mo" für Morgen oder „ML“ für Messlöffel 
können missverständlich sein. 
- Beim Einnahmehinweis „nüchtern“ ist der einzuhaltende Abstand zu den Mahlzeiten für 
Patienten unklar.  
- Reservedosierungen sollen so deutlich wie möglich ausformuliert werden.  
- Das Verständnis eines Medikationsplans ist individuell unterschiedlich und soll mit einer 
mündlichen Instruktion unterstützt werden. 
- Die von Fachpersonen entwickelten Pläne entsprechen den Bedürfnissen der Patienten nicht in 
allen gestalterischen und inhaltlichen Aspekten. 
 
Schlüsselwörter 
Medikationsplan – medication chart 
Verständlichkeit – comprehensibility 
Patienteninterview – patient interview 
Dosierungsanweisung – dosing instruction 




Introduction: Patients leaving hospital often have to continue their treatments without help. It is 
therefore most important to provide all necessary information adapted to the patient’s health literacy. 
One possibility is that hospitals give written information, for example medication charts (MC, syn. 
medication plan, medication card). So far it is unknown how these medication charts differ from 
hospital to hospital and if they meet the patient’s needs and wishes.  
Methods: Through literature search and personal contacts established MCs were identified and 
compared regarding content and format. In a focus group with different hospital staff these MCs 
were then evaluated. Four MCs were chosen for a following interview. For this structured survey 
patients from internal medicine, surgery and dialysis wards of the cantonal hospital of Baden 
(Switzerland) were recruited during three weeks. The aim of the survey was the evaluation of 
comprehensibility and patient’s preferences for MCs.  
Results: All nine evaluated MCs contained brand name, strength, dosage form and a dosing 
scheme. The indication was mentioned in 5 out of 9, the duration of treatment in 3 out of 9 MC. Most 
of the hospital staff (3 out of 5) chose the “eMediplan” (“Brennpunkte Gesundheit Thurgau”, 
Switzerland) as their favourite MC. 45 (67.6 ± 12.0 years, 40% female) out of 206 patients were 
interviewed. 24.4% misinterpreted the abbreviation „Mo“ for the german word for morning (“Morgen”) 
as Monday. 55.6% interpreted the abbreviation „Na“ (night, german = “Nacht”) correctly as before 
going to bed, 24.4% would take the medication during the night or in the afternoon instead. The 
maximum daily dose for the intake instruction „3x/d 1 tablet“ was correctly interpreted by 82.2% of all 
participants. 42.2% interpreted correctly the intake instruction „max. 2 tablets max. 4x/24h“. 36 of 45 
interviewees interpreted the expression „on empty stomach“ (the german word means the same as 
sober) as medication intake without food. 2 subjects would take the tablet one hour before meal. The 
dosing instruction “3 ML” (ML = “Messlöffel”, measuring spoon) was properly understood by 24.4%, 
57.8% decoded it as 3 milliliter. In case of the prescription of a solution in milligrams, 20.0% of the 
participants were able to calculate the needed milliliters. There was a preference towards the use of 
“1/2” instead of “0.5” for half tablets. The interviewees preferred brand names in the first column 
(p<0.001), however in many MCs active compounds are mentioned first. “eMediplan” and “AMTS-
Apothekenplan” (“AMTS-Aktionsplan”, Germany) are possibly more clearly representing the content 
than other MCs (14 and 13 out of 45 probands, p=0.605). There was a trend to “eMediplan” being 
the favourite MC (p=0.169).  
Discussion & Conclusion: Medication charts used in daily practice differ in their content and 
graphic aspects. Patients’ views of the most suitable medication chart are not the same as those of 
health care professionals. For patients, many dosing instructions were difficult to understand. This 
could potentially lead to a lower effect or to side effects of the therapy when not noticed by health 
professionals. These study results are not only applicable for medication charts but also for patient 
education and instructions on medication packages. Through consideration of a suitable format and 




Hintergrund: Patienten nehmen ihre Medikamente nach einem Krankenhausaufenthalt oft 
selbständig ein. Die dafür erforderlichen Therapieanweisungen werden üblicherweise in Form eines 
Medikationsplans abgegeben. Unklar ist bisher, ob Patienten diese verstehen und wie gut die Pläne 
ihren Bedürfnissen entsprechen.  
Methode: Patienten des Kantonsspitals Baden wurden fiktive Tabellen mit Therapieanweisungen 
und vier deutschsprachige Medikationspläne vorgelegt. Die Verständlichkeit der Anweisungen sowie 
gestalterische und inhaltliche Wünsche der Patienten an einen Medikationsplan wurden in 
strukturierten Interviews untersucht. 
Ergebnisse: In Interviews mit 45 Patienten (67.6±12.0 Jahre) interpretierten 73% der Patienten die 
Abkürzung „Mo“ korrekt als Morgen und 24% fälschlicherweise als Montag. „Na“ für „auf die 
Nacht“ war für 56% verständlich, während 11% der Patienten das Medikament nachmittags 
angewendet hätten. Die maximale Tagesdosis wurde bei der Dosierungsanweisung „max. 2 Stk. 
max. 4x/24h“ von 42% korrekt gedeutet. „Nüchtern“ verstanden 80% der Patienten richtig als eine 
Einnahme ohne Essen. Die Abkürzung „3ML“ für Messlöffel war für 24% verständlich. 
In Medikationsplänen wünschten sich 91% der Patienten an erster Stelle den Medikamentennamen 
(p<0.001), wohingegen in bestehenden Medikationsplänen oft der Wirkstoff priorisiert wird. Die 
Zusammenfassung mehrerer Informationen pro Spalte wurde von 62% gewünscht. 
Schlussfolgerungen: Medikationspläne, insbesondere Abkürzungen und Reserveschemata sind 





Ein Aufenthalt im Krankenhaus ist oft mit Therapieänderungen verbunden und nach Austritt ist der 
Patient meistens wieder selber für die korrekte Anwendung der Medikamente verantwortlich [102]. 
Mangelndes Verständnis der Instruktionen kann zu Diskrepanzen und verminderter Adhärenz führen 
[74, 103]. Eine patientengerechte, verständliche Information ist deshalb unumgänglich und kann in 
schriftlicher Form, zum Beispiel als Medikationsplan (MP) verfasst werden [43, 52, 102, 104, 105]. 
Diverse Projekte im deutsch- und englischsprachigen Raum messen dem MP grosses Potential zu, 
und verschiedene Ausführungen wurden entworfen [43, 106-108]. Diese setzen sich immer aus 
einer Tabelle und zusätzlichen Informationen zusammen, unterscheiden sich jedoch in grafischen 
und inhaltlichen Aspekten. 
Damit die Therapieanweisungen verstanden und korrekt umgesetzt werden können, müssen diese 
insbesondere für Menschen mit verminderter kognitiver Fähigkeit oder funktionaler 
Gesundheitskompetenz verständlich formuliert sein [43, 109, 110]. Die Gesundheitskompetenz setzt 
sich aus grundlegenden Lese- und Schreibfertigkeiten zusammen, um einfache 
Gesundheitsinformationen zu verstehen [44]. Schwierigkeiten können zum Beispiel 
Dosierungsanweisungen wie „3x täglich“ oder „alle 12 Stunden“ bereiten. Deshalb wurden 
Empfehlungen ausgearbeitet, um solche Formulierungen zu vereinfachen [109, 111]. Der „Universal 
Medication Schedule“ empfiehlt explizite Anweisungen mit Tageszeiten anstelle von Frequenzen 
oder Zeitabständen [112]. Ebenfalls können Piktogramme die Verständlichkeit unterstützen [113].  
Häufig werden MPs von Fachpersonen entworfen und für den Patienten ausgefüllt. Dieser wird bei 
der Gestaltung kaum involviert und es ist unklar, ob die etablierten MPs die Bedürfnisse der Nutzer 
erfüllen. Unklar ist ebenfalls, wie gut Formulierungen in MPs verstanden werden.  
Zielsetzungen und Fragestellungen 
Die primären Ziele waren die Untersuchung der Verständlichkeit von tabellarischen 
Therapieanweisungen und die Erhebung von Patientenwünschen. Als sekundäres Ziel wurde die 





Die Vorgehensweise umfasste folgende Schritte: Mittels Literaturrecherche wurden MPs gesucht. 
Eine Fokusgruppe selektierte diese nach verschiedenen Kriterien für die anschliessenden 
Patienteninterviews. Die Studie wurde von der zuständigen Ethikkommission als unbedenklich 
eingestuft.  
Literaturrecherche 
In Medline, Fachzeitschriften, Kongressbeiträgen und Google wurden mit den Suchbegriffen 
„medication plan/card/chart/regimen/schedule“, „drug/pill card“, „treatment plan“, respektive 
„Medikationsplan/-karte“, „Medikamenten-/Medi-/Therapieplan“, „Medikamenten-
/Dosierungskarte“ nach MPs gesucht. Zusätzlich wurden die Referenzen relevanter Publikationen 
geprüft. Ausgeschlossen wurden Beilagen zu Dosierhilfen, MPs für spezielle Patientengruppen oder 
für Fachpersonen und durch Patienten auszufüllende MPs.  
Fokusgruppe 
Aus den gefundenen MPs wurden in einer Fokusgruppe vier Exemplare für ein Patienteninterview 
ausgewählt. Diese waren der MP des Studienkrankenhauses, der Favorit der Teilnehmer und zwei 
weitere im Konsens bestimmte, möglichst unterschiedliche MPs. Die Zahl wurde auf vier festgelegt, 
da diese beim Interview der Übersichtlichkeit halber auf einem DIN A2-Karton präsentiert wurden. 
Die Fokusgruppe wurde mit einem Arzt, einer Pflegeexpertin, einer Offizinapothekerin, einem 
Krankenhausapotheker und einer Care Managerin des Studienortes und nach einem vordefinierten 
Skript durchgeführt.  
 
Patienteninterview 
Das Patienteninterview gliederte sich in fünf Teile:  
1) Verständlichkeit von tabellarischen Therapieanweisungen: Sieben Anweisungen wurden in 
einfachen Tabellen (Word, Times New Roman, Schriftgrösse 14, Figure 8) dargestellt und 
den Patienten vorgelegt. Darin wurden risikoreiche Formulierungen und übliche 
Formulierungen aus dem MP des Studienkrankenhauses integriert. Es wurden fiktive 
Handelsnamen verwendet, um eine Beeinflussung durch bekannte Medikamente zu 
minimieren. Neben Dauertherapien wurden auch Reservemedikationen integriert. Es 
wurden offene Fragen gestellt, zum Beispiel „Wie würden Sie das Medikament 
einnehmen?“. Für Prinivol wurde die Menge und der Zeitpunkt der Einnahme erhoben, für 
Zegrid zusätzlich die Einnahmeregelmässigkeit. Die Reservetherapien (Motran, Actamen) 
wurden auf die Verständlichkeit der maximalen Tagesdosis und der Zeitabstände geprüft. 
Für Mucomyt und Unikom musste das Einnahmevolumen angegeben werden. 
2) Soziodemographische Daten und funktionale Gesundheitskompetenz mittels 6 Fragen (Q3, 
4, 9, 10, 14, 15) des HLS-EU-Q16 [114]. Die Fragen lauteten „Wie einfach ist es Ihrer 
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Meinung nach...“. Antworten konnten auf einer 4-stufigen Likert-Skala von 1=sehr schwierig 
bis 4=sehr einfach gegeben werden. 
3) Gewünschter Inhalt eines MPs zusätzlich zum Standardinhalt (gemäss Literaturrecherche: 
Medikamentenname, Stärke, Arzneiform, Menge und Häufigkeit der Anwendung): Diese 
Multiple Choice Frage wurde vom Patienten schriftlich beantwortet. Mehrfachnennungen 
waren möglich. 
4) Freie Anordnung von Spaltenüberschriften (Kärtchen mit den Bezeichnungen Medikament, 
Wirkstoff, Dosierung, Dauer, Grund, Hinweise) in eine leere Tabelle.  
5) Auswahl des übersichtlichsten und eines Favoritenplans aus den vier vorgelegten MPs.  
Der strukturierte Interviewleitfaden wurde mit fünf Laien und Fachpersonen pilotiert und angepasst. 
Die Befragung wurde am Kantonsspital Baden (Schweiz) während drei Wochen mit Patienten der 
Dialysestation, Chirurgie und inneren Medizin durchgeführt. Ausschlusskriterien waren 
Unmündigkeit, unzureichende Deutschkenntnisse, Seh- oder Hörbeeinträchtigung, 
Gesundheitszustand, welcher eine sinnhafte Kommunikation nicht zuliess (zum Beispiel Delir), 
Isolation, palliative Situation, nach Angaben von Arzt- oder Pflegedienst zu krank für eine 
Teilnahme. Alle Patienten erhielten eine schriftliche und mündliche Studieninformation und 
unterschrieben eine Einverständniserklärung.  
Medikamentenname Mo* Mi* Ab* Na* Hinweise 
Zegrid Kapseln 20mg 1 0 0 0  
Prinivol Tabletten 5mg 0 0 0 1/2  
Motran Filmtabletten 
600mg 
    In Reserve bei Schmerzen, 
max. 3x/d 1 Tablette einnehmen. 
Actamen Filmtabletten 
500mg 
    In Reserve bei Schmerzen,  
max. 2 Stk. max. 4x/24h einnehmen. 
Medikamentenname Morgen Mittag Abend Nacht Hinweise 
Mucomyt Sirup 200 
mg/5ml 
3 ML 0 0 0  
Unikom Lösung 10 
mg/ml 
0 0 0 10 mg  
Lipiton Kapseln 40mg 0 0 1 0 Einnahme nüchtern 
Figure 8: Medikationstabellen für das Patienteninterview. Therapieanweisungen wurden mit fiktiven 
Handelsnamen beschrieben. *Die Abkürzungen Mo, Mi, Ab, Na stehen für die Einnahmezeitpunkte Morgen, 




Die Datenanalyse wurde mit SPSS (IBM, Version 22.0) durchgeführt. Häufigkeiten wurden mit dem 
Chiquadrat-Test auf statistische Signifikanz überprüft. Die Korrelationen der Gesundheitskompetenz 
(Summe der Punkte der Likert-Skalen, maximal mögliche Punktzahl: 24) und des Alters mit der 
Verständlichkeit (prozentual zur möglichen Maximalpunktzahl) wurden mit dem Spearman 
Rangkorrelationskoeffizient berechnet.  
Ergebnisse 
Fokusgruppe 
Der Favorit der Fokusgruppenteilnehmer war der eMediplan (Brennpunkte Gesundheit Thurgau, CH, 
[106]). Neben dem vorgegebenen MP des Studienortes (Kantonsspital Baden, CH, internes 
Dokument) wurden der MP des Universitätsklinikums Heidelberg [43] und ein AMTS-Apothekenplan 
(Medikationsplan der AMTS-Initiative der Apothekerkammer Westfalen-Lippe, erhalten von Cornelia 
Schweizer, Apotheke im Facharztzentrum, Mersinweg 22, 33100 Paderborn, DE) aus Deutschland 
für das Interview ausgewählt. 
Verständlichkeit von Therapieanweisungen  
Von 95 eingeschlossenen Patienten lehnten 40 die Teilnahme ab. Die Charakteristika der 45 
befragten Patienten sind in Table 3 ersichtlich. Die Resultate zur Verständlichkeit sind in Table 4 
und Table 5 aufgeführt.  
 
Table 3: Patientencharakteristika  
 
 
Table 4: Interpretationen der tabellarischen Therapieanweisungen. Die korrekten Antworten sind mit 
einem * gekennzeichnet. Bei den Reservedosierungen von Mucomyt und Unikom wurden nur jene 
Probanden weiter nach dem Zeitpunkt befragt, welche die korrekte Tagesdosis angaben. 
 
 
Patienten (n=45) n (%) 
Alter [Jahre: Mittelwert ± SD] 67.6 ± 12.0 
Weiblich 18 (40) 
Tätigkeit im Gesundheitswesen  3 (7) 
Medikationsplan-Erfahrung 24 (53) 
Bildungsgrad  
Obligatorische Schule  5 (11) 
Allgemein- und Berufsbildung 20 (44) 
Höhere Berufsbildung 12 (27) 
Hochschulen  8 (18) 
Gesundheitskompetenz [Mittelwert ± SD] 19.8 ± 2.7 
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Antworten (n=45) n (%) 
Dosierungsanweisung zu Zegrid: „1“ im Feld „Mo“ 45 (100) 
Menge der Einnahme  
1 Kapsel* 44 (98) 
Keine Angabe 1 (2) 
Zeitpunkt der Einnahme  
Am Morgen* 33 (73) 
Am Montag 11 (24) 
Keine Angabe 1 (2) 
Regelmässigkeit der Einnahme  
Jeden Tag*  32 (71) 
Jede Woche  5 (11) 
Einmalig 6 (13) 
Keine Angabe 2 (4) 
Dosierungsanweisung zu Prinivol: „1/2“ im Feld „Na“ 45 (100) 
Menge der Einnahme  
Halbe Tablette* 41 (91) 
Keine Angabe 4 (9) 
Zeitpunkt der Einnahme  
Auf die Nacht /vor dem Schlafengehen* 25 (56) 
In der Nacht  6 (13) 
Am Nachmittag 5 (11) 
andere oder keine Angabe 9 (20) 
Dosierungsanweisung zu Motran: „max. 3x/d 1 Tablette“  45 (100) 
Tagesdosis der Einnahme  
Tagesdosis 3 Tabletten* 37 (82) 
andere oder keine Angabe 8 (18) 
Zeitpunkte der Einnahme (n=37)  
zu 3 unterschiedlichen Zeitpunkten* 23 
andere oder keine Angabe 14 
Dosierungsanweisung zu Actamen: „max. 2 Stk. max. 4x/24h“ 45 (100) 
Tagesdosis der Einnahme  
Tagesdosis 8 Tabletten* 19 (42) 
Tagesdosis 4 Tabletten 15 (33) 
Tagesdosis 2 Tabletten 4 (9) 
andere oder keine Angabe 7 (16) 
Zeitpunkte der Einnahme (n=19)  
zu 4 unterschiedlichen Zeitpunkten* 12 
andere oder keine Angabe 7 
Dosierungsanweisung zu Mucomyt: „3 ML“: Menge der Einnahme 45 (100) 
3 Messlöffel* 11 (24) 
3 Milliliter 26 (58) 
andere oder keine Angabe 8 (18) 
Dosierungsanweisung zu Unikom: „10 mg“: Menge der Einnahme 45 (100) 
1 Milliliter* 9 (20) 
10 Milliliter 20 (44) 




Insgesamt wurde zwischen der Gesundheitskompetenz (19.8 ± 2.7 Punkte) und dem Verständnis 
der Therapieanweisungen eine mittlere signifikante Korrelation (Korrelationskoeffizient 0.52, p < 
0.001) gefunden. Steigendes Alter ist mit einer abnehmenden Gesundheitskompetenz verbunden 
(Korrelationskoeffizient -0.383, p=0.009). 
 
Table 5: Interpretation der Anweisung „nüchtern“: Interpretation von nüchtern und des dazu nötigen 
Zeitabstandes. Der Zeitabstand wurde nur erfragt, wenn als Antwort „vor dem Nachtessen“ genannt wurde 
(n=26). Die korrekten Antworten sind mit einem * gekennzeichnet. 
Antworten (n=45) n (%) 
Antwort betreffend Nahrungsaufnahme* 36 (80) 
vor dem Nachtessen 26 (58) 
Zeitabstand 1 Stunde* 2 
Zeitabstand 1/2 Stunde 8 
Zeitabstand direkt vor dem Essen 13 
andere oder keine Antwort zum Zeitabstand 3 
Abend und nüchtern ist ein Widerspruch 5 (11) 
andere Antwort (z.B. nach dem Nachtessen nichts mehr essen) 5 (11) 
andere (nicht betreffend Nahrungsaufnahme) oder keine Antwort 9 (20) 
 
Gewünschter Inhalt und Darstellung 
Zusätzlich zu den Standardinhalten von MPs wurden folgende Tabelleninhalte am häufigsten 
gewünscht (135 Antworten von 45 Patienten): Einnahmehinweise (33 Nennungen), Therapiegrund 
(26), Therapiedauer (19), Wirkstoff (16) und Anwendungshinweise (15). Weitere Bedürfnisse waren 
Piktogramme, Medikamentenabbildungen oder Art und Name des Verschreibers (insgesamt 26). Ein 
Patient äusserte den Wunsch, dass die Einnahmeregelmässigkeit spezifiziert wird, zum Beispiel 
„Tägliche Einnahme". Die Wünsche waren individuell unterschiedlich. 
Bezüglich Spaltengliederung empfand es die Mehrheit der Patienten (62%, 28/45, p=0.101) 
übersichtlicher, mehrere Informationen in einer Spalte zusammengefasst, anstatt eine einzelne 
Information pro Spalte darzustellen.  
Mussten die Patienten Spaltenüberschriften horizontal anordnen, war der am häufigsten gewählte 
Inhalt für Position 1: Medikament (41/45, 91%), Position 2: Wirkstoff (19/45, 42%), Position 3: Grund 
(17/45, 38%), Position 4: Dosierung (16/45, 36%), Position 5: Hinweise (15/45, 33%), Position 6: 
Dauer (22/45, 49%). Die Unterschiede waren statistisch signifikant (p<0.001), ausser für die 
Hinweise. 
Aus den vier vorgelegten, etablierten Plänen wurden der eMediplan am häufigsten als 
übersichtlichster MP (31%, 14/45, p=0.605) und der AMTS-Apothekenplan am häufigsten als 




Verständlichkeit von Therapieanweisungen 
In der durchgeführten Studie wurden 45 Patienten zu MPs befragt. Bei allen Therapieanweisungen 
gab es Patienten, die den Inhalt nicht korrekt verstanden haben. Besonders Abkürzungen führten zu 
Missverständnissen. So wurden „Mo“ und „Na“ leicht als Montag respektive als Nachmittag oder 
nachts missverstanden. Diese Abkürzungen werden häufig aufgrund enger Platzverhältnisse 
verwendet. Folgen können eine falsche Einnahmeregelmässigkeit (wöchentlich oder einmalig statt 
täglich) oder ein falscher Einnahmezeitpunkt sein. Dies wiederum kann zu hohen oder zu niedrigen 
Plasmaspiegeln führen und die Wirkung beeinflussen. Kürzlich wurde der AMTS-Plan entsprechend 
angepasst und die Tageszeiten wie „Mo“ für Morgen ausgeschrieben [115]. Gemäss einer 
amerikanischen Studie werden Tageszeiten wie „Morgen“ besser verstanden als Uhrzeiten wie „8.00 
Uhr“ und sollen deshalb vorgezogen werden [109].  
Reservedosierungen können unterschiedlich beschrieben werden. Üblicherweise werden 
Einzeldosis, Häufigkeit oder Frequenz und allenfalls die maximale Tagesdosis genannt. Die 
Formulierung „max. 2 Stk. max. 4x/24h“ wird im Kantonsspital Baden bei Entlassung automatisch 
aus der stationären Reserveverordnung generiert und wurde deshalb so getestet. Die meisten 
Patienten verstanden die korrekte Tagesdosis bei beiden Reservetherapien, wobei die Formulierung 
„max. 3x/d 1 Tablette“ besser verständlich war. Dies könnte auf eine Ähnlichkeit mit dem 
mündlichen Sprachgebrauch hinweisen („Drei Mal pro Tag eine Tablette einnehmen.“). Der 
amerikanische „Universal Medication Schedule“ befürwortet numerische Mengenangaben ("3" statt 
"drei") zur Erhöhung der Verständlichkeit [112]. Es wird dabei aber von Freitext in Satz-Form 
ausgegangen, wofür in tabellarischen MPs kaum Platz ist. Deshalb sollten ausgeschriebene, jedoch 
kurze und explizite Anweisungen verwendet werden und nur eindeutige Begriffe wie "maximal" oder 
"bis" abgekürzt werden. Abkürzungen wie „x“, „/d“ oder „/24h“ sollten vermieden und durch „mal“, 
„pro Tag“ oder „pro 24 Stunden“ ersetzt werden. Die Reservedosierung könnte also 
folgendermassen formuliert werden: "Bei Schmerzen max. 4 mal täglich 1-2 Tabletten einnehmen". 
Eine Fehlinterpretation führte in unseren Patientenbefragungen nur zu potentiellen Unter-, aber nicht 
zu Überdosierungen, was je nach Indikationsgebiet unterschiedliche Konsequenzen haben kann. 
Von den meisten Patienten wurde korrekt erkannt, dass die Einzeldosen zu verschiedenen 
Tageszeiten einzunehmen sind. Es kann davon ausgegangen werden, dass die Tageszeiten mit den 
Mahlzeiten in Verbindung gebracht werden. Bei einer 6-stündlichen Einnahme, kann dies dem 
vorgesehenen Schema entsprechen (Frühstück, Mittagessen, Abendessen und vor dem Schlafen). 
Ist eine Medikation jedoch alle 8 Stunden einzunehmen, würde die Einnahme zu den Mahlzeiten zu 
einem Spiegelabfall zwischen Abendessen und Frühstück führen. Je nach Indikation, zum Beispiel 




Die Abkürzung „ML“ für Messlöffel wird oft aus Platzgründen verwendet. Dies wird leicht m it Milliliter 
verwechselt, wie die Resultate gezeigt haben. Ein geeigneter beiliegender Messlöffel in der 
Umverpackung hilft beim Verständnis und der Umsetzung der Dosierung. Flüssige Arzneimittel mit 
unterschiedlichen Konzentrationen werden im Krankenhaus häufig in Milligramm verordnet, um 
eindeutige Anweisungen zu gewährleisten. Pflegefachpersonen sind sich die Umrechnung von 
Milligramm in Volumina gewohnt, für die befragten Patienten war dies anspruchsvoll. Die Resultate 
zeigten, dass es zu einer 10-fachen Überdosierung kommen könnte. 
In der Medizin wird der Begriff „nüchtern“ verwendet, um eine Arzneimitteleinnahme mindestens 
eine Stunde vor oder mindestens zwei Stunden nach einer Mahlzeit zu beschreiben. 
Erstaunlicherweise interpretierten 80% aller Patienten die Anweisung korrekterweise als eine 
„Einnahme ohne Nahrung“. Niemand brachte den Begriff mit einer Alkoholkarenz in Verbindung. 
Allerdings war der einzuhaltende Abstand zum Essen unklar. Eine Einnahme direkt vor der 
Nahrungsmittelaufnahme war die häufigste Antwort. Dadurch kann es zu einer 
Wirkungsveränderung des Arzneimittels kommen, was den Therapieerfolg beispielsweise bei 
Schilddrüsenhormonen gefährden kann. Insbesondere bei einer Abenddosis kann der Begriff 
„nüchtern“ verwirrend sein. Diese Formulierung sollte daher nicht verwendet werden. Stattdessen 
sollten explizite Angaben wie „1 Stunde vor oder 2 Stunden nach dem Essen“ benutzt werden. Da 
sich diese Angabe meist nicht in dem Einnahmeschema sondern in den Hinweisfeldern findet, kann 
eine gewisse Ausformulierung vorgenommen werden.  
Die Verständlichkeit der Therapieanweisungen korrelierte mässig mit der funktionalen 
Gesundheitskompetenz. Die sechs Fragen, welche aus dem HLS-EU-Q16 extrahiert wurden, sind 
somit kein sicherer Indikator für das Verständnis von Therapieanweisungen. Die inverse Korrelation 
mit dem Alter könnte darauf hindeuten, dass ältere Patienten ein Risiko für kognitive Dysfunktionen 
haben und die Verständlichkeit tendenziell abnimmt. Es liegt jedoch eine grosse Streuung vor. Die 
befragten Patienten sind in ihrem Bildungsstand repräsentativ für die Schweizer Bevölkerung [116]. 
In einer zukünftigen Studie sollte ein reliables und validiertes, kurzes deutsches Instrument 
eingesetzt werden, um den Zusammenhang zwischen Verständlichkeit und Gesundheitskompetenz 
genauer zu untersuchen.  
Gewünschter Inhalt und Darstellung 
MPs weisen gemäss Literaturrecherche einen Standardinhalt auf. Als zusätzliche Inhalte wurden 
von den Patienten am häufigsten Einnahmehinweise gewünscht. Diese können eine korrekte 
Einnahme unterstützen und sollten mindestens in einer allgemeinen Bemerkungsspalte Platz finden. 
Piktogramme und Medikamentenabbildungen wurden überraschenderweise nur von einem kleinen 
Teil der Patienten befürwortet. Möglicherweise wären diese in einem anderen Kontext vermehrt 
gewünscht worden, wie es in Studien zu Piktogrammen der Fall war [113]. Allenfalls waren sich die 
Patienten des Nutzens nicht bewusst, da sie zuvor keinen bebilderten MP gesehen hatten. Bei der 
späteren Vorlage der vier MPs (davon einer mit Piktogrammen) wurde das Einfügen von 
Abbildungen von einigen Patienten befürwortet, was auf eine Beeinflussung hindeutet. Ebenfalls ist 
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eine Beeinflussung durch einen persönlichen MP nicht auszuschliessen. Die Angabe der Indikation 
wurde kaum gewünscht, obwohl dies für das Therapieverständnis des Patienten wichtig wäre. Auch 
die Nennung des Verschreibers war nicht prioritär. Möglicherweise sind dies Informationen, welche 
besonders den Fachpersonen zur Förderung der Therapiesicherheit nützlich erscheinen. Dies 
verdeutlicht, dass neben der Sicht der Fachpersonen ebenso Patientenwünsche berücksichtigt 
werden sollten, wenn der MP für Patienten erstellt und von ihnen genutzt werden soll.  
Bezüglich Darstellung bevorzugten Patienten die Zusammenfassung von mehreren Informationen 
pro Spalte. MPs mit zusammengefassten Spalten erscheinen vermutlich auf den ersten Blick 
übersichtlicher und erlauben eine grössere Schrift. Es wurden MPs entworfen, bei denen der 
Wirkstoff in der ersten Spalte vorgesehen ist [108]. In den Patienteninterviews wurde für die erste 
Spalte jedoch am häufigsten der Medikamentenname ausgewählt. Dies sollte bei der Gestaltung 
von MPs berücksichtigt werden. 
Insgesamt waren die genannten Wünsche der befragten Patienten an einen MP divers. Die Wahl 
des Favoritenplans war nicht eindeutig, obwohl sich die Mehrheit der befragten Patienten für den 
AMTS-Apothekenplan entschied. Diese Resultate sprechen deshalb für eine individuelle Anpassung 
eines MPs. 
Limitationen  
Die beschränkte Zahl der verwendeten Therapieanweisungen und der MPs ist eine Limitation für die 
durchgeführte Studie. Daher können die Resultate nicht generalisiert werden. In einer anderen 
Population, zum Beispiel bei ambulanten Patienten, könnten die Verständlichkeit und Wünsche von 
unseren Resultaten abweichen. Dies gilt ebenfalls für die getesteten Anweisungen. Weitere 
Untersuchungen mit anderen oralen Schemata oder Applikationsarten wie Inhalativa sind 
wünschenswert. 
Wichtig zu beachten ist, dass die Resultate keinen Hinweis darauf geben, ob die interpretierten 
Dosierungsanweisungen in Realität umgesetzt würden. Die Patienten haben sich maximal einige 
Minuten mit den MPs auseinandergesetzt und es handelte sich für die Befragten um fiktive 
Anweisungen. Diverse Faktoren wie Plausibilität, Bequemlichkeit, Adhärenz oder Rücksprache mit 
einer Fachperson oder mit dem Umfeld könnten trotz erstmaliger Fehlinterpretation zu einer 
adäquaten Therapie führen. Ebenfalls ist zu vermuten, dass die Patienten, die keine Antwort 





Tabellarische Therapieanweisungen, besonders Reservedosierungen wie „max. 2 Stk. max. 
4x/24h“ und Abkürzungen wie „ML“ sind für Patienten schwer verständlich und sollten daher 
ausformuliert werden. Beim Ausfüllen eines Medikationsplanes muss das individuelle Verständnis 
berücksichtigt werden. Die Abgabe sollte daher immer mit einer mündlichen Instruktion und 
Verständnisprüfung erfolgen. Die Gestaltung und der Inhalt von Medikationsplänen entsprechen den 
Bedürfnissen und Wünschen der Patienten nicht in allen Aspekten. Deshalb sollten neu zu 
gestaltende und bestehende Medikationspläne betreffend Patientensicht evaluiert werden.  
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Background: The hospital-to-home transition is a vulnerable stage in patient care, where patients 
can encounter several problems. Problems in medication supply can lead to therapy gaps, and 
inadequate instructions at discharge may affect adherence. To date there is not much known about 
discharge processes or problems with medication instruction and supply encountered by Swiss 
patients after discharge. Patient satisfaction with the instructions from the hospital is also unknown. 
Aims: The objectives of this study were to investigate patient experiences with medication 
instruction and supply after hospitalisation. A further objective was to identify the current discharge 
process and possible optimisations. 
Methods: A telephone interview was conducted with 100 patients from the surgical and internal 




 day after discharge. 
Results were discussed in an interview with five physicians from the study site. Data were analysed 
qualitatively as well as quantitatively for relative risk (RR) values. The Fischer’s exact test was used 
for categorical variables and the Mann-Whitney U-test for ordinal variables.  
Results: Knowledge about medication indications and changes was high among all patients, 95% 
and 96%, respectively, reported by the patients themselves. Instructions about medication were 
preferred mainly as a combination of oral and written form (69%), and 55% of the patients received it 
this way. According to the physicians, all patients should have received oral and written instructions, 
according to standard procedures.  
Seventy-seven out of 100 patients had had their discharge prescription filled when they were called. 
It took until the 6
th
 day after discharge for all 77 patients to receive their prescribed medication. Until 
the 2
nd
 day, when the first interviews took place, 75 patients had already filled the prescription and 
73 had obtained all prescribed medications. Despite supply problems for 14 of 77 patients (18%), 
there were only four patients with therapy gaps. Patients discharged from internal medicine wards 
had a higher risk of supply problems than those from surgical wards (RR = 5.56, p = 0.007). Patients 
experiencing supply problems had statistically significantly more medicines on a daily basis (8.0 ± 
4.32 vs. 4.9 ± 3.04, p = 0.010). Physicians stated that therapy gaps seemed unexpectedly low, 
although too many patients experience supply problems. 
Most patients (88%) were satisfied with the general discharge process from KSB, however there is 
room for optimisation. When asked if communication between hospital and the community pharmacy 
should be optimised, 21% agreed, but other ideas, such as a bridging medication supply were 





Discussion and conclusions: Discharged patients recieved less instruction than they expected 
and optimisation is needed. The study nevertheless showed good medication knowledge, but there 
was no control for the correctness of a patient’s response.  
The time needed until prescriptions were filled after discharge is long, and a quarter of all patients 
claimed not having filled their prescription at the time of the interview. The increased risk for supply 
problems with a higher medication intake on a daily basis and discharge from internal medicine 
wards may be due to patients with co-morbidities. However, therapy gaps were infrequent. 
In both interviewed groups, there was no clear consensus on how to optimise hospital discharge. As 
findings about improved information transfer from hospital to community pharmacies proved to be 





During hospitalisation, a patient’s admission medication regimen is often adapted [117, 118]. Owing 
to the current stage of disease, patient adherence or side effects, new medication may be 
prescribed and previous medication may be stopped [39]. At discharge, any medication changes 
have to be communicated to the patient. A study from Israel found that 60% of patients received no 
counselling about new medication [55]. The results also showed that 93% of patients knew the 
indication for their previous medication, but only 73% knew the indication for their newly prescribed 
medication. Dudas et al. conducted pharmacist follow-up phone calls with discharged patients and 
found that 25% of patients had questions regarding their medications within two days of discharge 
[119]. Insufficient instruction can lead to confusion, anxiety and non-adherence. A study showed that 
four out of nine medications were not taken because the patient did not know the indication [52]. A 
Swiss study confirmed that the more patients knew about their medication, the less likely they were 
to “discontinue medication without medical justification” [120]. Furthermore, inadequate medication 
knowledge is thought to be associated with a higher likelihood of ADEs resulting in hospital 
readmission [121].  
Polypharmacy, especially frequent in the elderly, also affects patient knowledge and appropriate use 
of medication. The more medications a patient has to take, the greater the complexity of instructions 
the patient gets. Patients are not able to process all given explanations and knowledge is adversely 
affected [122]. Researchers from Geneva investigated patient’s medication knowledge after 
discharge in relation to their adherence by telephone interview [120]. They identified that patient-
centred discharge interviews and a medication treatment card for the patient as positive tools to 
improve patient medication knowledge, adherence and patient safety. It is therefore important to 
ensure that the patient understands the given instructions, especially in patients with cognitive 
impairments or low health literacy. Good instruction is limited by the staff’s time constraints, and, if 
instructions take place, they may be ineffective. Written instruction could be supportive [52, 120].  
Researchers studied the influence of in-patient counselling by clinical pharmacists prior to discharge. 
Pharmacists explained that discharge counselling within the hospital was an important service [123]. 
They could review a patient’s medication together with the patient to ensure they understood the 
prescription, and the need to fill their prescription at the community pharmacy, which clears barriers 
regarding adherence. Furthermore, they could highlight changes in dosage or time of intake 





Depending on Swiss health care legislation, patients in some cantons can obtain medication from 
GPs and/or hospitals. Discharged patients in other cantons do not receive any take-home 
medication supply from the hospital, and the patient obtains medication from a community pharmacy 
[124]. Timely medication supply is important to prevent therapy gaps. Medication supply depends on 
a patient’s efforts to collect the medications from the community pharmacy [69]. It is unknown how 
many patients regularly visit the same pharmacy, although continuity in ambulatory care seems to 
be highly important [9].  
As stated before, in-patient counselling may enhance the rate of filling of discharge prescriptions 
[123]. A study from the USA pointed out that 20% of patients had problems obtaining all of their post 
discharge medication within two days, with more problems in polypharmacy patients [119]. Also in 
paediatric patients, who are often prescribed off-label medication, problems obtaining medication 
may affect up to 33% of patients [125]. These British findings are supported by Swiss data. 
Caregivers encountered delays in supply for 25% of the studied children [126]. Causes included 
medications being out of stock or being rare. Community pharmacists had troubles dispensing 
medication in 21% of cases because there was information missing on prescriptions, such as 
dosage or contact details for further questions. The supply problems may lead to therapy gaps [125, 
126], but no data on Swiss adult patients is available, to our knowledge. 
Discharge process optimisation 
To ensure that community pharmacists to take an active role in transitions of care, information has to 
be available. At present, community pharmacists in Switzerland are not usually contacted upon a 
patient’s discharge, and communication between hospitals and pharmacies is only established in 
some hospitals [127]. Discharge letters are sent to the GP, but not to pharmacies, even though 78% 
of community pharmacists wish to receive them [39, 128]. Complex medication regimens are harder 
to reconcile without access to updated medication lists and clinical medical records [129]. A 
questionnaire sent to English community pharmacists showed that 87.5% of pharmacists would like 
to receive the patient’s “medicine record sheet” [93]. Also, changes to prescribed medications was 
information indicated as helpful by 75% of pharmacists. In the same country, community 
pharmacists believe that this information is important to streamline patient counselling and to 
prevent discontinuity in a patient’s care [39]. Through better communication, patient compliance can 
be facilitated and gaps in medication therapy can be prevented [90]. This was proven in a Swiss 
study, where a pharmaceutical handover communicated medication changes to the community 
pharmacists [18]. It was shown that necessary PIs post discharge were significantly reduced by the 
handover. These findings highlight the importance of a fast and adequate information transfer 
between different health care providers such as hospitals and community pharmacies.  
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Aims 
To summarise, the following knowledge of the Swiss health system is available: It is known that 
paediatric and adult patients may experience problems after discharge. These problems may be 
caused by insufficient instruction before discharge, or missing medication supply, or suboptimal 
discharge processes.  
It is unknown if instructions about medications at the hospital are satisfying and if patient knowledge 
is adequate. The supply problems were seldomly investigated. Regarding pharmaceutical 
optimisation strategies, for example, intensified communication between hospital and community 
pharmacies, it is not known if international strategies, described in literature, would meet the Swiss 
patients’ needs. Furthermore, it is unknown if physicians responsible for discharging their patients 
are aware of the current processes and how they could be optimised.  
The goal of this observation study was to investigate the current processes and optimisation 
strategies of hospital discharge. We aimed  
1. to identify the most important problems regarding medication instruction and the subsequent 
knowledge, 
2. to estimate post-discharge medication supply and therapy gaps, 
3. and to acquire different views from patients and physicians on the hospital discharge 
process and optimisation ideas. 
 
Methods 
Two observational methods were used to achieve these aims. A telephone interview with patients 
was conducted, followed by face-to-face interviews with physicians, presenting the obtained results 
from the patient interviews. The two methods are described chronologically in the following. Results 
and discussion are divided thematically according to the aims into “Part 1: Medication instruction”, 
“Part 2: Medication supply” and “Part 3: Discharge process optimisation” for easier understanding. 
Patient interviews 
Hospitalised patients on study wards (surgical wards CHI71, CHI72, CHI91, and internal medicine 
wards MED111, MED112, and MED121) were handed out a study information flyer by the nurses 
(appendix 9.2.2). The electronic patient records were screened daily for discharged patients from 
study wards and inclusion and exclusion criteria were applied (Table 6). One patient could meet 
several exclusion criteria and this was documented accordingly. It was planned to interview 100 
consecutively discharged patients. Screening was done between the 10
th







Patients were called on the second day following the day of discharge. Three attempts to call were 
made within one week after discharge before the patient was categorised as “lost to follow-up”. All 
reached patients were asked for immediate participation. The ones that did not receive the 
information flyer were informed in detail about the study. Patients gave their oral informed consent. 
The study was approved by the responsible ethics committee (EKNZ 2016-00377, appendix 9.1.1).  
Table 6: Inclusion and exclusion criteria for the patient’s telephone interview 
Inclusion criteria Exclusion criteria  
- Patients discharged from study site 
- Patients ≥ 50 years old on the day of inclusion  
- Patients with ≥ 1 prescribed medication 
- Patients discharged to their home 
- No informed consent given  
- Underage patients 
- Dementia (e.g. MMS ≤ 25 points) 
- Patients with insufficient hearing or language 
skills 
- Patients not reachable or living abroad 
- Patients readmitted before the first call 
- Employees as patients  
- Outsourced patients from other departments 
 
A draft for the structured telephone interview was created based on a literature search. The 
questions covered the following topics: Demographic data, instruction received and knowledge 
about their medication, problems in medication supply, and questions about hospital discharge 
processes in general. These were either multiple choice, single choice or open-ended questions.  
The interview was piloted with five pharmacy students and laymen, focusing on the information 
flyer’s content and interview duration. Adaptions to the flyer were made. A second pilot study was 
performed with the target population, focusing on study procedure, the flyer’s content and interview 
duration. Thirty-three patients were included and the interview was conducted with four patients. The 
study procedure proved to be efficient. The content of the flyer and duration of the interview 
(approximately 9 minutes) was satisfying for all patients. There were a few changes made to clarify 
questions for easier data management (final version appendix 9.2.3). 
Data were analysed with Excel (Microsoft Excel 2010, Redmond WA, USA) and SPSS (IBM, version 
23, Armonk NY, USA). Frequencies, mean values, median, and standard deviation were calculated, 
and compared between different groups by the Fisher’s exact test, and for ordinal variables by the 
Mann-Whitney U-test, with a statistical significance level of p = 0.05. Data were analysed 
quantitatively for relative risk (RR) values. 
Physician interviews 
Interviews with four resident physicians (R, 2 CHI, 2 MED) and one senior physician (SP, MED) 
were performed. The interviews started with a short oral introduction about the study and included a 
graphical presentation of data already obtained from the patient interviews. The resident interview 
consisted of ten open-ended questions on instructions, medication supply, and the discharge 
process (appendix 9.2.4). The interview with the SP consisted of seven similar questions. The 
interview was conducted in Swiss-German, recorded, summarised and translated to English.  
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A2.1 Medication instruction 
Results 
Patient interview 
During the study period, 422 patients were discharged from the study wards. As shown in Figure 9, 
191 patients met the inclusion criteria. The telephone interview was conducted with 100 
consecutively included patients. In two of the cases, it was conducted with the wife or husband of 
the patient, as they were in charge of the patient’s medication. Demographic characteristics of the 
patients are summarised in Table 7. One patient was discharged, and therefore included, twice.  
 
 
Figure 9: Flow chart displaying the process of patient recruitment and screening (n = 422) 
 
 
Table 7: Patient characteristics (n=100) 
Variable Percentage [%] Mean ± SD 
Female 39  
Patients discharged from MED 53  
Age [y]  65.6 ± 17.4 
Day post discharge when interview took place  3.5 ± 1.4 
No. of medications taken/applied on a daily basis  5.41 ± 3.50 
No. of medications taken/applied only if necessary   0.72 ± 0.95 
Patients visiting the pharmacy independently 97  
Patients living alone 14  
Patients with support regarding obtaining medication  10  
Patients with support regarding preparing medication  13  




Of 100 interviewed patients, 95 stated that they fully know the indication of their current medication, 
and 96 knew if and what adaptions were made. Four patients did neither know their latest changes 
nor any newly added drugs. Assessing patient knowledge, 74 patients stated to have received 
instructions about their medication. Of the remaining 26 patients, 21 indicated not having needed 
any instruction due to unchanged therapy.  
Of those patients with any support at home regarding medication (n = 20), 75% (15) stated that their 
caregivers were instructed, 10% (2) of caregivers did not receive instructions and 15% (3) of patients 
did not know if their caregivers were informed. Patients receiving instructions rated them on a scale 
from one to six. 72 patients indicated satisfaction (4.5-6 points). One patient indicated dissatisfaction 
(1-3.5 points) and one indicated neutral (4 points).  
Figure 10 shows the proportions of desired and actually received instructions on the surgical and 
internal medicine wards. Most instructions were given in a combination of oral and written form, and 
this was more frequent on MED than on CHI, but not statistically significant (p = 0.302).  
 
 
Figure 10: Instructions at discharge. Form of received and desired instructions about medication on 
surgical and internal medicine wards. The bars describe how patients on surgical wards received (black 
with dots ) and desired (white with dots ) instructions (n = 47) and how patients on internal medicine 

































All patients who desired (n = 69) a combination of oral and written instructions were asked in what 
form they would like them to be presented (Table 8). MCs were the most desired written instruction, 
followed by the prescription itself.  
Table 8: Format of desired written instructions (n=69) 
Format of written instruction No. of patients 
Medication chart 25 
Prescription 21 
Prescription and medication chart  9 
Discharge summary 6 
Discharge summary and prescription 1 
Label on drug packages 2 
Others/ other combinations 5 
 
The patient participating twice first received oral instructions and was satisfied with it; while on his 
second discharge he received oral and written instruction (medication chart) and then preferred 
these combined instructions for further discharges.  
When asked about contacted persons in case of uncertainties (multiple choice question), the most 
named health care provider was the GP (58), followed by the community pharmacy (35), the hospital 
(32) and others (9). Patients were asked if they desired explanations from the community pharmacist 
when obtaining prescribed medication. Answers, including reasons, are summarised in Table 9. 
From the 14 patients with medication supply problems, seven did not wish for more explanations, 
four wished for additional explanations, two said it would depend on the prescription and one could 




Table 9: Reasons why patients wish or do not wish for further explanations about their medications from 
community pharmacist (n = 100) 
 No. of patients 
Explanations generally needed 33 
Clarify medication (e.g. indication) 10 
Patient security 8 
Repeat information given at the hospital 5 
Clarify questions 4 
Others, e.g. interaction check, about side effects, application or dosing regimens 6 
Explanations needed depending on the situation 17 
New medication / change in medication 12 
Questions / uncertainties of patients 9 
Special medication / special things that need to be considered 3 
Others, e.g. application explanations, inform about side effects 2 
Explanations not needed 48 
Same medication for a long time 13 
Sufficient information received at the hospital 12 
Read package insert 7 
Indication is clear 5 
Label on package  4 
Medication delivery from community pharmacy / obtained from GP 4 
Patient asks if there are questions 4 




The characteristics of interviewed residents and the senior physician are shown in Table 10.  
 
Table 10: Characteristics of the interviewed physicians. R = Resident physician, SP = Senior physician, n = 5; 
* worked on CHI the last two years 
 R1 R2 R3 R4 SP1 
Age [y] 26 27 31 29 36 
Gender Female Male Female Male Male 
Ward CHI CHI MED  MED MED 




All interviewed physicians stated that they personally give oral and written instructions on discharge. 
All MED patients were provided with a discharge summary, a prescription and a medication chart. 
Creating a medication chart for CHI patients would be too much effort for the hospital, according to 
one physician. 
 “Basically, all patients should have received oral and written instructions.” (R1) 
 “Ideally every patient should have explanations about his drugs.” (R3) 
All physicians explained that they focus their explanations on dosing regimens, changed or new 
medications, and indications. The senior physician said that they try to hand out the MC for the 
patient on the day prior to discharge, leaving them time to study the MC. If this is not possible, the 
patient receives the MC before the ward rounds on the day of discharge. On the day of discharge, it 
is discussed and questions are answered. On MED, both residents said they explain the MC, with 
ongoing clarifications if questions arise. One resident also claimed to inform patients that the 
community pharmacist can call them if problems arise. One of them said that instructions are given 
individually depending on their patients’ needs, but no physicians specifically claimed to ask patients 
about their information needs.  
“Residents know who needs more or less instructions on their medication.” (R1) 
Regarding results on instructions, both residents on CHI and the senior physician from MED 
indicated that the results do not correspond to reality. But time constraints may lead to insufficient 
instructions.  
On MED, both residents admitted that the results display reality to a certain point. One thought there 
might be fewer, about 20% of patients, who did not receive instructions. They said that it had to be 
considered that patients were in a new surrounding and might have received too much information 
to remember everything.  
“Did the patients really not receive any instructions or did they simply not notice that instructions 
were given?” (R4) 
“Maybe some patients might have received oral instructions, and the envelope with the 
discharge summary and the prescription was just handed to them.” (R2) 
“If there are lots of discharges on one day, some might just drop off the discharge summary 
without further explanations.” (R1) 
All residents indicated that the desired instruction format should be achievable. According to MED 
residents, the senior physician checks if MCs are available for every patient. One resident thought 
the discharge process and the time spent is already very good compared to other hospitals, whilst 
the other said that the process could still be optimised. He named standardised processes or trained 




Upon hospital discharge, instructions seem to be suboptimal and not given to all patients. Almost all 
patients indicated that they know the indications of their medication and that they are aware of any 
medication changes. However, many patients wished for more information than they actually 
received. Physicians reported higher instruction levels than their patients did. 
One of the primary aims was to identify problems regarding medication instruction given before 
discharge and knowledge after discharge. This was investigated by asking patients if they received 
instructions on their medication, if they knew the indications of their current drugs or if they knew 
about any medication changes. Our patients indicated a higher level of knowledge about indications 
(95%). According to an American study, only 64% of patients knew the purpose of newly prescribed 
medication [110]. Our results were surprising, considering the low amount of received instructions. 
Reasons might be that patients read package inserts or asked health care professionals. We 
assessed knowledge from all medications at once, so this may be inaccurate and knowledge may 
have been overestimated. Additionally, patients may have felt tested, and the correctness of the 
given answers was not assessed. Therefore, these self-reported results need to be interpreted with 
caution and are not an applicable indicator for the risk of therapy discontinuation, as in other studies 
[52, 120]. 
Our study showed that 74 of 100 patients received some instruction about medication. There was a 
difference in the form of instructions received on the study wards, where MED wards apparently give 
more instructions in combined form. On one side, this difference can be explained because on MED, 
the process of prescribing is more standardised than on CHI. CHI patients mostly received a 
prescription, only listing newly added drugs, without receiving a MC. On the other side, instructions 
about medication depends on the physician and on the medication (e.g. common pain killers, 
antibiotics, or psychiatric medication) [130]. More instructions are given for drugs associated with a 
higher potential for ADEs. Surprisingly for the study team and the physicians, there were some 
patients from both wards that indicated not having received any instructions. They may not have 
categorised prescriptions as written instruction, whilst other patients did. But on the other hand, 
prescriptions were often preferred as format of the written instruction. Compared to the finding of 
Kerzman et al., where 60% received no instruction on new medication, there were fewer patients in 
our study without instruction at all [55]. However, its content and subject matter were not assessed.  
It is not known if the given instructions were effective. Patients might understand “receiving 
instructions” differently than receiving a medication chart or a prescription with an oral explanation, 
or they might have received too little information and stated that there were no instructions given at 
all. Patients also may not have checked the received envelope with the documents in it. These 
findings were still surprising, since all interviewed physicians stated that every patient receives oral 
and written instructions about their current therapy. However, the physicians emphasised that 
instructions might have been short due to time constraints. Further, discharge could have been 
stressful for patients, or they might have received too much information to remember, especially in 
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polypharmacy patients. Polypharmacy may reduce the ability to process received information [122]. 
A patient’s desire to go home can also affect the absorbed information [131]. Instructions to patients 
might have been ineffective even though they took place [55]. To conclude, these different views 
demonstrate that information given by physicians may not completely reach the patient. To ensure a 
patient’s understanding, physicians could ask if the given information is clear [57], and if the patient 
understands their regimen [132]. Teach-back would be a possible strategy to control understanding. 
Patients mostly desire a combination of oral and written instructions. Studies found that information 
given as a combination is better remembered [130] and preferred by most patients in other settings 
as well [52]. The patient discharged twice changed his opinion in between hospital visits. Therefore, 
it could be assumed that patients accept the form of instruction they receive, or the form they could 
imagine. Overall, satisfaction about received instructions was still high. Most caregivers (e.g. 
relatives) were informed. This can enhance the correct use of medication [55].  
An American study found that the GP is contacted mostly in case of uncertainties [110] and it was 
assumed that these findings are transferable to Swiss patients. As expected, the GP would be called 
by most of our study patients if questions arose. A patient probably feels more confident to contact 
the GP, since they receive discharge letters and are informed about the current health condition of 
their patient. Also, according to an Australian study, patients visit their community pharmacy earlier 
than their GP, at a median time of six and twelve days after discharge, respectively [133]. Especially 
in cases where patients did not receive enough instructions about medication or when patients were 
prescribed special medication, pharmacists may play a valuable role. It has to be kept in mind that 
community pharmacists mostly receive the prescription, but no summary with background 
information about the patients’ situation. 
Regarding further instructions by community pharmacists, patients’ opinions were divided and 
depended upon the patient’s situation. Patients with long-term medication seem not to need further 
explanations when filling their prescription, but in case of medication changes, instructions were 
needed. An evaluation performed at our study site revealed that patients in internal medicine were 
admitted with a mean of 4 and discharged with a mean of 6 medications [134]. Therefore, therapy 
changes arise very often and affect most patients. It might therefore be appropriate for the 
pharmacist to give explanations to all patients. To perform in-depth counselling, community 
pharmacies should obtain detailed information from the hospital.  
To conclude, results showed instructions given at discharge are insufficient and could be optimised. 




A2.2 Medication supply 
Results 
Patients’ and physicians’ characteristics are shown in chapter A2.1. 
Patient interviews 
Of the 100 patients interviewed after discharge, 97 stated to regularly visit the same community 
pharmacy. Five patients claimed they had not received a prescription upon discharge. Of the 
remaining 95 patients, 75 filled their prescription before the 2
nd
 day of discharge. By the 6
th
 day after 
discharge when the last interviews were performed (mean 3.5±1.4 days after discharge), 77 patients 
visited the community pharmacy to fill their prescription. In addition to the 5 patients without 
prescriptions, 18 had not filled their prescription when they were called (total 23 patients). When 
asked “When did you fill the prescription?" 78% (60 of 77) of patients went to the community 
pharmacy on the day of discharge, mostly on their way home from the hospital (Figure 11). In the 
median, prescriptions were filled on the day of discharge.  
 
Figure 11: Medication supply after discharge. Time span to fill prescriptions (squares, n=100), to receive all 
prescribed medication (triangles, n=77) and to follow the dosing regimen without gaps (bullets, n=77, 63 
without problems and 14 with problems), presented in number of patients. 23 patients did not fill a 
prescription. 0 = day of discharge 
 
Patients who filled their prescription (n=77) were asked "How long did it take until you received all 
prescribed medication after hospital discharge?". By the 2
nd
 day of discharge, 73 (97%) of 75 
patients filling the prescription obtained all medication. By the 6
th
 day after discharge, all patients 
who filled the prescription had obtained all medication. Fourteen out of 77 patients (18%) had 
problems with medication supply.  
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Days after discharge 
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The following problems were stated: 
- Medication was not in stock, e.g. right strength or package size, and had to be ordered.  
- Prescribed medication was unlicensed in Switzerland and had to be ordered from abroad. 
- The community pharmacy had a clarification request with the prescriber.  
The 14 patients with supply problems were asked about therapy gaps. For the other 63 patients 
without problems it was assumed that they had no gaps. Four of the 14 patients experienced a gap 
in therapy due to delayed medication supply, which reached from the day of discharge until and 
including the 2
nd
 day after discharge (Figure 11). Problems in medication supply were significantly 
more likely in patients with more prescribed daily medicines, and in patients discharged from MED 
(Table 11 and Table 12). Living alone seemed like a risk factor for supply problems, although this 
was not statistically significant.  
 
Table 11: Variables associated with problems in medication supply. (n= 100; *statistically significant; p-
values were calculated using the Mann-Whitney U-test) 
Variable Supply problems No supply problems p 
Age [y] (mean ± SD) 71.14 ± 9.87 69.78 ± 9.46 0.530 
Number of medicines on a daily basis  
(mean ± SD) 
8.00 ± 4.32 4.90 ± 3.04 0.010* 
 
 
Table 12: Variables influencing medication supply. (n = patients with supply problems, ntotal = 14; N = 
respectively applicable and inapplicable on variable (female gender etc.), Ntotal = 77 ; *statistically 






Female Gender 7/33 (21.2) 7/44 (15.9) 1.33 0.566 
Internal medicine’s ward patients 12/40 (30.0) 2/37 (5.4) 5.56 0.007* 
Living alone 5/13 (38.5) 9/64 (14.1) 2.73 0.053 
No support with medication at home 13/61 (21.3) 1/16 (6.3) 3.38 0.277 
 
 
From all 77 patients filling their prescription, 57% (44) obtained medication by themselves, in 36% 
(28) of cases relatives received the medication, 4% (3) had home delivery by the community 





Most physicians, including the senior physician, found it surprising or alarming that not all 
prescriptions were filled immediately after discharge.  
“There is a reason why medication is prescribed, so filling of prescriptions should be done 
quickly.” (R4) 
“A prescription is handed to patients because there is new medication and therefore filling the 
prescriptions should be done quickly.” (SP1) 
Residents also indicated that patients are believed to fill their prescriptions on the way home and on 
the day of discharge, however this might be difficult for immobile or elderly patients. According to the 
senior physician, patients should obtain their medication quickly depending on the medicines (e.g. 
anticoagulants). Three physicians mentioned that gaps are unfavourable. To prevent it, one resident 
said he had once called the community pharmacy to check the availability of a drug. Another said 
that either alternatives should be found for drugs unlicensed in Switzerland or a bridging supply 
should be provided for a few days to avoid therapy gaps.  
“There should not be any gap due to unlicensed drugs.” (R4) 
According to the senior physician, four gaps in 100 discharged patients was a relatively good result. 
One resident was surprised about the gap of up to two days due to the fact that the community 
pharmacy near the hospital is open 24 hours a day. All physicians received requests from 
community pharmacists regarding medication ranging in frequency from once every 4-6 months up 





Part A2.2 of the observation study about supply revealed that a quarter of all patients did not fill a 




 day after discharge). It took up to one 
week until they received all prescribed medication. 14 patients experienced supply problems but 
only four had a gap in therapy due to delayed supply. Most physicians were astonished by these 
results and were concerned about the medical outcomes.  
According to our study, not all patients are filling their prescription within one week after discharge 
and a few patients apparently did not receive the prepared prescription at all, although patients were 
only eligible with at least one prescribed medicine in the hospital’s patient records. Interviewed 
physicians believed that older patients have more difficulties in prompt medication acquisition. 
Reasons might be that they depend on relatives or others assisting them with visiting the community 
pharmacy. If patients still have medication at home they are more likely to fill prescriptions later. This 
is supported by the fact that there were only few gaps. The median time point to visit the community 
pharmacy was the day of discharge. This differed from the results found by Roughead et al., where 
patients needed a median of six days [133]. However, this study was performed with Australian 
veterans, who possibly have received some bridging supply. Within two days, 95% of our 
interviewed patients who had filled their prescription were able to obtain all prescribed medications, 
which was higher compared to the American study of Dudas et al., where this was the case in only 
81% of patients [119]. The methodology of our interviews has to be taken into account, as patients 
reachable at the 2
nd
 day after discharge who did not fill their prescription so far were not called 
anymore. Therefore, later prescription filling may be underestimated.  
Depending on the prescribed medication, such time spans could be unfavourable. If patients were 
prescribed, for example, anticoagulants, filling the prescription should be done on the day of 
discharge [70]. For antibiotics, the time span of our findings is too long, since adherence to the 
therapy regimen is very important to prevent antibiotic resistances. But it has to be considered that 
late filling of prescriptions does not automatically mean that patients had gap in their therapy.  
Questions were adapted to the methodology of Wong et al. to determine if patients in Switzerland 
cope with the same type of difficulties in medication supply as in UK [125]. Whilst 33% of patients in 
their study experienced problems in medication supply, this only occurred to 18% of patients in our 
study. The local pharmacy not having the medication in stock was the most named reason for 
delayed medication supply in both studies. If the resulting gaps in a patient’s therapy are compared 
to a study conducted in the area of Geneva, where four of 16 paediatric patients had a therapy gap, 
there were only four in every 100 patients in our study with gaps [126]. Explanations for our 
favourable results could be that the study from Geneva focused on another population (paediatrics) 
where more problems can occur due to special medication or compounded formulations. Another 
reason could be that there is a community pharmacy open 24 hours a day in the neighbourhood of 
our study site. Patients with chronic comorbidities may still have medicines at home, or their 
pharmacy has their patients’ medicines on regular stock. Considering the number of supply 
  
71 
problems, gaps were infrequent. Ordered medication is usually delivered twice daily to local 
community pharmacies in Switzerland, leading to fast availability. This may have prevented therapy 
gaps in our cases. However, mail delivery pharmacies are slower in medication delivery. We 
suggest that the fast availability has an influence on the actually taken medication. Adherence was 
not determined in this study, but high adherence after hospital discharge leads to lower health care 
costs and readmission rates [135].  
As expected, the number of medicines on a daily basis was associated with experiencing medication 
supply problems. An increased number of medicines already showed to decrease the ability to 
obtain all of them [69], therefore this association was expected. But causality was not studied here. 
Patients being discharged from MED also had a 5.56 times higher risk for supply problems than CHI 
patients. A possible explanation is that patients on CHI are only prescribed new medication on 
discharge compared to MED patients, where all current medication is written on the discharge 
prescription. Also, as emphasised by the physicians, patients on MED are polymorbid and therefore 
have a higher average daily drug intake. Patients living alone or having no support with medication 
tend to have more supply problems, but the results were not statistically significant. Considering the 
sample size in our study, there might have been a statistical significance with a higher number of 
patients.  
To conclude, there is a substantial portion of patients that did not rapidly fill their prescription. This 
may possibly lead to unfavourable health outcomes. However, therapy gaps were seldom. Rapid 
delivery and having medication at home may enhance medication intake. 
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A2.3 Discharge process optimisation  
Results 
Patients’ and physicians’ characteristics are shown in chapter A2.1. 
Patient interviews 
To evaluate the experienced discharge, patients were asked to comment on the general discharge 
process. Most patients were satisfied (Table 13).  
 
Table 13: Comments of patients on the general discharge process (n = 100) 
Comments No. of patients 
Satisfied with the general discharge process 88 
Unsatisfied with time management (unclear or waiting time) 6 
Unsatisfied by the discharge documents  2 
Other comments 4 
  
 
Patients were asked if they would welcome better communication between hospital and community 
pharmacies. Out of 100 patients, 21 would welcome it (Table 14). We analysed all patients who 
answered both the question about the communication and about the supply problems (73 patients). 
Seventeen of them would welcome better communication, of which 7 (41.2%) had experienced 
supply problems. Fifty-six would oppose better information transfer, of which 6 (10.7%) had 
experienced supply problems. Therefore, the experience of supply problems correlated significantly 
with seeing benefit in enhanced communication (p = 0.009).  
Reasons why better communication should be established or not are given Table 14. Patients 
without an answer to that question had mostly not been involved in the process of medication 
acquisition after hospitalisation due to relatives, community pharmacies, or mail-order pharmacies 
delivering the medicines.  
Patients were asked for their own ideas on how to facilitate medication supply post-discharge. Most 
patients (87%) did not have any suggestions. Eight out of 13 suggestions were that hospitals should 
provide patients with medication for a few days:  
“This would be especially useful for patients discharged in the evening when community 
pharmacies are already closed or in case a patient feels weak and cannot or does not want to go 
to the community pharmacy on the day of discharge.” (P175, female, 55 y) 
“The hospital should provide drugs for three days to avoid gaps in a patient’s treatment plan.” 
(P155, female, 75 y) 
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“Medication should be provided especially when drugs are unlicensed in Switzerland, because 
they first have to be ordered by the community pharmacy which takes time and leads to gaps in 
drug therapy.” (P130, female, 78 y) 
Two patients stated that medication often comes in inappropriate packaging, and that drugs should 
be filled and prepared in the right amount. Other ideas were home delivery through a mail-order 
pharmacy, sending the prescription to the community pharmacy and that the hospital should get in 
touch with the community pharmacy prior to a patient’s discharge: 
“Especially in cases where patients need social support and cannot obtain medication by 
themselves, and home delivery from the community pharmacy might be necessary, early contact 
with the community pharmacy can be useful”. (P 157, female, 73 y) 
 
Table 14: Opinions about information transfer. Reasons opposing and favouring information transfer 
between hospitals and community pharmacies (n = 100, multiple answers were possible) 
 No. of statements  
Reasons opposing information transfer 83 
No problems with medication supply 39 
No need for medication supply from the pharmacy 17 
Not necessary or only for special medication 9 
Easy access to a pharmacy (close to home or hospital) 5 
Too much effort for the hospital 3 
Privacy concerns 3 
Does not visit the same pharmacy for medication supply 3 
Unclear time of discharge 2 
No gaps experienced through delayed medication supply 2 
Reasons favouring information transfer 22 
For easier and faster medication supply within one visit 8 
To pre-order urgent, unlicensed or unavailable medication  5 
Pharmacy is prepared and clarifications are possible earlier 5 
To avoid delays in supply and therapy gaps  3 
Patient would feel respected 1 





Regarding the current discharge process, the interviewed physicians saw different problems and 
suggested possibilities for improvement (Table 15). There were reasons in favour of, and opposing, 
better communication (Table 16). Physicians questioned the increased workload if they additionally 
would have to send prescriptions to the community pharmacies. But they said that in cases of 
special or unlicensed medication it would definitely be useful. 
Table 15: Physicians’ views on the discharge process. Problems occurring during the current discharge 
process seen by physicians and improvement suggestions (n = 5, multiple answers were possible) 
Problem No. of statements 
Collection of all information about drugs on admission and during hospitalisation to 
prepare discharge summary 
1 
Uncertainty of patients about medication (e.g. time of intake) 1 
Wound dressing and anticoagulation 1 
Time pressure of residents 1 
Errors in copying medication when writing prescription (missing MedRec) 2 
Improvement suggestions No. of statements 
Give bridging supply 2 
Inform patients about community pharmacy across the street (open 24h) 2 
Send prescription to community pharmacy 1 
Instructions given one day prior and on day of discharge 1 
Instructions kept simple and short 1 
Instructions to caregivers 1 
Instructions given by the hospital pharmacy  1 
Instructions given by the community pharmacist, and check for interactions 1 
Double check for duplications and errors on prescriptions 1 
Prescribe same basic medication on each ward (e.g. analgesics) 1 
Trained staff (e.g. physicians or nurses), available by phone for questions 1 
 
Table 16: Opinions about information transfer. Favourable and unfavourable reasons as well as concerns 
to send prescription to community pharmacy (n = 5; multiple answers possible) 
Favourable reasons No. of statements 
Unlicensed or special medication  2 
Improve patient security if no pharmacy-hopping 1 
Unfavourable reasons No. of statements 
Pharmacy-hopping 2 
If prescription is sent, patient does not have it to fill it at another pharmacy  2 
Prescription is only ready on the day of discharge  1 
Too much effort  1 
Concerns No. of statements 
Is the valid prescription available at the community pharmacy? 1 
Can lead to errors. 1 
Does every hospital send prescriptions to community pharmacies? 1 




Satisfaction about the general discharge process was high among patients. The problem identified 
most was the uncertainty of the discharge time, which was also found in another study from the UK 
[52]. This again may hinder early prescription transfer. From the physician’s point of view, problems 
are seen in MedRec and the correctness of prescriptions.  
Since almost all patients indicated that they visit the same community pharmacy for medication 
supply (Project A2.1), improved information transfer between the hospital and the community 
pharmacist could be a promising discharge optimisation strategy. Different studies focusing on 
information transfer showed benefits on discharge outcomes, with services such as “liaison 
pharmacists” [93], “pharmacy discharge plans” [90], sending discharge letters to community 
pharmacies [128], or an “integrated discharge prescription form” to enhance information transfer 
[136]. However, most interviewed patients did not see a need for improved communication, which 
was an unexpected result. This may be explained by the fact that most of our patients had an 
unproblematic discharge process. But communication was significantly more welcomed in patients 
with supply problems. Patients opposing information transfer might not have visited a local 
pharmacy and therefore communication would be useless. Spontaneously visiting an unknown 
pharmacy at discharge may also hinder previous information transfer. As expected, physicians were 
undecided whether sending the prescription would improve supply. It seemed like they did not fully 
understand why the communication should be improved, since all of them rarely received requests 
from community pharmacists. Additionally, there was the impression that some of them were not 
aware of problems that could arise with discharge prescriptions. They emphasised their increased 
workload if they additionally have to send prescriptions to community pharmacies. However, it was 
said that in cases of special or unlicensed medication it would be useful. This supports opinions of 
patients, and also the finding that unlicensed medication posed problems to study patients. 
According to physicians, there are barriers to the implementation. Additionally, the prescription 
needs to be sent the day of discharge at the latest, since results showed that most patients fill 
prescription on the same day. Also, the optimal time of sending the prescription would need further 
investigation in the community setting. 
Improving communication between health care providers is a current topic as part of the strategy 
“Gesundheit 2020” [137]. To date, the Swiss health care system is working on the implementation of 
a shared electronic health record. The aim is to improve medical treatment and processes, as well 
as patient safety. The related law came into force in 2017. However, due to decentralisation in 
Switzerland and data protection, implementation of shared electronic health records is complicated 
[138]. As information exchange is a broadly discussed topic in health care, it was expected that our 
results would reflect the opinion of the policy makers in Switzerland.  
The most named improvement strategy by patients and physicians was to provide medication for a 
few days, which, due to the cantonal legislation, is not allowed at the KSB [124]. Therefore, sending 
prescriptions or other information to the dispensing professional may be the better option. However, 
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in cantons with self-dispensing by GPs, there is a variety of possibilities to obtain medication, which 
makes it difficult to identify the receiver of the information. Sending prescriptions to community 
pharmacies may be easier in cantons without self-dispensing. 
Strengths and limitations 
A strength of the observation study in Project A2 was the telephone interview as a method to survey 
patients. A sufficient number of patients were reached and interviewed during a short period of time. 
The participation rate was quite high. The interviewer, who was able to explain unclear questions, 
could guarantee data completeness. Another strength of the study was the inclusion of patients from 
two different wards, and the comparison of patients’ and physicians’ views. 
We aimed to formulate valid and evaluable questions, yet there were still questions in the interview 
guide where data analysis was difficult due to unclear wording of the question. It was not always 
clear if patients referred to the current discharge or on all experiences they ever made with hospital 
stays, e.g. for the question about discharge satisfaction. Also, patients’ statements could not be 
verified, especially the ones about their medication knowledge. Furthermore, influencing factors on 
medication supply could not be assessed because there were only a few patients experiencing 
medication supply problems. Types of medications associated with supply problems were not 
assessed either. 
Findings of this study are limited to surgical and internal medicine patients from the KSB discharged 
to their homes. Due to inclusion criteria, the age of interviewed patients was higher than the age of 
the Swiss population [139]. Therefore, patients in this study are not representative of the Swiss 
population as a whole. The representativeness is also reduced due to exclusion of patients with 
hearing and language problems. It would have been interesting to investigate if foreign language 
also has an impact on medication supply and knowledge, as shown by an American study [140].  
Selection biases could have emerged from handing information flyers to patients, and in recruiting 
physicians for the interview. Thus, the study sample might not adequately represent the according 
populations. With the method used, only patient and physician views were researched and there 
was no focus on how community pharmacists experience medication supply of discharged patients 
and what their problems are. Community pharmacists’ problems are therefore under investigation in 
Project B of this thesis. But, through investigating both present views, results are more valid. A 
further bias could be the small sample size of interviewed physicians, which does not adequately 
represent the KSB. However, young physicians were chosen over experienced chief physicians, 




Conclusion and Outlook 
The hospital discharge is a critical phase in patient care. Regarding patient medication knowledge, 
there did not seem to be problems, as almost all patients reported knowing the indications of their 
current medication and changes in medication. There was a delay in discharge prescription filling 
which was not expected by the physicians. Fortunately, there were only a few gaps in patient 
therapy plans due to delayed medication supply. But, depending on the specific medication, gaps 
still may be unfavourable. Patients were satisfied with the general hospital discharge process and, 
like physicians, did not see the need for further optimisations like enhanced information transfer to 
community pharmacies. However, other suggestions were made, e.g. bridging supplies to avoid 
urgent medication acquisition. 
It would be interesting to further investigate which kind of medications lead to supply problems and 
to assess whether PIs by a clinical pharmacist at the hospital would have an impact on medication 
supply problems. Since physicians indicated time pressure at discharge as a limiting factor to give 
instructions, the clinical pharmacists taking responsibility for MedRec, a prescription check and 
counselling could be a starting point for a service. Physicians would be unburdened and the time 
issue would be reduced. It could also be considered if pharmacy technicians could counsel patients 
regarding the economic aspects [141]. To further investigate medication knowledge among Swiss 
patients and to obtain more accurate results, patients should be asked more in-depth questions on 
their medication knowledge than only indications, since patients are most informed about indications 
[55]. Because patients discharged from internal medicine wards have a 5.56 times higher risk of 
experiencing supply problems compared to surgical ward patients, services of further studies aiming 
to decrease supply problems should be addressed to internal medicine ward patients, as they would 
probably have a greater benefit.  
 







In addition to the evidence gained in Project A, the community pharmacists’ views of hospital 
discharge, assessed in Project B, will help to develop a preliminary study design (Figure 12). 
 
 
Figure 12: Overview of thesis approach, Project B 
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Objective: After hospital discharge, community pharmacists are often the first health care 
professionals the discharged patient encounters. They reconcile and dispense prescribed medicines 
and provide pharmaceutical care. Compared to the roles of general practitioners, the pharmacists’ 
needs to perform these tasks are not well known. This study aims to a) Identify community 
pharmacists’ current problems and roles at hospital discharge, b) Assess their information needs, 
specifically the availability and usefulness of information, and c) Gain insight into pharmacists’ 
objectives and ideas for discharge optimisation. 
Methods: A focus group was conducted with a sample of six community pharmacists from different 
Swiss regions. Based on these qualitative results, a nationwide online-questionnaire was sent to 
1348 Swiss pharmacies. 
Results: The focus group participants were concerned about their extensive workload with 
discharge prescriptions and about gaps in therapy. They emphasised the importance of more 
extensive information transfer. This applied especially to medication changes, unclear prescriptions, 
and information about a patient's medication supplies. Participants identified treatment continuity as 
a main objective when it comes to discharge optimisation. 
There were 194 questionnaires returned (response rate 14.4%). The majority of respondents 
reported to fulfil their role as defined by the Joint-FIP/WHO Guideline on Good Pharmacy Practice 
(rather) badly. They reported many unavailable but useful information items, like therapy changes, 
allergies, specifications for “off-label” medication use or contact information. Information should be 
delivered in a structured way, but no clear preference for one particular transfer method was found. 
Pharmacists requested this information in order to improve treatment continuity and patient safety, 
and to be able to provide better pharmaceutical care services.  
Conclusion: Surveyed Swiss community pharmacists rarely receive sufficient information along with 
discharge prescriptions, although it would be needed for medication reconciliation. According to the 





Hospital discharge is a critical step in patient care. A patient experiences a mean of four medication 
changes and may suffer from ADEs during their stay [117, 118, 142]. The therapy prescribed at 
discharge has to be continued as prescribed by the clinicians until the next consultation with a 
general practitioner (GP). However studies from Australia and Switzerland show that GP 
appointments are often delayed [18, 133]. In some countries, community pharmacists are therefore 
the first health care professionals encountered by the recently discharged patient, providing 
medication supply and pharmaceutical care [118]. 
Insufficient communication between hospitals and community pharmacists was identified as a main 
barrier to appropriate medication reconciliation [129]. It can lead to discrepancies between different 
documentation [45, 90], medication supply gaps [143], and subsequent hospital readmissions [93]. 
The readmission rate may be reduced by a community pharmacy-based intervention [144]. Drug 
related problems were detected in 25% of hospital discharge prescriptions [73]. In these cases, 
pharmacies had to handle prescriptions without quantities or with unusual doses. A recent 
intervention study in a Swiss region, aiming at optimising communication found a reduction of PIs by 
the community pharmacies after an in-hospital intervention [18]. But it is unknown if the performed 
optimisations met the pharmacists’ needs and objectives. To our knowledge, no study so far has 
compared the currently available information with the desired information in a mixed method study. 
The needs and wishes of subsequent health professionals when dealing with discharged patients 
have been studied for GPs, pointing out the insufficient quality and quantity of information transfer 
[40, 145-148]. One study in GPs compared the available and desired information after discharge and 
found significant discrepancies [39]. Information about drug discontinuation was available for 14% of 
GPs, while 89% desired to receive it. The authors also compared information desire between GPs 
and community pharmacists and found very similar needs. Even though pharmacists are often 
encountered earlier as many patients visit them before the GP, there are only a few studies focusing 
on them [39, 76, 87, 89, 91, 149]. These studies assessed the information transfer from hospitals, 
the community pharmacists’ challenges and needs in France, United Kingdom and Belgium [91]. 
The survey with Belgian community pharmacists conducted after a prospective study found that they 
are highly interested in obtaining more information at discharge [91]. 
In Switzerland, GPs are automatically provided with the discharge summary, but its content depends 
on the hospital software and the prescriber 
12,16
. Patients usually receive summaries along with their 
discharge prescription, but it remains unclear how many of them hand it to their pharmacist. A 
specialty of the Swiss health care system is, that in some regions prescribed medicines may be 
dispensed directly by physicians, their medical team or hospitals (so called “self-dispensing”) [2]. 
Some hospitals provide bridging supplies to their discharged patients, whilst others have public 
pharmacies. Therefore, community pharmacies in Switzerland may play different roles depending on 
regions.  
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According to the Joint-FIP/WHO Guidelines on Good Pharmacy Practice, pharmacists should fulfil 
certain roles, such as “provide effective medication therapy management” (Role 2) [86]. Specifically, 
Function B („manage patient medication therapy“) outlines that pharmacists play an essential role in 
evidence based treatment. They take the responsibility for coordinating the interdisciplinary team’s 
work, and transfer their knowledge to other health care professionals in order to ensure appropriate 
medication use. Function C encourages community pharmacists to „monitor patient progress and 
outcomes“. By assessing, interpreting and documenting clinical data and test results, pharmacists 
may monitor and influence health outcomes of their patients. But, in order to fulfil these roles, access 
to therapy-related, health-related and care-related data and collaboration on an organisation-related 
level are essential. To our knowledge, there is no study evaluating if pharmacists fulfil these roles. 
 
This study aims to a) Identify community pharmacists’ current problems at hospital discharge, their 
self-defined roles and the fulfilment of internationally defined roles, b) Assess the information needs 
by evaluating current availability and usefulness of information in community pharmacies, 
specifically therapy-, health-, care- and organisation-related information, and c) Gain insight into 
community pharmacists’ objectives and strategies for discharge optimisation. 
Methods  
The mixed method approach comprised both qualitative and quantitative measures. The qualitative 
focus group discussion helped to gain a deeper insight in the subject in order to design the 
subsequent quantitative questionnaire [150].  
This study did not involve health related patient information, nor were health or illnesses studied. 
Therefore, according to Swiss law on human research, no ethical approval was needed [151]. 
Focus group  
The focus group was conducted with a convenience sample of six community pharmacists. They 
were pragmatically chosen from the authors’ professional contacts to represent different subgroups 
in age, sex, regional health care system (e.g. self-dispensing model), experience and position within 
the pharmacy. The inclusion criterion was current employment in a Swiss community pharmacy. 
Pharmacists were initially contacted by phone. 





1. “Please state the role of your pharmacy when your client is discharged from hospital.” 
2. “In your experience, what are the most frequent problems that you encounter at hospital 
discharge?” 
3. “Assume that the hospital staff (e.g. physician, pharmacist, nurse) provides information 
about the discharged patient, in addition to the standard prescription. Please state all 
information that would be useful or interesting for your daily work.”  
4. ”We collected useful and interesting information items and the study team added some 
ideas. Please vote with green and orange cards for useful and unuseful items, and vote 
with the yellow card for a neutral opinion.”  
5. “So far we collected information items that could be transferred to community pharmacies 
in future. Pharmacists need competencies to deal with such information. Which 
competencies do pharmacists have that should be used, and which competencies are 
not available but should be acquired?” 
6. “Assume that the selected information items could be transferred to the community 
pharmacy. How should they be transferred?” 
7. “We talked a lot about information transfer. Do you have other suggestions, how to 
facilitate care after discharge?" 
The discussion was videotaped, to have a clear identification of the speakers on the audio line. Data 
saturation was not addressed. After a verbatim transcription of the discussion, a content analysis 
was performed inductively using a framework approach [152]. The transcript was fragmented and 
categorised by two investigators separately with MAXQDA (version 11.0.1, Foxit Software Company, 
Berlin) [152]. Different fragmentation and categorisation of the data were discussed between authors 
until consensus was reached. Statements within a category are summarised in the results section to 




The questionnaire was developed by all authors according to the aims and inspired by findings of 
the focus group. Structure, question types and wording were discussed extensively. The final 
version included six subjects:  
 
a) Sociodemographic and pharmacy characteristics adapted to other Swiss surveys for 
comparability [10, 153-155];  
b) Estimated numbers and origin of prescriptions (The categorisation of hospital types was 
adapted from the Federal Office of Public Health reporting style [156]);  
c) Fulfilments of the fully presented Functions B and C of the Joint-FIP/WHO Guideline [86], 
evaluated with a 5-point Likert-scale (very good, good, satisfactory, bad, very bad). For 
easier presentation in the results’ section, the 5 points were symmetrically aggregated to 3 
points;  
d) 28 items addressing information (derived from the focus group discussion), divided into four 
categories: therapy-related (A, see Table 20), health-related (B), care-related (C), and 
organisation-related information items (D), supplemented by two items on collaboration on 
an organisational level (E). They were evaluated on their availability by a 3-point Likert-scale 
(always or almost always, sometimes, never or almost never available), and on their 
usefulness by a 4-point Likert-scale (essential, desirable, neutral, not desirable [157]);  
e) Objectives for discharge optimisation derived from the focus group and presented in a 
single-choice question with respondents asked to choose one out of a possible five 
answers;  
f) An empty text field for additional comments. 
The questionnaire was piloted by three focus group participants and two pharmacists with both 
research and practical hospital experience. After minor adjustments in wording and methodology, 
the questionnaire in German was translated forwards and backwards into French and Italian, the two 
most widespread of the four official Swiss languages after German. All translators were native 
speakers of the language they translated into, and resided within Switzerland, as proposed by Wild 
et al. [158]. They were hospital or clinical pharmacists with experience in community pharmacies. 
The questionnaire was formatted electronically (Flexiform 2.7.0, University of Basel) and sent by 
email to all managers of pharmacies belonging to the Swiss Pharmacist’s Association (n=1348). A 
reminder was sent after 24 days and the survey was closed after 49 days. Data analysis was done 





Thematically similar results from the focus group discussion and the questionnaire are presented, 
related to each other, in the results' subsections. Subsections refer to the three aims. Pharmacists 
contributing to the focus group are named „participants“, while pharmacists answering the 
questionnaire are called „respondents“. Characteristics of participants and respondents are shown in 
Table 17 and Table 18. Of 1348 questionnaires sent out, 194 (14.4%) were completed and returned.  
 
Table 17: Participant characteristics: Characteristics of the six focus group participants. Mean age was 
47.3 ± 13.7 years. 
Participants Sex Age 
[y] 




Dispensing by physicians in 
the pharmacist’s region 
Participant 1 Female 40 15 Employee No self-dispensing 
Participant 2 Male 65 38 Owner No self-dispensing 
Participant 3 Male 30 5 Employee No self-dispensing 
Participant 4 Female 40 15 Manager No self-dispensing 
Participant 5 Male 47 15 Owner Self-dispensing 
Participant 6 Female 62 26 Employee Self-dispensing 
 
Current problems and roles  
The study aimed to identify the community pharmacists’ most important problems at hospital 
discharge. Focus group participants identified significant challenges within the current practice. Their 
workload and organisational barriers were addressed repeatedly (12 statements), which lead to 
waiting times for the discharged patients. 
“The hospital […] discharge is a huge problem, because it mostly happens during the weekends. 
And on weekends, the respective general practitioners are not available.” (P3) 
“We telephoned for hours, because the doctor on call wasn’t there anymore.” (P4) 
The change of medication or brands was judged as a major safety issue for patients (19 
statements):  
“It has happened more than once that the same active ingredient is prescribed multiple times. 
The general practitioner prescribes, then you are admitted to the hospital, the discharge 
prescription comes back […].” (P2) 
Participants referred to the expectations of patients and other health care professionals. They 
experienced being assigned the role of a supplier only (2 statements): 
“[...] the expectation when you enter a pharmacy is that you have to get it [the medication] 
immediately. That’s the expectation of my clients.” (P5)  
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Mean age [years±SD] 49.7±10.8 
Female sex 98 (50.5) 
Experience in community pharmacy  
< 2 years 2 (1.0) 
2 – 5 years 11 (5.7) 
5 – 10 years 16 (8.2) 
10 – 20 years 35 (18.0) 
> 20 years 130 (67.0) 
Pharmacies  
Location  
City center 47 (24.2) 
Urban quartier 58 (29.9) 
Agglomeration 37 (19.1) 
Countryside 52 (26.8) 
Pharmacist full-time equivalent  
< 100% 10 (5.2) 
101 - 200% 111 (57.2) 
201 - 300% 54 (27.8) 
> 300% 19 (9.8) 
Median prescriptions per month [number±SD] (5 invalid) 800 ±1127 
Discharge prescriptions as percentage of all filled prescriptions  
0% 3 (1.5) 
10% 120 (61.9) 
25% 52 (26.8) 
> 50% 19 (9.8) 
Most frequent origin of discharge prescriptions  
Hospitals for centralised care (e.g. university hospitals) 113 (58.2) 
Hospitals for basic care (e.g. regional hospitals) 76 (39.2) 






Participants considered the collaboration with other health professionals as one of their 
competencies, and ensuring the treatment continuity was emphasised as an important task. 
Confronted with the complete Functions B and C out of Role 2 from the Joint-FIP/WHO-Guidelines, 
56.7% and 73.7% of questionnaire respondents respectively judged their ability to fulfil these roles 
as (rather) bad (Table 19). Good or rather good fulfilment was declared by 19.1% and 10.3% of 
respondents respectively. 
Table 19: Role fulfiling: Answers of questionnaire respondents about fulfiling Joint-FIP/WHO Guidelines on 
Good Pharmacy Practice. The five item Likert-scale was symmetrically aggregated to 3 items. 
 
Table 20: Information rating Questionnaire results about availability (1st-3rd column) and usefulness (4th-
7th column) of categories A-D addressing information and organisational collaboration (n=194). Results 
are supplemented with ratings with green card in the focus group (n=6, last column). Some information 
was not proposed for rating and therefore not rated (n.r.) during focus group. The most frequent answers 









Function B: Manage patient medication therapy 37 (19.1) 47 (24.2) 110 (56.7) 


















































































































A: Therapy-related information         
Complete patient identification, e.g. age 181 12 1 177 15 1 1 n.r. 
Complete, up to date medication list 56 117 21 154 39 1 - 5 
Therapy on admission 34 90 70 51 116 26 1 6 
Therapy changes in hospital 24 97 73 110 79 4 1 6 
Reasons for therapy changes 6 33 155 80 102 11 1 1 
Therapy duration 82 104 8 169 24 1 - 6 
Therapy goals 6 38 150 49 127 16 2 6 
Therapy indication 8 51 135 54 124 14 2 4 
Off-label use is marked 10 41 143 127 57 9 1 6 
Emergency limits, e.g. blood pressure 8 43 143 89 93 10 2 6 
Interventions performed in hospital 16 26 152 53 118 20 3 4 
Information about if supply was given to 
the patient (n=193) 
18 40 135 52 108 23 1 4 
B: Health-related information         
Reason for hospital admission 6 43 145 28 127 35 4 4 
Major and minor diagnoses 1 28 165 43 129 20 2 3 
Description of wounds and their treatment 1 42 151 56 117 20 1 6 
Allergies  7 72 115 143 48 3 - 6 
Laboratory values to control therapy - 20 174 26 108 51 9 6 
Laboratory values to control side effects  1 7 186 24 99 59 12 6 
Laboratory values of kidney and liver  1 8 185 27 85 69 13 6 
C: Care-related information         
Next health care provider appointment 3 82 108 45 124 23 2 4 
Further care organisation, e.g. nurse visits  4 68 122 35 140 16 3 6 
D: Organisation-related information         
Contact information of treating personnel 85 96 13 142 49 2 1 6 
Contact information of hospital pharmacy 
(n=193)  
46 59 88 40 105 46 3 n.r. 
Hospital’s formulary  10 48 136 22 117 53 2 n.r. 
Hospital pharmacy’s documents e.g. lists 
about tablet crushing 
20 66 108 45 116 30 3 3 
Hospital’s compounding formulations  23 103 68 56 125 12 1 n.r. 
Hospital’s guidelines on diseases 4 39 151 35 125 32 2 n.r. 
Information about how to order special 
medicines  
20 62 112 40 113 41 - 4 
E: Organisational collaboration         
Hospitals give supply to patients at 
discharge 
15 83 96 52 108 28 6 4 




The 28 different information items from the questionnaire (A-D) are presented in Table 20. 
The category of therapy-related information (A) was considered the most useful by focus group 
participants (24 statements), e.g. specifications of the prescription like therapy duration or “off-label” 
use and medication changes. 
“[...] we have a lot of work to reconstruct what changed in the hospital and what didn’t. It needs a 
lot of work.” (P1) 
Changes of brands were highlighted to be frequent. Participants mentioned that for consumers 
registered in their pharmacy, the medication history allows them to reconstruct changes. But, if the 
prescription contains only a selection of medication – those which have to be obtained at the 
pharmacy – and not the whole medication list, missing products might be interpreted as 
discontinued.  
“What troubles me is retracing what has been stopped [...]. So, was phenprocoumon stopped or 
was it forgotten on the prescription or is only acetylsalicylic acid the current treatment [...]. That is 
a big problem […]." (P1) 
All participants suggested that prescriptions should be specified with “stopped” or "new since”. The 
reasons for therapy changes were desired only by one participant, others indicating they would be 
unsure how to deal with such clinical details. They state lacking expertise in interpreting and 
validating the decisions of other health care professionals. Therefore, they thought the knowledge 
that there was a change would suffice. This is congruent with the answers to the questionnaire, 
where 110 (56.7%) respondents stated to be satisfied knowing that there was a change performed, 
and 80 (41.2%) respondents judged the reason for the change as essential information. 
Focus group participants complained about insufficient information on intended unusual dosages or 
“off-label” use. All six said that the provision of explicit specification like the Latin “sic” would be 
useful (10 suggestions). This would save pharmacists from “running after these things” (P1). 127 of 
194 (65.4%) questionnaire respondents supported this statement about specifications for “off-label” 
use.  
Concerning the category of health-related information (B), all participants stated that information 
about patients’ wound care would be helpful. Participants felt competent in wound management, but 
said that their knowledge could be extended. Opinions about the importance of other health-related 
information like diagnoses were controversial between the two groups. Laboratory values were 
desired by all participants, but only with a clear purpose, e.g. to detect side effects. They confirmed 
being familiar with common values like blood glucose levels, however, they felt incompetent in 
judging the clinical relevance of uncommon values and called for further training. Allergy information 
was rated as essential by all six participants. In the questionnaire, 79 (40.7%) respondents declared 
to have at least sometimes access to allergies, and 191 (98.4%) desired access.  
92 
Regarding care-related information (C), all six participants said it is important to know the follow-up 
procedure (10 suggestions), for example, who is caring for the patient after discharge. This was 
supported by 175 of 194 (90.2%) questionnaire respondents, whilst only 19 (9.8%) had a neutral or 
opposing opinion. 
Objectives and strategies for discharge optimisation  
An urgent need for optimisation of the discharge process was claimed by all focus group 
participants, and different objectives were suggested. A reduction of workload was an objective often 
mentioned, with regard to their own work (12 statements, Table 21). But for patients, they saw 
treatment continuity as the major objective (22 statements), with pharmacists feeling responsible for 
bridging patients’ medication supply gaps. In the questionnaire, respondents chose better 
pharmaceutical counselling and care to be targeted by any discharge optimisation, whereas the 
workload was not a priority in this single-choice question (Table 21).  
 
Table 21: Objectives: Objectives of pharmacists for potential discharge optimisations, stated in the focus 
group (n=6) and in the questionnaire (single choice question, n=194). 
 
Statements in focus group n 
(%) 
Answers in questionnaire n 
(%) 
Improved continuity of supply 22 (32.4) 48 (24.7) 
Improved medical treatment (e.g. safety) 19 (27.9) 63 (32.5) 
Reduction of work load 12 (17.6) 1 (0.5) 
Improved counselling and 
pharmaceutical care  
11 (16.2)  77 (39.7) 






Table 22: Information transfer: Preferred transfer methods and display of information (single-choice 
question, n=194 respondents). 
 n (%) 
Medium  
as electronically accessible record 52 (26.8) 
as separate, special form 49 (25.3) 
on the discharge prescription 47 (24.2) 
on the medication chart 26 (13.4) 
on the discharge summary 18 (9.3) 
other (e.g. personal message) 2 (1.0) 
Design  
Addition of structured information (e.g. as checkboxes) 82 (42.3) 
Specification of existing information (e.g. 'sic', 'stop' for certain prescription lines) 72 (37.1) 
Addition of free text 36 (18.6) 
Others (e.g. pictograms, electronic patient record) 4 (2.0) 
 
 
Different strategies to achieve the stated objectives were found. Besides the information content, its 
transfer and display were discussed in the focus group. Participants emphasised the need for new 
information technology like electronic patient records (17 statements), but were concerned about 
their confidentiality. Therefore, paper-based solutions were requested (8 statements). The 
questionnaire respondents’ major preference was for electronic methods (52 of 194, 26.8%, Table 
22), this was especially true for respondents with 5 - 10 years of experience. The less experienced 
the respondents were, the more likely they preferred the prescription. This and other paper-based 
solutions like summaries or medication charts were also highly rated as acceptable methods by the 
respondents (Table 22). The timing of information transfer was judged to be crucial. Participants 
suggested that prescriptions with additional information should be sent to the pharmacy before 
discharging the patient (16 statements).  
Concerning display, participants noted that it should be possible to write the information simply and 
briefly (6 statements). Structured information was prioritised over free text by 154 questionnaire 
respondents (Table 22), which was similar to the focus group. 
“In the end, to be realistic, you have to bring it in a form that also saves time for the doctor.” (P3) 
Participants preferred to receive concise and clearly arranged information over long summaries, in 
order to find the essential into information quickly (10 statements).  




Besides optimisation through an enhanced information transfer regarding patient therapy, health and 
care, participants expressed a need for general collaboration between hospitals and pharmacies. 
Questionnaire respondents stated a desire for the provision of organisation-related information (D, 
Table 20). Focus group participants repeatedly stated that they feel dependent on hospitals. They 
lack information about hospital's guidelines and formularies to adapt their stock (16 statements). 
Participants described further initiatives: 
“What I experienced more than once and what I greatly appreciated was: When [...] the doctor 
already knew that it was a special product or an uncommon medicine, he called before 
discharging the patient [...] and asked if we had it in stock.” (P3) 
Further suggestions for the provision of organisation-related information were to get lists of 
medicines prescribed for “off-label” use, to get instructions on extemporaneously compounding 
formulations, and on where to order foreign medication. Pharmacists also called for contact 
information of the hospital pharmacy staff. Four participants stated they would appreciate if the 
hospitals provided supply to prevent therapy gaps, and it would be good to know if a patient already 
had received supply on discharge. They called for shared education to enhance collaboration on an 
organisational level (E, Table 20). 
When asked for other optimisation ideas in a text field of the questionnaire, respondents again 
mentioned already discussed subjects. These were namely the importance of knowing medication 
changes for the patient’s safety and the advantages of information being available early. No new 
ideas were raised. 
Discussion 
This is the first published study evaluating current practices of information transfer between hospitals 
and community pharmacies in Switzerland, in direct comparison with the needs and objectives 
expressed by community pharmacists. To summarise, community pharmacists stated to have limited 
access to essential information, and they called for further therapy-related, health-related, care-
related, and organisation-related information. A need for discharge optimisation and organisational 
collaboration was claimed by both the participants in focus group discussion and the community 
pharmacists responding to the questionnaire. Better counselling, treatment continuity for patients, 
and reduced workload for pharmacists were identified as major objectives.  
In particular, this study revealed that community pharmacists see the hospital discharge as an 
important step in care transition. Participants and respondents complained about a lack of 
information, which impairs patient care in daily practice. These challenges are as well described in 
the literature [76, 159]. Both groups reported treatment gaps to be a frequent consequence. To 
compensate, community pharmacists invest a lot of time and effort in avoiding therapy gaps and in 
fulfiling their role as therapy managers. However, questionnaire respondents who were confronted 
with the Joint-FIP/WHO Guideline on Good Pharmacy Practice stated that they do fulfil their role 
(rather) badly. Focus group participants felt capable of doing more than just dispensing medicine, 
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and they wished to apply their expertise more often. A comparison of the provision of 
pharmaceutical care by community pharmacists across Europe revealed over-average scores for 
Switzerland e.g. in direct patient care activities and in patient monitoring [10]. These conflicting 
findings may be due to methodology that limits the value of self-reported behaviour. It would be of 
interest to study how other European pharmacists judge their role fulfilment if confronted with the 
Joint-FIP/WHO Guideline. Nevertheless, our study indicates a high need for better exchange of 
information at discharge, and revealed the potential of community pharmacists to improve treatment 
continuity.  
Regarding content of the information, four categories (A-D) evolved from the focus group discussion 
(Table 20). The availability of the different items varied significantly, and it differed also among 
pharmacies. This is possibly due to special settings which combine a GP practice and a pharmacy; a 
new development in Switzerland. Outstanding examples of pharmacies with extended collaboration 
were also described before [89], but it is unknown if specialised pharmacies with a GP practice in 
the community pharmacy responded to the questionnaire. It needs to be taken into account, that 
respondents may have answered for general availability of information, and not always specifically 
for recently discharged patients. However, all respondents deplored insufficient quantity and quality 
of information, as well as delayed information transfer. 
Looking at the categories (A-D) in detail reveals a mixed pattern. Therapy-related items (A) like 
patient identification, therapy duration or up-to-date medication lists were rated with the highest 
availability. In accordance with that, they are also valued the most essential by the respondents. 
During a hospital stay, therapy changes such as new or altered treatments are common [117]. 
However, our results show that they are usually not communicated, which makes medication 
reconciliation labour-intensive. Therefore, detailed information on changes was strongly desired, as 
well as a complete list containing all medicines a patient should use. Other studies had similar 
findings, where pharmacists and GPs also stated a need for more information about medication 
changes [129, 147]. Surprisingly, information about reasons for changes was not as desired as the 
information that there was a change. This is congruent with a Belgian study [91]. Pharmacists seem 
not to reevaluate clinical decisions, which may be due to a lack of time or limited clinical expertise. 
Regarding stop orders, focus group participants repeatedly stated that insufficient transfer of such 
information may put patients at risk. The explicit need for this information was supported by 
literature, where 76% of interviewed American pharmacists saw a need for this information [39]. 
Likewise, this was put on a “wish list” by Kennelty et al. [129]. A second therapy-related focus was 
“off-label” use. It usually remains hidden because diagnoses are rarely accessible for community 
pharmacists. In this situation the indication would be essential in order to check the appropriateness 
of the prescription.  
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Information items categorised as health-related (B) are almost never available. Within those items, 
allergies were accessible to some responding pharmacies. Allergy information was considered 
essential by most of the respondents, matching results of previous studies [39, 91]. Interestingly, 
other health-related items like kidney function results were significantly less desired. This may be 
due to a lack of experience in judging the appropriateness of individual doses. This low interest in 
clinical details opposes earlier statements, that pharmacists would rather be seen as competent 
health care professionals. Although, focus group participants called for further education in these 
topics, for example evaluation of laboratory results and wound care. 
Besides dispensing and counselling a patient, pharmacists have a role in coordinating patient care 
[86]. Therefore, care-related information (C) would be helpful but is currently only sometimes 
available. The knowledge of a patient’s social situation, the needs for support in the management of 
medicines or the information about the next appointment with the GP would enable community 
pharmacists to fulfil their role more adequately. Our findings underline similar results from other 
studies, where the date of the next GP appointment or knowing how the patient manages their 
medication at home were highly rated [91, 129]. With this information, coordinating care within the 
interdisciplinary team would be easier for pharmacists.  
In both study parts, different objectives for discharge optimisation evolved. During focus group 
discussion, there was a desire for reducing the pharmacist's workload, whilst in the questionnaire, 
more patient-oriented than pharmacist-oriented objectives were chosen. This discrepancy may be 
due to methodological reasons (free discussion versus single-choice question). However, objectives 
expressed by participants and respondents were similar to a Belgian and a Swiss intervention study, 
where continuity of treatment was targeted [91, 160]. To achieve the above mentioned optimisations, 
different strategies were discussed. Participants and respondents suggested an enhanced 
information transfer from hospital to community pharmacy. No other substantial concepts were 
discussed when participants were asked for additional ideas, highlighting this as a priority issue.  
Pharmacists in both settings insisted on an early transfer of information. They preferred concise and 
clearly structured information. A well-designed form would help hospitals to implement such 
documentation, and pharmacists to read it efficiently. While questionnaire respondents prioritised 
electronic tools, focus group participants preferred paper-based solutions like handovers, because 
they were afraid of any implementation delay with a new system. Surprisingly, there was no clear 
trend of younger pharmacists preferring electronic tools. However, electronic platforms were 
welcomed for organisation-related information (D). Such organisation-related information was 
sometimes or seldom accessible, although rated as very helpful. As a general impression from the 
focus group discussion, pharmacists see their surrounding hospitals as “lucky dips” or "black boxes”, 
not knowing what happens inside and being surprised by what comes out. Similar opinions have 
been collected among Swiss GPs [40]. Personal knowledge of the treating personnel may enhance 
collaboration [91, 129]. Through extended collaboration on an organisational level (E), e.g. shared 
education, this impression of GPs and community pharmacists may be diminished.  
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Some limitations have to be taken into account. This was a mixed method approach leading to 
qualitative, and subsequent quantitative results. Country- and population-specific characteristics like 
self-dispensing may limit applicability to other health care systems. There may be a selection bias 
for pharmacists, however, age [153, 161], gender [153, 154, 161] and experience [10] of 
respondents, as well as location [10, 153] and size [155, 161] of pharmacies, were very similar in 
both groups compared to other studies. There was no evaluation of different pharmacy settings, 
which would have been useful to compare. Response to the questionnaire was rather low compared 
to response rates of 43 - 57.4% in similar settings [10, 153, 154, 161]. This may be due to an 
overload of surveys being sent to this population lately and the fact that the questionnaire was sent 
to pharmacies and not to personal email accounts. A response bias cannot be excluded. The mixed 
method approach helped to enrich the knowledge gained from the 194 respondents, enabling a 
broader insight in the subject. Through focusing on information transfer, other important strategies of 
discharge optimisation may have gone underreported. 
Conclusion 
To conclude, insufficient communication at hospital discharge may cause therapy gaps and 
introduce additional workload for community pharmacists. Although the very essential therapy-
related information is sometimes available for Swiss community pharmacists, desired health-related 
and care-related information is mostly inaccessible. Interviewed community pharmacists called for 
enhanced collaboration to support patient safety, mainly through information transfer. Its layout was 
hoped to be concise and well-structured to enable quick and easy reading. No clear preference for a 
transfer method was identified. We recommend that any optimisation of hospital discharge should be 
adapted to community pharmacists’ competencies and needs. With this, they would possibly be 
more able to support patients in their therapy to their best.  
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The main topic of Project C is the POMMES service: Pharmazeutische Optimierung des 
Medikamenten Managements nach Entlassung aus dem Spital, engl. Pharmaceutical Optimisation 
of the Medication Management after dischargE from hoSpital. 
The preliminary study design of the POMMES RCT, which was developed based on Projects A and 
B, is now tested for feasibility, efficiency and quality in Project C1 (Figure 13). Based on gained 
knowledge, the study design can be further developed and evaluated for effectiveness in Project C2.  
Further insights in the effects are gained from Project C3.  
 
 
Figure 13: Overview of thesis approach, Project C 
  
C. Optimising hospital discharge by the POMMES service  
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C1. Development and feasibility testing of a preliminary 








Many intervention studies in seamless care fail to show effects, often due to a suboptimal study 
design [60, 162]. It is of utmost importance that good evidence about services is gathered in order to 
motivate policy makers to facilitate and promote implementation [162]. Furthermore, it is important to 
distinguish between explanatory trials and pragmatic trials. Explanatory trials aim to show the 
efficacy of a service in an ideal setting, whilst pragmatic trials prove effectiveness in the reality of 
daily clinical practice [98, 99]. It is therefore indispensable that the goal of a study is well-defined, 
and that the goal determines the study design. Potential risks should be forseen in a list of key 
uncertainties and criteria that have to be fulfilled to successfully conduct the study [100]. If these 
potential risks occur, they can have an impact on feasibility and outcomes, therefore it is important to 
estimate and target these risks. Hughes and colleagues summarised well that in pharmacy practice 
research, the approach ISLAGIATT (“it seemed like a good idea at that time”) is too often applied 
[163]. Careful study planning should therefore be done for every pharmacy practice research project. 
The MRC guidance describes how to develop and evaluate complex interventions (services) [100]. 
The POMMES approach qualifies as complex service, as there are many interacting components: 
The service is affected by different organisational levels and stakeholders, behaviour of involved 
hospital staff is important, the service is standardised, but should also allow some flexibility. The 
cycle of the MRC framework, containing the four steps of development, feasibility and piloting, 
evaluation and implementation can be applied to the development of a pragmatic in-hospital 
POMMES service [100, 162].  
In Projects A and B, evidence was gained to develop the service. The development of a preliminary 
study design for the POMMES study (Pharmaceutical Optimisation of the Medication Management 
after dischargE from hoSpital) was done through multiple brainstorming sessions. The pragmatic in-
hospital service to optimise hospital discharge should later be evaluated for effectiveness in a 
randomised controlled trial. It was planned to include patients from internal medicine wards. They 
should be informed about the study and give informed consent. It was planned that the service 
would comprise a discharge prescription check and optimisation, in collaboration with the 
responsible ward resident physician. This check would follow a standardised procedure, and would 
result in suggestions for adaptations of the perscription. These would be discussed with the resident, 
and adaptations made to the prescriptions. The patient would then be discharged as usual, and visit 
their usual community pharmacy to fill the prescription. Pharmacies would be asked for participation. 
At the patient’s discharge, the pharmacy is informed and recieves a “pharmacy case report form” 
(pCRF). PIs in the community pharmacy when filling the prescription should be documented on the 
pCRF. The pCRF would then be delivered back to the study team for data sampling. The primary 




The aim of this Project (C1) was to complete a list of key uncertainties and criteria (summarised as 
uncertainties in the following) related to the preliminary POMMES study design. These uncertainties 
would then be assessed through feasibility testing, to ensure our preliminary POMMES study design 
to be feasible, efficient and of high quality.  
Methods 
A brainstorming session with three clinical pharmacists with experience in discharge topics was 
performed. Key uncertainties for the study, which could influence quality, feasibility and efficiency 
were compiled in a list. Important uncertainties contained questions which had to be answered, as 
well as possible risks for the study success. The uncertaintes were organised according to the 
phase of study they are relevant for, based on a method used in a multidrug blister pack study [164]: 
1. Preparation 
2. Patient screening 
3. Patient recruitment 
4. Randomisation 
5. Service: prescription check 
6. Service: prescription optimisation 
7. Prescription filling 
8. Documentation of interventions 
9. Data management 
10. Outcomes 
Further definitions were made for every uncertainty [164]: 
- concerning process or structure [165] 
- affecting the study’s feasibility, quality or efficiency  
- indicator to be measured 
- assessment method 
Examples are given in the Table 23. All 55 uncertainties with their categorisation and the results are 




Table 23: Example of the sampled uncertainities and criteria. Full table in appendix 9.4.1. 



















to be defined 
for the study 
team 








A colleague CB replaces LB in 
case of absences to perform the 
service. For data collection and 
data entry, PW and ML replace 
GP in case of absence. 
Patient recruitment 




P E Duration of 
the 
recruitment 
for a single 
patient 
PPS Patient recruitment duration was 
mostly finished within 5 minutes. 
For a more efficient recruitment, 
the patient can be informed orally 
and the written information with 
the consent form can be handed 
out to read. Later, the filled 
consent form can be sampled in 
all rooms. We conclude that 
recruitment duration is feasible.  
 
A measurable indicator could be a number, percentage or a list of arguments. There were different 
assessment methods. Interviews and brainstormings were conducted with key persons with broad 
knowledge of the processes or structures in question. These were, for example, physicians, 
statisticians, community pharmacists and clinical pharmacists. A second assessment method was 
literature research, which aimed, for example, to estimate characteristics of the targeted population 
and intervention. A third assessment method was piloting. Three different pilot studies were 
necessary to assess all uncertainties with their indicators;  
- a “screening pilot study (SPS)”, where the screening method was tested, 
- a “community pharmacy pilot study (CPPS)”, where the processes in the community 
pharmacy were tested,  
- and a “procedural pilot study (PPS)”, where the entire study procedure was tested  
The screening pilot studies are described with their respective methods and results in the following. 
The other key uncertainties that were assessed are listed and described in the appendix 9.4.1. 
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Screening pilot study (SPS) 
Methods 
The SPS aimed to estimate the possible size and characteristics of the target population, as well as 
the duration of the screenings. A random patient sample of the hospitalised population on the 
planned study wards was screened for preliminary inclusion and exclusion criteria (Table 24). A first 
SPS was performed from 18.4.2016 until 22.4.2016, when patients from wards 111, 112, 121 and 
122 from the internal medicine department were screened. A second SPS was performed from 
31.10.2016 to 2.11.2016. More precise inclusion and exclusion criteria were applied, e.g. ward 
selection was specified in the meanwhile due to the wards’ specialisations, and private insurance 
patients were excluded because they are treated by a special team and not by the usual ward team. 
During the procedural pilot study, there was a third (real-life) testing of the screening, which is 
described later. 
 
Table 24: Inclusion and exclusion criteria in the two screening pilot studies (SPS) 
Inclusion criteria first SPS second SPS 
Study wards  111, 112, 121, 122 111, 121 
Exclusion criteria   
Not discharged to their home x x 
Patient not from internal medicine department x x 
No discharge prescription x x 
Underage x x 
Private insurance   x 
 
Results 
In 100 screened patients from the first SPS, 26 were not discharged to their home but to a 
rehabilitation centre, elderly’s home or equivalent, 12 were not internal medicine patients, and 5 had 
no discharge prescription written. No patient was underage. In total, 37 of 100 patients fulfilling one 
or more exclusion criteria were excluded. Patients had a median of 10.1 ± 4.17 prescribed 
medicines. 
In the second SPS, 54 patients were screened. The following exclusion criteria were applied in this 
order: internal medicine patients (54 remaining patients), ≥18 years old (54), semi-private or 
standard insurance (53), and discharge to home (36). In total, 36 of the 54 screened patients 
remained eligible after application of exclusion criteria. The total duration for the 6 screening 
sessions (3 days on 2 wards) was 26 minutes, with the first days needing significantly more time 
than the following days (max. 11 minutes, min. 1 minute).  
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Community pharmacy pilot study (CPPS) 
Methods 
The CPPS was conducted to evaluate the suitability of a video training for community pharmacists, 
the pCRF, and the general suitability of the study procedure for the community pharmacy. A 
preliminary 3 minute video training about the pilot study was produced with power point slides and 
accompanying audio explanations. Participants had to advance slides when prompted. It contained 
information about the POMMES study background, a definition of a PI, as well as goals of, and 
explanations about, the CPPS. 
Pharmacists and pharmacy technicians (professional contacts of LB) were asked for participation. 
Participants were asked to watch the video carefully. They received a first fictive prescription, a 
fictive patient history (both in appendix 9.4.2) and a preliminary pCRF (Figure 14). This first case 
was to imitate a control group case. Participants were asked to fill the prescription hypothetically and 
complete the pCRF. All PIs had to be documented. A few days after returning the pCRF, they 
received a fictive intervention group prescription with a second pCRF, which had already been 
adapted according to answer quality on the first pCRFs sent back. Within a few days of completing 
of the second pCRF, participants were called for a telephone interview. The interview (appendix 
9.4.3) comprised both open and Likert-scale questions about the video training and about the pCRF. 
The preliminary POMMES study procedure was evaluated by the participants for feasibility from a 
community pharmacy’s perspective, as well as barriers and facilitators to pharmacies for 








Figure 15: The final version of the pCRF 
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Results 
In total, 5 pharmacists and 3 pharmacy technicians completed the CPPS. One pharmacist gave 
consent to participate, but filled only the first pCRF. The last interview was performed within one 
month of the first case study. 
The video training was judged as the most comfortable training method. Other options, like personal 
training or letters were deemed unsuitable. The length of the video was judged as appropriate, and 
few technical optimisations were suggested. The content was mostly clear, and only some 
suggestions for further information were made, e.g. an additional explanatory case was desired to 
illustrate the mentioned theory. 
For the pCRFs’ content, participants mentioned difficulties when documenting a PI. The definition of 
a PI was unclear. Therefore, the documentation was inconsistent. The term “adherence” was 
suggested to be changed to “compliance” for better understanding. Other questions were deemed 
easy to understand. It was suggested that the pCRF should additionally contain the day time of 
prescription filling, as this would be interesting to analyse. Space limitations were a barrier to 
document all PIs, but the participants suggested that the pCRF should not exceed one page. 
Participants judged the time needed to fill the pCRF as appropriate. The final pCRF is shown in 
Figure 15. Faxing of the pCRFs to the pharmacy and back to the study team was feasible. 
The complexity and feasibility of the POMMES study procedure was judged as reasonable. The 
following barriers for community pharmacies to give consent to participate in the study were found: 
The time effort to watch the video, fill the pCRF, time constraints and work effort with seemingly no 
benefit or only a future benefit. In contrast, some facilitators were found: Filling discharge 
prescriptions takes a long time anyway. If the study showed good results, the workload would be 
reduced in the future. Participants were enthusiastic about the difference they saw between the first 
(control group) and second (intervention group) prescriptions. Medication safety and patient 




Procedural pilot study (PPS)  
Methods 
The PPS was performed to test the entire POMMES study procedure in real life at the hospital and 
at the community pharmacy. A special focus laid on the feasibility of patient screening and 
recruitment, the in-hospital communication, the suitability of the preliminary hospital case report form 
(hCRF, final version 9.4.8), and the further amended pCRF (after the CPPS). 
In the hospital, resident physicians were informed about the PPS by mail and at a daily departmental 
meeting. Patient screening was started on the 12
th
 of December 2016 on the predefined internal 
medicine wards (111 and 121). Inclusion and exclusion criteria are shown in the flow chart (Figure 
16). Criteria were already adapted from the earlier pilot study and were now newly divided into 
inclusion and exclusion criteria, and carefully ordered according to working procedures. Eligible 
patients were contacted bedside and informed orally and in written form about the study (by GP and 
LB). They gave written informed consent. All patients were allocated to the intervention group, as 
this study arm was judged to be more important to test than standard care. Findings from the 
intervention group could give an insight into problems in the control group.  
The study procedure was performed according to the study idea described previously. When an 
enrolled patient was discharged, their pharmacy was informed by phone about the PPS. No earlier 
information or recruitment of pharmacies for the pilot study was performed. A staff member was 
instructed about the procedures and how to fill the pCRF. The pCRF was then faxed to the 
pharmacies in advance of the patient’s discharge. After filling the prescription, the pCRF was faxed 
back to the study team and was revised based on data quality and completeness. Experiences of 
the procedures in the hospital were discussed with residents in an unstructured form to optimise 
communication.  
Results 
The eligibility screening was performed with 66 patients. Applied inclusion and exclusion criteria, 
with corresponding numbers are shown in the flow chart (Figure 16).  
Daily screening needed between 5 and 20 minutes (average 12 ± 7 minutes), and the service at the 
hospital, were done within 4 and 32 minutes (average also 12 ± 7 minutes). Many patients were 
missed for recruitment due to their absence in their rooms, or the presence of visitors. The patients 
for whom the service was performed had a median of 10.5 ± 5.2  medicines. In the hospital, the 
preliminary hCRF did not meet the study team’s needs, as data fields were in an unfeasible order 





Figure 16: Inclusion and exclusion criteria used in the procedural pilot study (PPS).  
 
In the hospital, interviewed resident physicians claimed to not knowing which of their patients were 
included in the study. Therefore, they were not able to inform the study team about the discharge. 
This may be a reason why the number of patients already discharged before the intervention could 
take place (5 of 23) was high. Physicians asked for a note in the electronic patient record that a 
patient was included. The frequent telephone calls from the study team were not stressful for them 
and they said that collaboration was good. General information about the study in the daily 
department meeting was judged appropriate.  
In the community pharmacy, 5 pharmacists and 4 technicians filled the 9 prescriptions. Filling 
needed 20 ± 22 minutes (on average, median 15 minutes). There was one outlier, needing 75 
minutes for filling a prescription with 22 medicines. The pharmacy staff were rather or very satisfied 
with the prescription quality. Data quality on the returned pCRFs was better than in the CPPS, and 
was good overall. For two patients, no filled pCRF was returned by the pharmacy, despite a 
reminder. This was a relative high number, although no consent was asked from the pharmacies for 




Based on the MRC framework, we used an approach to test the feasibility, effectiveness and quality 
of the preliminary POMMES study design. The definition of a list of key uncertainties helped to 
perform pilot studies with a specified aim. Several conclusions can be drawn from the pilot studies 
for all the procedures. 
Screening and recruitment 
Patient screening was tested with different inclusion and exclusion criteria and was specified 
according to the previous findings. In the end, a list of inclusion and exclusion criteria in a certain 
order was created. Patients were excluded by the first exclusion criterion which applied to them. 
Therefore, it is not possible that a patient would be excluded for several reasons. This suited the 
data management and enabled a clearly structured procedure.  
With the three screenings, good knowledge about the eligible population was gained. This helped to 
estimate study duration. It was surprising that many patients were missed for recruitment and this 
had to be taken into account for study duration. A change of timepoints for recruitment was 
suggested to reduce the number of missed patients. Overall, the recruitment was suitable. 
Procedures at the hospital 
Collaboration with the resident physicians was good. They only criticised that they did not recognise 
included patients. That was a main reason for the study team to miss patients at discharge. 
Residents suggested to add a note in the electronic patient record, so that they could inform the 
study team about the upcoming discharge. The time management at discharge proved to be 
feasible. In most cases, the prescriptions were ready in advance. Residents were not stressed by 
frequent calls, therefore this communication method was not changed. The preliminary hCRF used 
for the service was not suitable. Therefore, the performed pilot studies were helpful to adapt the 
hCRF (final version appendix 9.4.8). 
Procedures at the community pharmacy 
The CPPS showed that teaching pharmacy staff with videos was reasonable. It should well explain 
what a PI is, and furthermore include a case study. The documentation of PIs was difficult and 
amendments to wording and design of the form were done. Time constraints were suggested as the 
main barrier for pharmacies to participate in the study. However, some facilitators were named. We 
concluded therefore that motivating pharmacies to participate would be possible with the right 
arguments. The study procedure was judged as suitable, and receiving and sending the pCRF by 
fax was feasible. Therefore, no changes to that procedure were made. 
In the PPS, pharmacies were informed about their included patients on the day of discharge. It was 
not an inclusion criteria for patients that their pharmacies participated in the study. Therefore, some 
pharmacies did not fill in the pCRF, and their patients were therefore categorised as drop-outs. The 
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drop-out rate was therefore possibly overestimated, as in the later POMMES study, only patients 
indicating to visit a participating pharmacy will be included. 
Conclusion 
With the application of the MRC framework, we gained knowledge about the feasibility, effectiveness 
and quality of a preliminary study design. Uncertainties could be assessed. The results from the 
piloting helped to define the final study design that should be used in the final POMMES RCT (C2).  
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According to the cycle described by the MRC, Project C2 was constantly checked for feasibility, 
effectiveness and quality. Adaptations were made if necessary. As they are not described in the 
publication and thematically fit in this chapter, they are shortly described here. 
Following problems for feasibility, effectiveness and quality were identified later, and adaptions were 
made: 
- The inclusion rates of patients were continuously monitored over the first weeks and 
extrapolated to the planned study duration. There were too few patients included to reach the 
goal of a three months study duration. Therefore, a third ward was included to recruit 
patients.  
- In the piloting, it was defined that screening is sufficient if performed only once a day. It was 
detected that the pharmacy student performed the screening of patients twice daily instead of 
once daily, which made the screening inefficient. Through teaching, the screening procedure 
could be adapted.  
- Stopped medicines should be annotated on the prescription, which contains a table with all 
the patient’s medicines. For the first cases, the stopped medicines were added as new 
prescription lines in this table, like an active prescription, and the “stop” annotation was given 
in the standard remark column. A resident physician pointed out that this could be 
misunderstood as an active prescription, if the annotation is overseen. Therefore, we decided 
to list the stopped medication as a comment below the table.  
- During data entry, we recognised that data should be double checked when entered into the 
database. Therefore, every dataset was checked by a blinded investigator. In addition, the 
significance of performed PIs in the community pharmacy should be investigated, to have a 
deeper insight into the relevance of the service. Therefore, we added a CLEOde 
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To improve discharge prescription quality and to transfer information to improve post-hospital care 
by a pragmatic in-hospital service. 
Design 
A single-centre, randomised controlled trial 
Setting 
Internal medicine wards in a Swiss teaching hospital 
Participants 
Adult patients discharged to home, 76 in the intervention and 76 in the control group 
Intervention 
Medication reconciliation at discharge by a clinical pharmacist, a prescription check for formal flaws, 
interactions and missing therapy durations. Important information was annotated on the prescription. 
Main Outcome Measures 
At medication dispensing, the community pharmacy staff documented their pharmaceutical 
interventions when filling the prescription. A Poisson regression model was used to compare the 
number of interventions (primary outcome). The significance of the pharmaceutical interventions was 
categorised by the study team. Comparative analysis was used for the significance of interventions 
(secondary outcome). 
Results 
The community pharmacy staff performed 183 interventions in the control group, and 169 in the 
intervention group. The regression model revealed a relative risk for an intervention of 0.78 (95% CI 
0.62-0.99, p=0.04) in the intervention group. The rate of clinically significant interventions was lower 
in the intervention group than in the control group (72 of 169 (42%) vs. 108 of 183 (59%), p<0.01), 
but more economically significant interventions were performed (98, 58% vs. 80, 44%, p<0.01).  
Conclusions 
The pragmatic in-hospital service increased the quality of prescriptions. The number of 
pharmaceutical interventions was significantly reduced, especially the clinically significant ones. 




Community pharmacists are often the first health care professionals in contact with the discharged 
patient [133]. They reported that dispensing to this population is related to relevant safety issues 
[166]. Drug related problems (DRPs), which affect 33-63.7% of discharged patients, may be 
identified by the community pharmacists [75, 83, 93]. Pharmaceutical interventions (PIs) may solve 
DRPs, but are often time-consuming [49, 84].  
The lack of information, like in unclear prescriptions, was shown to hinder the identification of DRPs 
[83, 84, 166]. Pharmacists in Switzerland and other countries reported that this applies for many 
essential information items, and they called for complete and updated information [91, 129, 166]. 
These are, in particular, complete medication lists, information on medication changes, interactions 
or more detailed information about compounded medication.  
Different services to overcome inefficient or low information transfer have been described in the 
literature. These include instructions for health care professionals [167], liaison pharmacists [93], 
and information transfer from hospital [91]. Many of these explanatory studies used new processes 
or extensive resources that may hinder later implementation [98, 129]. If a service should be 
implementable, it should be taken into account that a country may have limited clinical pharmacy 
resources, like Switzerland has [23]. Pragmatic approaches with realistic resource use, which are 
based on existing processes are easier to implement in daily practice.  
As clinical outcomes may be difficult to measure and depend highly on the patient’s health status, 
process measures can serve as useful indicators for the success of a service [60]. These may be 
medication errors [168] or satisfaction of health care professionals [93]. Other possible outcomes 
could be process measures representing the dispensing activities by community pharmacists, like 
PIs [66]. Literature lacks findings about the effect of a pragmatic intervention at the hospital on the 
number of PIs at the community pharmacy.  
Aims 
We designed a pragmatic in-hospital service by a clinical pharmacist, focusing on a discharge 
prescription check, and transfer of discharge information to the community pharmacies. The primary 
aim was to increase quality of discharge prescription in the intervention group, measured by a 
reduction of PIs at the community pharmacy. We aimed to reduce the workload of the community 
pharmacists and other health care professionals when filling the discharge prescription, measured 
by time needed for prescription filling and by established contacts, and to increase the satisfaction of 
the community pharmacist with the prescriptions. Furthermore, readmission rates, and the feasibility 





The study was a single-centre, parallel, randomised controlled trial conducted at a tertiary 360-bed 
teaching hospital in Baden, Switzerland. The procedures were developed and piloted according to 
the Medical Research Council guidance to ensure successful methodological conduction [100]. 
Ethical approval was given by the local ethics committee (EKNZ 2016-02051).  
Patient recruitment 
Three wards of the internal medicine department (with specialisations A: stroke and respiratory, B: 
infectious diseases, nephrology, and cardiology, C: acute geriatric ward) with a total of 76 beds took 
part in the study. Patient records were consecutively screened for eligible patients on a daily basis 
during 13 weeks from January to April 2017. Inclusion criteria were: Patients of the internal medicine 
department, ≥ 18 years old, without isolation due to infection, with standard or semi-private 
insurance, without cognitive impairment (e.g. acute delirium or severe dementia) that hinders 
patients from giving informed consent. Exclusion criteria were: Insufficient hearing or speaking skills 
to give consent, no consent, no medication on the discharge prescription, discharge on weekends, 
patients not being discharged to their homes. Patients were also excluded if they planned to fill their 
prescription in a non-participating pharmacy. Pharmacies were recruited in advance at a meeting of 
the regional pharmacists’ association and through mailing. All pharmacies within the region (canton 
Aargau) were eligible, and 70 of 121 pharmacies participated. Eligible patients were visited in their 
hospital room and informed about the study by the investigators (LB, GP) in oral and written form. 
Patients gave written informed consent.  
Study procedure  
Shortly before the upcoming hospital discharge of enrolled patients, they were 1:1 block randomised 
by LB in groups of 10 by means of a computer-generated randomisation list. Consecutive numbers 
were given to consecutively discharged patients. Demographic data of the included patients were 
recorded. The prescription was prepared as usual by the resident physician in charge. In both 
groups, a label was added to all prescriptions that allowed the community pharmacy to recognise the 
prescriptions of study patients.  
In the intervention group, a clinical pharmacist (LB, CB) performed the service (exposure) according 
to a defined procedure. The service consisted of a prescription check to identify DRPs and to 
discuss PIs for optimisation, which were the following:  
- Medication reconciliation was performed with the medication list from admission and from 
the last day on the ward. Medication changes were clarified with the resident physician, 
mostly on the phone. Unintentional changes were corrected and intentional changes were 
specified on the prescription (e.g. “new”, “stopped”, “changed dose”) 
- If opioids were prescribed on the normal prescription, the resident was informed that a 
special narcotic prescription form was needed.  
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- Formal flaws in names or units, unlicensed or compounding medication were identified and 
clarified with the resident; flaws were corrected or specified on the prescription (e.g. 
“compounding medication”, “medication available in Germany”). 
- Missing therapy duration for anti-infectives and subcutaneous heparin was clarified with the 
resident and added to the prescription. 
- Drug-drug interactions grade 1-3 (1: “contraindicated”, 3: “Surveillance/Adjustment”) 
according to the Pharmavista software were checked [169]. Relevant interactions according 
to the clinical pharmacist's expertise were discussed and solved with the resident. 
Acceptable interactions were commented on the prescription (“Interactions were checked 
and can be tolerated”). 
PIs accepted by the resident were implemented by the clinical pharmacist (LB, CB) directly on the 
usual prescription in the electronic patient records of the hospital.  
At discharge, the resident physician handed out the newly printed prescription to the patient in both 
groups as usual. Residents regularly counsel patients about prescribed medicines. If needed, nurses 
instruct patients about wound care or subcutaneous injections. For all enrolled patients, a pharmacy 
case report form (pCRF) was faxed to the patient’s community pharmacy. Previous to the study 
start, a Youtube video training was provided explaining the study procedure and how to fill the case 
report form (duration 5 minutes). A second video explained the pCRF in more detail with an 
explanatory case (8 minutes). The videos did not inform in detail about the service to limit reporting 
bias.  
The community pharmacies were blinded to the patient’s allocation to either group. When the 
prescription was filled at the patient’s preferred pharmacy, all PIs were documented on the pCRF 
and categorised by the staff using an adapted form of pharmDISC (categories C-F), a validated 
classification system for community pharmacies [82]. On the pCRF, the day and duration of 
prescription filling, the staff’s job role within the pharmacy was recorded and satisfaction with the 
prescription quality was documented with a 5-point Likert scale (very/rather satisfied, rather/very 
unsatisfied, not applicable).  
The pCRF was then sent back to the study team. If no data was provided within some days after the 
patient’s discharge, the pharmacy was called to ask for data transmission or to identify drop-outs. 
Drop-outs were defined as patients who never filled their discharge prescription in the named or 
another participating pharmacy, or patients whose pharmacy did not provide data.   
Data entry was done by blinded investigators (GP, PW). If needed, they called the pharmacy to 
clarify documentation. After data entry, all PIs were categorised using CLEOde  by the same 
investigators [85]. CLEOde is a simple validated tool to categorise the clinical, economical and 
organisational significance of a PI. All data was double-checked by another blinded investigator 
(ML). Readmission rates were provided by the medical controlling unit, and were categorised as 





The primary outcome was defined as the number of PIs performed in the community pharmacy. 
Secondary outcomes were the duration of prescription filling, established contacts for a PI, and 
satisfaction with the prescription quality. Furthermore, outcomes were the frequency pattern of 
performed PIs, the staff’s job role within the pharmacy, the time to fill the prescription after 
discharge, and readmission rates. 
For the primary outcome, i.e. the number of PIs, we fitted a Poisson regression model. Independent 
predictors were selected on the basis of literature [172-174] and discussion, and included gender, 
age, emergency admission, length of stay, number of medications, and the staff’s job role. In 
addition, we categorised prescriptions into two groups, in prescriptions with at least one PI and those 
with no PI, and fitted a logistic regression model with the same predictors. 
Comparative statistical analysis was used to describe patient characteristics and outcomes in both 
groups. A Kruskal Wallis Test was applied to discrete and continuous variables (e.g. age, number of 
prescriptions, number of contacts, time needed to fill prescription), and a Fisher’s Exact Test was 
applied to categorical variables (e.g. sex, profession, satisfaction, readmission rates).  
Calculations and analyses were performed using the software R, version 3.4.0 (R Foundation for 
Statistical Computing, Vienna, Austria). A two-sided p-value of <0.05 was considered as statistically 
significant. Power analysis based on the primary outcome with a level of significance α = 0.05 and a 
power of 1-β = 0.8 revealed a sample size of 75 complete patient data sets in each group.  
 
Results 
Of 866 screened patients, 172 were included in the study (Figure 17). With 10 drop outs in each 
group, complete data sets were obtained for 152 patients (equal to 152 prescriptions). No 
statistically significant differences in their baseline characteristics were found (Table 25). In the 
intervention group, the in-hospital service by the clinical pharmacist took a median of 7 minutes [IQR 
4, 9].  
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Figure 17: Flow chart of patient enrolment with inclusion and exclusion criteria 
 
Table 25: Baseline characteristics and outcomes of 152 enrolled patients, each 86 in both groups. Fisher’s 
Exact Test was used for categorial variables, Kruskal-Wallis Test for continuous and discrete variables. 
 Control group (n=76) Intervention group (n=76) p 
Age, median [IQR] 70.50 [57.00, 79.00] 71.50 [60.75, 79.25] 0.46 
Male gender, n (%)  43 (56.6) 48 (63.2) 0.51 
Swiss nationality, n (%)  63 (82.9) 64 (84.2) 1.00 
Semi-private insurance, n (%) 14 (18.4) 13 (17.1) 1.00 
Emergency admission, n (%)  57 (75.0) 63 (82.9) 0.32 
Hospitalisation ward, n (%) 
Ward A 
Ward B 
Ward C  
 
28 (36.8)  







Length of stay, median days [IQR] 7.00 [4.75, 10.00]   5.50 [4.00, 8.00] 0.51 





Community pharmacies performed 183 PIs for the 76 control group prescriptions, and 169 PIs for 
the 76 intervention group prescriptions. Per patient in the control group, a median of 2 [1, 3] PIs 
were performed, while 1 [0, 3] PIs were performed in the intervention group (p=0.10). Calculated per 
medicine, there were 0.33 [0.17-0.50] PIs in control group patients, and 0.17 [0.00, 0.44] PIs in 
intervention group patients (p=0.051).  
The Poisson regression analysis (Table 26) revealed that being allocated to the intervention group 
was an independent predictor for lower number of PIs (relative risk 0.78 (CI 0.62-0.99), p=0.04). 
With increasing length of stay, the number of PIs decreased. Pharmacists filling a patient’s 
prescription compared to other pharmacy staff, and increasing number of prescription items 
correlated with a higher number of PIs. In the logistic regression analysis (Table 27), being in the 
intervention group was also an independent predictor for having any PI (0.33 (0.13-0.78), p=0.01)).  
 
Table 26: Poisson regression analysis model for the primary outcome for the number of interventions, 
n=152, * = statistically significant, CI= Confidence interval 
 Relative Risk (95% CI) p 
Intervention group  0.78 (0.62-0.99) 0.04* 
Emergency admission 0.80 (0.64-1.02) 0.07   
Male sex 0.96 (0.76-1.21) 0.73 
Length of hospital stay 0.97 (0.95-0.99) <0.01*  
Age 0.99 (0.99-1.00) 0.16 
Number of prescribed items 1.17 (1-14-1.20) <0.01* 
Pharmacy technician filling 1.24 (0.89-1.76) 0.21 
Pharmacist filling 1.56 (1.11-2.24) 0.01* 
 
Table 27: Logistic regression analysis models for the number of prescriptions with no or at least 1 
intervention, n=152, * = statistically significant, CI= Confidence interval 
 Odds ratio (95% CI) p 
Intervention group  0.33 (0.13- 0.78) 0.01* 
Emergency admission 0.56 ( 0.14-1.89) 0.37 
Male sex 0.39 (0.15-0.95) 0.04* 
Length of hospital stay 0.86 (0.77-0.97) 0.01* 
Age 0.99 (0.96-1.02) 0.47 
Number of prescribed items 1.39 (1.19-1.68) <0.01* 
Pharmacy technician filling 1.29 (0.39-4.10) 0.67 




Table 28: Filling of the prescription, significance of performed interventions and data on readmission. 
Fisher’s Exact Test was used for categorical variables, Kruskal-Wallis Test for continuous or discrete 
variables. a 0=day of discharge, * = statistically significant, IQR = Interquartile range 





Significance of performed interventions    
Clinical significance (any clinical benefit) 108 (59.0) 71 (42.0) <0.01* 
Economic significance (lower costs)  80 (43.8) 98 (58.0) <0.01*  
Organisational significance (lower effort)  60 (32.8) 47 (27.8) 0.35 







Contacts established for the PI, n (%)   0.04* 
Only pharmacist  104 (56.8)  95 (56.2)  
Hospital physician 25 (13.7) 10 (5.9)  
General practitioner 0 1 (0.6)  
Hospital caregiver 0 3 (1.8)   
Home care  1 (0.5)    2 (1.2)  
Patient / relative 52 (28.4) 57 (33.7)  
Other 1 (0.5) 1 (0.6)  





















, n (%) 
within 7 days 
within 18 days 

















0 [0, 0]  0 [0, 1] 0.09 















Secondary outcomes are presented in Table 28. PIs with any clinical significance significantly 
decreased in the intervention group, and those with an economic significance increased. There were 
statistically significant differences between the intervention and the control group in terms of 
contacts established for the clarification of a PI by the pharmacy staff and in the satisfaction of the 
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pharmacy staff. However, no differences were found for the time needed to fill the prescription. In 
the supplementary table (Table 30), the pattern of performed PIs in the community pharmacy are 
shown. PIs caused by interactions decreased from 19 (10.4%) of all PIs to 3 (1.8%) in the control 
group, and those due to therapy duration increased (36, 19.7% vs. 57, 33.7%). Clarifications as a 
type of PI were reduced from 42 (23.0%) of all PIs to 17 (10.1%).  
 
Discussion 
We conducted a randomised controlled trial with a pragmatic in-hospital service performed by a 
clinical pharmacist before discharge. The service did reduce the number of PIs in the intervention 
group (primary aim). Clinically significant PIs were significantly reduced in the intervention group. 
The distribution of contacts did differ between the groups, and there were more hospital physicians 
contacted in the intervention group. Prescription filling was of equal duration in both groups. 
Satisfaction of the pharmacy staff with the quality of prescription was enhanced through the 
pragmatic in-hospital service. 
The patients in the control group and intervention group did not differ in their baseline 
characteristics. The median age and number of medicines of our population were lower compared to 
other Swiss trials [18, 36]. This could be due to ward specialisation, as we also included young 
stroke patients which furthermore have less medicines. Length of stay (median 6 days) was 
comparable to countrywide and the study site’s official data (mean 5.6 days in 2015) [13]. Patients 
filled their prescription mostly on the day of discharge, which is positive, and earlier than in a 
previous study, using self-reported data [175].  
Primary outcome 
Overall, the number of PIs was statistically significantly reduced according to the Poisson 
regression, as was hypothesised based on similar services [18]. The effect was even stronger when 
prescriptions were categorised to weather they needed no or any PI. A longer length of stay 
correlated with a lower PI rate. It can be hypothesised that with longer hospital stay, discharge 
therapies and prescriptions were more carefully prepared. The length of stay in Swiss acute care 
settings decreased in recent years [35]. This may be due to new remuneration systems which make 
early discharges economically more attractive to hospitals. Our results show that this development 
may not be advantageous for patients. In the community pharmacy, the most qualified staff 
(pharmacists) performed the higher number of PIs, but the staff’s job role did not influence if there 
was a PI or not. Prescriptions of male patients were less likely to cause a PI than prescriptions of 
female patients. However, no influence of the gender on the number of PIs was seen. There might 
be a barrier to intervene in male patients, but if interventions are performed, there is an equal 
number of PIs in prescriptions of both genders.  
The rate of PIs per patient in the control group (median 2) was similar to a study in the German 
speaking region of Switzerland, which documented PIs not only in discharge prescriptions, where 
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there was an average of 1.2 PIs per patient [67]. However, the rate was much lower than in a study 
from the French speaking part of Switzerland (mean 6.9) [18]. This group studied older patients and 
had a study pharmacist facilitating PI documentation in the pharmacies. 
Secondary outcomes 
The performed PIs showed different beneficial significance for the patient and the health care 
system in both study groups. Through the service, there was a high and statistically significant effect 
on the clinical and economic significance of the PIs. There were significantly less PIs needed with 
any clinically beneficial significance in the intervention group. That can be interpreted as a quality 
indicator for the discharge prescription, which led less frequently to the identification of DRPs. On 
the other hand, significantly more economical PIs, which may reduce costs, were performed in the 
intervention group. This could be due to an increase of exact adaptation of package sizes to the 
annotated therapy duration. Another explanation could be that through fewer clinical interventions, 
which may be costly monitoring recommendations categorised as economically unfavourable PIs, 
the rate of economically beneficial PIs increased. It can be assumed that the health care costs would 
be reduced, but this was out of the scope of this study and should be evaluated in a cost-
effectiveness study.  
Contacts to other health care professionals statistically significantly differed in their pattern between 
the groups. There seemed to be less contacts to the hospital physicians, which would reduce 
resource need for the hospital. This shows that the in-hospital services were useful especially for 
hospital-related problems and questions that would usually be solved with a call to the hospital. 
Patients and relatives were more involved when DRPs were solved. It is unclear if these contacts 
were needed to clarify or to counsel patients.  
Satisfaction of community pharmacists with discharge prescriptions was already high in the control 
group, but was even higher in the intervention group. There were only a few prescriptions in the 
control group that dissatisfied the pharmacies. This is consistent with a prior discharge organisation 
trial at our study site, where the satisfaction of the next health care providers has been increased 
[36]. It is possible that the satisfaction was not specifically influenced by the service itself, but 
through general enhanced collaboration and the participation in the study.  
Interactions caused less PIs in the intervention group. There is an obvious correlation to the service, 
as interactions were checked and clarified or annotated on the prescription as tolerable. There were 
more PIs in the intervention group related to any issues with therapy duration. This may be due to 
the enhanced communication of a specified therapy duration, which, for example, triggered more 
exact adaptions of package sizes by the pharmacist. As the pragmatic service could not target all 
DRPs, some categories did not show any change. Clarifications were reduced in the intervention 
group, a task that was reported to be highly work-intensive in a previous study [166]. This is in 
contrast to the finding that prescription filling took an equal time in both groups. We hypothesised 
that the time needed would be reduced in the intervention group. A reason for the opposite finding 
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may be, that documentation was mostly done in round numbers (e.g. 10 minutes) instead of the 
exact time. Without exact assessment, data on time needed should be interpreted with caution.  
The intervention did not significantly influence the readmission rates, possibly due to the 
underpowered study for this outcome. But the rates in the control group were similar to countrywide 
data [35].  
Strengths and Limitations 
A strength of our study is that we used a RCT design, in contrast to a previous before-after study 
showing a greater effect [18].  A pragmatic approach was chosen for the design of the service, as 
the number of clinical pharmacists in our country are low and their competencies have to be used 
efficiently [23]. The intervention needed only 7 minutes per patient to perform, which is much shorter 
than in other trials, and can be judged as feasible [18]. On one hand, pragmatic trials best reflect 
effectiveness in clinical practice, and we think that it will support later implementation [98]. On the 
other hand, pragmatic services do not account for all DRPs and therefore may have a lower impact 
on process measures and a patient’s health outcome.  
It is not known, how equally community pharmacists documented PIs and if they used best or 
common practice. One shortcoming of our study is the fact that community pharmacists were 
blinded to randomisation, but they may have detected differences in information content on 
prescriptions. Therefore, we can not completely rule out that reporting of PIs and satisfaction have 
been influenced. Residents were informed about the study, and PIs to their patients' prescriptions 
could have led to higher quality of the following prescriptions.  
Topics chosen to be addressed in this RCT, such as medication changes and interactions were 
based on the findings of a previous study, where Swiss community pharmacists evaluated 
availability and usefulness of discharge information [166]. As such, this study highly meets the 
needs of Swiss community pharmacists. However, the study was performed only at one study site. 
Generalisability could therefore be limited, but the international literature has studied similar topics 
[90, 91]. Therefore, our findings may be generalisable to other regions or countries with a similar 
health care setting . It should be taken into account that with a higher baseline PI rate, a greater 




The pragmatic in-hospital service reduced the necessity to intervene at post-discharge medication 
dispensing. Measured by the number and significance of PIs, we found that a pragmatic approach 
would be able to increase the discharge prescription quality. Therefore, patients could possibly 
benefit of a safer transition of care, and health care professionals could invest resources effectively 
and efficiently. Overall, the pragmatic approach proved to be feasible and showed promising results. 
Acknowledgments 
We thank Silvia Georgina Puiu (GP) for screening, recruitment and documentation, Cristina Belenda 
(CB) for replacements and categorising PIs. Thanks go as well to Jürg H. Beer for enabling the 
study at the internal medicine department, and Thorsten Mühlhauser for data extraction. We thank 
William Caddy for proof reading the manuscript. 
Funding 





Table 29: Supplementary table:  Pharmaceutical interventions (PIs) documented and classified with 
categories C, D and F of pharmDISC. n=152, 76 patients in each group. 
 
 Control group  
(183 PIs) 
Intervention 
group (169 PIs) 
C Cause of intervention, all, n (%)   
C1.1 No concordance with guidelines, only suboptimal therapy possible - - 
C1.2 Contraindication  3 (1.6) -  
C1.3 Interaction 19 (10.4) 3 (1.8)    
C1.4 Drug not indicated - -  
C1.5 Duplication 4 (2.2)  1 (0.6)      
C1.6 Adverse effect - - 
C1.7 Missing patient documentation - - 
C2.1 Inappropriate dosage form/administration route 2 (1.1) 3 (1.8) 
C3.1 Underdose - - 
C3.2 Overdose      1 (0.5) 1 (0.6) 
C3.3 Inappropriate monitoring   1 (0.5) - 
C3.4 Dose not adjusted to organ function - - 
C4.1 Inappropriate timing or frequency of administration   5 (2.7) 2 (1.2) 
C4.2 Inappropriate application                            - 1 (0.6) 
C4.3 Inappropriate therapy duration 36 (19.7) 57 (33.7)  
C5.1 Insufficient compliance  3 (1.6) 3 (1.8) 
C5.2 Insufficient knowledge 7 (3.8) 4 (2.4) 
C5.3 Concerns about the treatment 14 (7.7) 13 (7.7) 
C5.4 Financial burden  16 (8.7) 17 (10.1)  
C6.1 Prescribed drug not available  18 (9.8) 24 (14.2) 
C6.2 Error in medication process                         30 (16.4)        17 (10.1)      
C6.2a Error in substitution due to process 2 (1.1)  7 (4.1)   
C7.1 Incomplete/unclear prescription 13 (7.1)   9 (5.3)  
C7.2 Illegible prescription -  -  
C7.3 Missing prescription of necessary application aids 6 (3.3) 5 (3.0)  
C7.4 Formal/regulatory reason 3 (1.6) 2 (1.2) 
D Type of Intervention, all, n (%)   
D1 Substitution 52 (28.4) 52 (30.8)        
D2 Dose adjustment                                        4 (2.2)  1 (0.6)           
D3 Adjustment of package size/quantity 40 (21.9) 66 (39.1)                       
D4 Optimisation of administration/route 12 (6.6) 4 (2.4)                         
D5 Therapy stopped/no delivery 9 (4.9) 2 (1.2)                         
D6 Therapy started/continued 6 (3.3) 13 (7.7)                        
D7 In-depth counselling of patient 10 (5.5) 4 (2.4)                         
D8 Application instruction (training)                                  1 (0.5) 8 (4.7)                         
D9 Delivery of compliance aid incl. counselling 4 (2.2) 2 (1.2) 
D10 Clarification/addition of information  42 (23.0) 17 (10.1)       
D11 Transmission of information - - 
D12 Proposition of therapy monitoring                           3 (1.6) -             





C3. Evaluation of the POMMES study through interviews with 
resident physicians and community pharmacists involved 
 
Evaluation der POMMES Studie mittels Interviews mit involvierten 
Assistenzärzten und Offizinapothekern 
 
 




Background: The POMMES study was conducted  to enhance the quality of discharge 
prescriptions. The aim of this qualitative study was to learn from experiences of participating resident 
physicians and community pharmacists, complement main quantitative outcomes and to learn for a 
later implementation of the service. 
Methods: After study completion, involved resident physicians and community pharmacists were 
invited to participate in semi-structured interviews. The interview was conducted with 5 persons of 
each group, was audiotaped and transcribed. The interview consisted of the four subjects: general 
impression of the POMMES study, methodology, topics and effects of the service, and wishes for 
future services and collaboration. 
Results: Both groups (physicians and pharmacists) had a very positive opinion of the study. It was 
appreciated that the hospital pharmacy got involved in hospital discharge. According to the 
participants, the study enhanced collaboration between the different settings, and the intervention 
increased patient safety. The POMMES methodology fitted the needs of the residents, as they 
clearly knew which patients were included in the study. Community pharmacists appreciated the 
early information of when a patient was being discharged. Both groups reported that the prescription 
is a useful tool to communicate between the hospital and the community pharmacy, although 
pharmacists claimed that additional MCs would be helpful.  
Residents claimed to have highly underestimated the role of, and procedures in, community 
pharmacies. They reported having learned how important communication to pharmacies is, 
especially for medication changes. Medication changes were also the topic where the residents felt 
a subjective effect through the service. They reported having changed their habits, communicating 
changes regularly from then on. Pharmacists did not report to have seen a big direct effect, as many 
pharmacists stated to have been attentive for discharges, even before the study.  
For the future, both groups would benefit from a continuation of the POMMES service. This would 
ensure that every prescription is checked by at least two persons, and would enhance patient safety. 
Residents appreciated the wider presence of hospital pharmacy staff on the ward, and community 
pharmacists reported a desire for any kind of collaboration.  
Conclusion: Qualitative results on the POMMES service were gained. Resident physicians got to 
know the role of community pharmacies, and learnt through the study how important it is to 
communicate medication changes on prescriptions. Both professional groups would appreciate if the 




Hintergrund und Ziele 
Im KSB wurde die POMMES Studie durchgeführt. Die randomisierte kontrollierte Interventionsstudie 
bei Spitalaustritt untersuchte den Effekt einer pragmatischen, pharmazeutischen Dienstleistung, die 
aus einer Validierung des Austrittsrezeptes und anschliessender Kommunikation in die 
Offizinapotheke bestand. Primärer Endpunkt war die Qualität der Rezepte, gemessen anhand der 
Anzahl durchgeführter pharmazeutischer Interventionen (PIs) in der Offizinapotheke.  
Um nach der Durchführung die Erfahrungen der Assistenzärzte und der Offizinapotheker qualitativ 
zu erheben und die quantitativen Endpunkte zu ergänzen, wurden mit diesen Berufsgruppen 
Interviews durchgeführt. Ziel war insbesondere, die Meinungen zur Methodik, die Sensibilisierung für 
die Studieninhalte sowie subjektive Effekte zu erfassen. Die Dienstleistung sollte gemäss MRC 
Framework [100] evaluiert werden, und Wünsche zur Implementierung der Dienstleistung sollten 
erhoben werden. 
Methoden 
Nach Abschluss der POMMES Studie wurde bei allen involvierten Assistenzärzten und 
Offizinapothekern per E-Mail zu den Interviews aufgerufen. Ein persönlicher Reminder wurde 
denjenigen Personen gesandt, welche jeweils mehr als fünf eingeschlossene Patienten im Spital 
respektive in der eigenen Offizinapotheke betreut hatten. Von einer Apotheke meldeten sich spontan 
zwei Apotheker. Deren Aussagen wurden gemeinsam als eine Aussage gewertet, damit eine 
gegenseitige Beeinflussung nicht überbewertet wurde. 
Das Interview folgte einem semi-strukturierten Leitfaden und bestand abgesehen von den 
Charakeristika bei beiden Berufsgruppen aus denselben Fragen (für Apotheker Appendix 9.4.12). 
Das Interview beinhaltete folgende Themen: 
- Charakteristika der Interviewpartner 
- Gesamteindruck 
- Methodik der Studie 
- Inhalt und Effekt der Studie 
- Zukunftswünsche 
 
Das Interview wurde auf Schweizerdeutsch durchgeführt, aufgezeichnet und anschliessend auf 





Es konnten Interviews mit fünf Assistenzärzten und sechs Offizinapothekern in fünf Apotheken 
durchgeführt werden. Die Charakteristika sind in Table 30 ersichtlich. Die zwei Apotheker aus einer 
Apotheke, mit denen das Interview gleichzeitig durchgeführt wurde, sind als 4a und 4b aufgeführt.  
 
Table 30: Charakteristika der befragten Assistenzärzte und Offizinapotheker, na = nicht anwendbar 
 Assistenzärzte  Offizinapotheker  
 1 2 3 4 5 1 2 3 4a, 4b 5 
Alter [Jahre] 29 27 29 29 33 51 27 55 39, 34 57 
Erfahrung im jetzigen Tätigkeitsfeld 
[Jahre] 
1 1 2 2 4 24 1 30 15, 9 25 
Funktion in Offizin: Angestellter 
Apotheker (A), Besitzer (B), 
Geschäftsführer (G)  
na na na na na A A B A, A B 
(Mit)bearbeitete POMMES-Rezepte 
[geschätzte Anzahl] 
20 8 12 35 12 4 4 3 3, 4 5 
 
Gesamteindruck 
Die zusammengefassten Antworten sind in im Appendix 9.4.13 und 9.4.14 aufgeführt. Der 
Gesamteindruck bei beiden Berufsgruppen war sehr positiv (Table 31). Bei den Apothekern stand 
vor allem die Initiative zur Zusammenarbeit positiv im Vordergrund. Es wurde geschätzt, dass das 
Spital bestrebt sei, Synergien zu nutzen. Für die Apotheker war die Studie jedoch mit einem 
Mehraufwand verbunden, insbesondere beim Ausfüllen des pCRFs.  
Die Assistenzärzte schätzten vor allem das Vieraugenprinzip und die strukturierte Arbeitsweise bei 
der zusätzlichen Rezeptvalidierung, die während der Studie durchgeführt wurde. Die Assistenzärzte 




Table 31: Antworten der Befragten zum Gesamteindruck von der POMMES Studie. AA = Assistenzarzt, APO 
= Apotheker 
Befragter Antwort zum Gesamteindruck 
AA 1 „Dass du [Studienapotheker] auch noch einmal über das Rezept geschaut hast, ist sicher als 
Kontrolle - im Zweiaugenprinzip - sicher gut gewesen. Da habe ich gemerkt, dass einige Sachen 
beim Patienten geändert haben, sei dies Dosisänderung oder Stoppverordnung, was die Ärzte 
nicht immer aufschreiben, das hat dem Patienten sicher geholfen.“ 
AA 2 „Ich finde es eine sehr gute Sache, eine gute Intervention. Etwas mit dem Zweiaugenprinzip. Es 
passieren doch häufig Fehler.“ 
AA 3 „Ich denke das war sicher etwas Gutes, dass wir auch eine dritte Kontrolle hatten, dass ich das 
kontrolliert habe, dass die Oberärzte auch kurz draufgeschaut haben, und dass ihr 
[Studienapotheker] auch ein zusätzliches Auge darauf hatten, dass ihr auch gefragt habt; ist das 
jetzt wirklich gewünscht, dass Insulin so und so, und das Antihypertensivum so, dass man sich 
wirklich kritisch gefragt hat, ob das so stimmt. “ 
AA 4 „Es ist ein sehr interessantes Projekt gewesen, das ich persönlich als sehr wichtig erachte, weil es 
darum ging bei uns [das] Bewusstsein für das Rezept zu erhöhen. Was passiert eigentlich genau 
damit, wer schaut in der Apotheke, auf was wird geschaut, und was wäre gut, wenn man noch eine 
Bemerkung dazu schreibt. Also die Sensibilisierung für das Thema, und auch Lerneffekt, der 
gegeben war. “ 
AA 5 „Ich fand es gut, weil es eine Struktur gab, vom Ablauf beim Austritt, und eine gewisse 
Rückversicherung, oder Klärung von Ungereimtheiten. “ 
APO 1 „Ich finde es eine sehr gute Idee. Ich schätze, dass man wirklich in Zukunft die Synergien nutzen 
[will] - die Zusammenarbeit haben [will]. Was ein bisschen mühsam war im Alltag, mit dieser 
Struktur, wie die Fragebögen aufgebaut sind, dann wirklich genau im richtigen Schema Antworten 
zu geben, damit es für euch wiederum einfach ist zum Auswerten. Ich sehe den Sinn dahinter, 
aber in unserem Alltag mit unseren Mitarbeitenden, die das nicht gewohnt sind, ist es etwas 
schwierig, die Antworten genau in dieses Schema zu geben. “ 
APO 2 „Ich habe es eine sehr gute Studie gefunden, die Dosierungen haben mir sehr gut gefallen, und 
[die] Betäubungsmitteldosierungen. “ 
APO 3 „Ich habe die Studie sehr begrüsst, weil es eine Schnittstelle ist, die nicht unproblematisch ist. 
Beim Spitalaustritt, da kann wirklich Einiges schief gehen. Es ist ein kommunikatives Problem, weil 
häufig der Patient selber gar nicht da ist, sondern es kommen auch Angehörige. Da ist natürlich 
der Kontakt zwischen der verschreibenden Stelle und uns, die es ausführen, wichtig. “ 
APO 4 4a: „Vom Aufbau her war es klar, was man ausfüllen musste. Was sind genau Interventionen? 
[Die] gute Rezeptausführung wie die [Anpassung von] Packungsgrössen, das ist der Alltag von 
uns. Manchmal hat es in gewissen Momenten mehr Zeit gebraucht zum Ausfüllen, aber das konnte 
man ja auch noch nachher machen. Der Aufwand war eigentlich noch im Rahmen. “ 
4b: „Das Design war so gemacht, dass man es gut in den Alltag integrieren kann. Die 
Bemühungen, das Ganze zu verbessern und zu strukturieren, finde ich super. Das ist gut und 
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wichtig. Nur, es gibt gewisse Sachen, die im Alltag nicht so funktionieren, wie man das gerne hätte, 
wenn man so eine Studie aufbaut. “ 
APO 5 „Für mich war es eine gute Sache. Mich hat es überzeugt, dass man realisiert hat, ob ein Rezept 
vorbearbeitet worden ist oder nicht. Ich erhoffe mir eigentlich, dass die Lehren daraus gezogen 
werden. “ 
 
Methodik der Studie 
Bei den Apothekern wurde die persönliche Rekrutierung der Apotheken durch das Studienteam an 
der Generalversammlung des Aargauer Apothekerverbandes geschätzt. Die spätere Kommunikation 
per Mail, Fax und Telefon war angepasst und die zur Verfügung gestellten Schulungsvideos wurden 
als instruktiv beurteilt. Drei Apotheker äusserten, dass nicht alle Kommunikationswege jede Person 
erreicht habe, teilweise wurde zum Beispiel das Schulungsvideo nicht gesehen oder das Mail nicht 
beachtet.  
Bei den Ärzten wurde die Information über die Studie per Mail von drei Ärzten für gut befunden. 
Zwei hatten das Informationsmail nicht erhalten, weil sie erst während der laufenden Studie 
eingestellt wurden. Zwei Ärzte merkten an, dass Informationsmails zu wenig beachtet worden sein 
könnten, wobei jemand die spätere Zugänglichkeit eines Mails als Vorteil sah. Drei Ärzte gaben an, 
eine mündliche Information an Rapporten zu schätzen. 
Bezüglich Methodik der POMMES Studie schätzten es drei Assistenzärzte, dass der 
Studieneinschluss der Patienten im Klinikinformationssystem mehrfach und gut sichtbar 
dokumentiert worden war. Wenn ein Austritt sehr kurzfristig geplant wurde, musste die 
Dienstleistung sehr speditiv durchgeführt werden. Vier Assistenzärzte gaben an, dass dies zu Stress 
geführt hatte. Ein Assistenzarzt räumte jedoch ein, dass dies bei eigenen guten Arbeitsmethoden 
grundsätzlich kein Problem darstelle.  
Aus allen zehn Interviews haben nur ein Apotheker und ein Assistenzarzt konkret angegeben, dass 
die Zugehörigkeit des Patienten zur Kontroll- oder Interventionsgruppe erkennbar gewesen sei. Das 
Rezept als Kommunikationsmittel wurde von beiden Berufsgruppen als geeignet beurteilt. Die 
gemeinsame Präsentation von zusammengehörenden Informationen auf einem Blatt wurde 
besonders begrüsst. Ein Arzt und ein Apotheker betonten, dass bisher noch gute Alternativen 
fehlten. Aus Apothekersicht wurde betont, dass jede Art von Kommunikation willkommen sei. 
Insbesondere bei Patienten, welche die Medikamente nicht selber in der Apotheke beziehen, sei die 
Kommunikation zwischen den Fachpersonen wichtig. Das Rezept als alleiniges 
Kommunikationsmittel wurde von zwei Apothekern als ungenügend befunden, der Medikationsplan 
sei als Ergänzung ebenfalls wichtig. Auch nützlich wären für einen Apotheker die Ergänzung einer 




„Ich hätte mir aber gewünscht, dass wir immer auch die Medikationsliste dazu haben. Weil wir 
doch oft merken, dass unsere Kunden vom Arzt, der sie entlassen hat, doch noch hier und da 
Instruktionen erhalten haben, die uns gefehlt haben. Das habe ich mir wirklich gewünscht, dass 
man auch den Medikationsplan hätte. Wir müssen uns voll auf den Kunden verlassen, wenn er 
sagt; Ich muss das Medikament 6 Wochen nehmen oder spritzen.“ (APO 1) 
Auf ärztlicher Seite wurde deutlich, dass die Relevanz jeglicher Kommunikation stark unterschätzt 
wurde. Besonders die Wichtigkeit der Therapieänderungen für die Apotheke war ihnen bisher nicht 
bewusst gewesen. Ein Assistenzarzt gab an, nicht gewusst zu haben, dass die Patienten eine Art 
Stammapotheke haben, und dass diese die Rezepte validiert: 
„Ich dachte, ich muss es einfach dem Patienten sagen, aber nicht, dass es für die Apotheke 
wichtig ist. Also das Verständnis für die Rolle der Apotheke, dass man dort auch mal nachfragen 
kann, das wusste ich vorher nicht, das mit der Stammapotheke.“ (AA 4) 
Die frühzeitige Übermittlung des pCRF an die Apotheken wurde geschätzt. In vier Apotheken hat 
das Ausfüllen des pCRFs Schwierigkeiten bereitet, wobei Pharmaassistentinnen mehr 
Schwierigkeiten hatten als Apotheker. Die telefonischen Nachfragen des Studienteams wurden als 
konzis (1 Aussage) und zeitnah (1 Aussage) beurteilt. Die Kompetenz des anrufenden 
Studienteammitglieds (Pharmaziestudentin) wurde jedoch von einem Apotheker in Frage gestellt, 
und für zwei Apotheker führten Telefonate in Randstunden zu Stresssituationen.  
Sensibilisierung durch die Studie 
Bei der ersten, offenen Frage (ohne Angabe der durch die Dienstleistung behandelten Inhalte) 
wurde von einem Teil der Befragten eine Sensibilisierung angegeben (Table 32, „spontan“). 
Nachdem die behandelten Inhalte offengelegt wurden, wurden eine grössere Sensibilisierung 
angegeben („auf Nachfrage“). Dies war bei beiden Berufsgruppen der Fall. Insbesondere fand bei 
den Assistenzärzten eine Sensibilisierung für die Kommunikation generell, und für 
Therapieänderungen im Speziellen statt.  
Die Apotheker wurden weniger stark sensibilisiert, da bereits vor der Studie ein grosser Fokus auf 
die Spitalaustrittsrezepte gelegt wurde. Die meisten Apotheker gaben an, bereits gute 
Arbeitsmethoden anzuwenden und sich der problembehafteten Schnittstelle des Spitalaustritts 
bewusst zu sein. In Einzelfällen wurde im Team aber vermehrt über das Thema gesprochen (1 
Aussage), und die Datenerhebung hatte dazu geführt, dass die Rezeptvalidierung etwas genauer 
durchgeführt wurde (2 Aussagen). 
„Ich würde behaupten, wir sind schon relativ gut. Aber es ist sicher eine Sensibilisierung da 
gewesen, dass man wirklich schaut, welche Medikamente waren schon vorher in der Therapie, 
was sind neue, dann auch nicht immer nur die kleinste Originalpackung mitgeben.“ (APO 1) 
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Table 32: Sensibilisierung durch die Studie. Angegebene Sensibilisierungen bei der allgemeinen Frage 
(„spontan“) und nach Vorlage der in der POMMES Studie behandelten Themen („auf Nachfrage“). n=5 
Ärzte und 5 Apotheker, AA = Assistenzarzt, APO = Apotheker,  na = nicht anwendbar,  
Sensibilisierung (n, spontan/auf Nachfrage) AA  APO 
Generelle Sensibilisierung 5/na 3/na 
Sensibilisierung für Studieninhalte   
Therapieänderungen 3/4 0/0 
Interaktionen 0/0 0/1 
Vorhandensein von Betäubungsmittelrezepten 0/0 0/0 
Formale Fehler wie falsche Einheiten, die Verordnung ausländischer 
oder herzustellender Medikamente, ungenaue Bezeichnung der 
Medikamente, unverständliche Bemerkungen oder Dosierung 
1/1 0/1 
Vorhandensein der Therapiedauer  0/0 1/0 
Sensibilisierung für andere Themen   
Wichtigkeit Abgleich Ein- und Austrittsmedikation 3/na  
Wichtigkeit der schriftlichen Dokumentation 1/na  
Wichtigkeit der Informationen für den Hausarzt 1/na  
Kontrolle und Verordnung der richtigen Dosis/Einheit 1/na 2/na 
Allgemeine bewusstere Rezeptkontrolle  2/na 
Kontrolle der Handhabbarkeit für den Patienten  1/na 
Bewusstsein für pharmazeutische Interventionen  1/na 
 
Effekt der Studie 
Nach den subjektiven Effekten der Studie gefragt, äusserten alle fünf Assistenzärzte, dass ein 
Lerneffekt stattgefunden habe. Erneut wurde das Bewusstsein für die Rolle der Apotheke 
angesprochen. Die Wichtigkeit des Informationsflusses an die Apotheke ist zwei Assistenzärzten 
bewusst geworden. Der systematische Abgleich zwischen Ein- und Austrittsmedikation, die 
Rücksubstitution auf die Medikation vor Spitaleintritt und die Dokumentation aller Änderungen hat 
gemäss den befragten Ärzten während und nach der Studie zugenommen. Ebenfalls wurde ein 
Einfluss auf die Rezeptqualität und die Patientensicherheit angegeben:  
„Vor allem im Verlauf der Studie habe ich mehr darauf geachtet, dass ich wieder die 
Eintrittsmedikamente verordne, und schon selber draufschreibe, was neu ist. Da hat es sicher 
etwas sensibilisiert. Und wenn die Studie noch länger gelaufen wäre, dann umso mehr.“ (AA 2) 
„Etwas was ich früher nicht gemacht habe, was ich jetzt doch noch denke, dass es wichtig ist: 
Dass der Patient dies merkt, und dass man schriftlich festhält, welche Änderungen gemacht 
worden sind. Das ist sicher auch hilfreich für den Hausarzt, wenn er es sieht.“ (AA 1) 
 „Dass man bessere und für Patienten klarere Rezepte abgibt, kann ich mir schon vorstellen.“ 
(AA 3) 
„Ich mache es jetzt wirklich konsequent so. Weil es ja eigentlich das Wichtigste ist, dass es nicht 
nur während der Hospitalisation klappt, sondern dass es auch nachher klappt. Sonst ist die 
Rehospitalisation ja vorprogrammiert, wenn sie die Änderungen gar nicht wahrnehmen.“ (AA 4) 
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Nach einem subjektiven Effekt gefragt, waren die Apotheker eher zurückhaltend, gaben aber 
Therapieänderungen (2 Aussagen), Interaktionen (1 Aussage) und Therapiedauer (2 Aussagen) als 
möglicherweise verbessert an.  
Zukunftswünsche 
„Für mich wäre von grossem Vorteil, wenn die Kommunikation, die stattgefunden hat via 
Rezeptformular, wenn [diese] fortgesetzt werden würde.“ (APO 5) 
Sowohl drei der Apotheker als auch alle fünf Assistenzärzte wünschten sich, dass diese 
Dienstleistung wie in der Studie weitergeführt wird. Die Weiterführung der Dienstleistung würde 
gemäss vier Ärzten eine Vieraugenkontrolle der Rezepte garantieren und die Patientensicherheit 
erhöhen. Zwei Assistenzärzte betonten, dass bei Weiterführung eine Priorisierung der Patienten 
gemäss Risiko (1x anhand Risikomedikamenten, 1x anhand relevanten PIs) zur Anwendung 
kommen sollte. Es wäre gemäss einem Assistenzarzt nötig, für kurzfristige Entlassungen einen 
besseren Prozess zu verwenden, da der verwendete Prozess zu Hektik führen kann. Ebenfalls 
wurde vorgeschlagen, dass der Assistenzarzt mittels Klinikinformationssystem mit der 
Spitalapotheke kommunizieren könnte und ein Auftrag zur Rezeptüberprüfung direkt dort erfasst 
werden könnte. Dies würde gemäss einem Assistenzarzt die Dienstleistung verbessern.  
Des Weiteren wurde gewünscht, dass die Spitalapotheke im Haus präsenter sei (1 Aussage), dass 
bereits vor Entlassung eine klinisch-pharmazeutische Kardexvisite stattfinde (1 Aussage), und dass 
zeitnah ein gemeinsames elektronisches Patientendossier für den stationären und ambulanten 
Bereich nötig sei (1 Aussage). Besonders begrüsst wurde, dass die öffentlichen Apotheken bei 
Fragen oder Problemen aktiv beim verschreibenden Arzt nachfrage. Dies sei im Interesse der 
Patienten, gaben zwei Assistenzärzte an. 
„Von mir aus dürfte die Apotheke auf jeden Fall anrufen, wenn sie eine Frage hat. Weisst du, ich 
bin froh, wenn sie anruft, wenn etwas komisch vorkommt, […] das dürfen sie unbedingt 
machen.“ (AA 4) 
Auf Seiten der Apotheker war auffällig, dass nicht diese spezielle Dienstleistung, sondern jegliche 
Art der Zusammenarbeit in Zukunft gewünscht wurde. Da den Apothekern die Effekte der 
behandelten Studieninhalte subjektiv eher gering erschienen, hatten sie auch andere Wünsche 
(Table 33). Die Apotheker begrüssten die übersichtliche Darstellung der Rezepte. Von einem 
Apotheker wurde angemerkt, dass die Delegation des Interaktionschecks von der Offizin an das 
Spital eine Neuerung wäre und zuerst etabliert werden müsste: 
„[…] da stand unten ein Kommentar „Interaktionscheck wurde von uns durchgeführt.“ Also nicht 
einfach alles annehmen, auch wenn man selber noch etwas fände. Das hat mich speziell 
gedünkt, aber korrekt. Ich musste mir dann sagen, das sind ja auch Pharmazeuten, die haben 
das für korrekt befunden. Jetzt braucht es mich nicht auch noch einmal. Ich musste mich wirklich 
bewusst zurücknehmen.“ (APO 5) 
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Erneut wurde die Wichtigkeit des Medikationsplanes betont. Die Zusammenarbeit mit der 
Spitalapotheke wurde von den befragten Apothekern gelobt. Weiter erwünscht waren der 
persönliche Kontakt und ein spitalpharmazeutischer Ansprechpartner für Rezepte. 
Table 33: Zukunftswünsche der Apotheker. Wünsche der Apotheker bei Weiterführung der Studie, 
respektive generelle Wünsche, mit Anzahl Nennungen, n=5 
Wünsche der Apotheker bei Weiterführung der Studie Anzahl Nennungen 
Kommunikation Interaktionen 3 
Kommunikation Therapiedauer 2 
Besseres Vorhandensein Betäubungsmittelrezepte 2 
Kommunikation Therapieänderungen  1 
Kommunikation Wundversorgung 1 
Kommunikation Laborwerte 1 
Kommunikation erfolgter Kostengutsprachen 1 
Kommunikation verordneter Hausspezialitäten 1 
Kommunikation nächster Patiententermine 1 
Digitalisierung der Kommunikation 1 
Beachtung der galenischen Formen bei der Verordnung 1 
Dokumentation off-label use mit „sic“ 1 
Visum des Spitalapothekers auf dem Rezept 1 
Wünsche der Apotheker generell  
Gemeinsame Events oder Schulungen  3 
Kommunikation des Sortiments (insbes. Wundmaterial) 3 
Unterstützung bei Hausspezialitäten (Abgabe oder Information) 3 
Schulung der Ärzte bezüglich ausländischer Medikamente 1 
Kommunikation Off-label Use 1 
Spitalapothekengeflüster (bestehender Newsletter der Spitalapotheke an die Offizin) 1 
Elektronisches Patientendossier 1 
Austausch im Fachverband 1 






Durch Interviews mit Assistenzärzten und Apothekern konnten qualitative Daten zu den Erfahrungen 
mit der POMMES Studie erhoben werden. Die befragten Personen beurteilten die Studienmethodik 
als grundsätzlich geeignet. Bei den Assistenzärzten war eine starke Sensibilisierung für 
Therapieänderungen zu bemerken. Gemäss deren Aussagen trug die Studie dazu bei, die Rolle der 
Stammapotheke und die Wichtigkeit der Kommunikation bei Spitalaustritt zu erkennen. Aus 
Ärztesicht wurde die Rezeptqualität verbessert. Eine Weiterführung dieser Dienstleistung wurde 
grundsätzlich von allen Befragten begrüsst. Die Apotheker schätzten vor allem die Initiative zur 
Zusammenarbeit und sehen neben der getesteten Dienstleistung weitere wichtige Handlungsfelder.  
Die Rekrutierung der Apotheken wurde als positiv beurteilt, besonders die persönliche Rekrutierung 
am Fachanlass. Die Aussagen waren abhängig davon, wie der betreffende Apotheker von der 
Studie erfahren hat. Die Mehrheit der Apotheker sagte aus, dass der eine oder andere 
Kommunikationsweg sie nicht erreicht hat. Die Nutzung verschiedener Kanäle hat deshalb 
ermöglicht, dass viele Apotheker informiert wurden. Im Vergleich mit den Pilotstudien war in der 
POMMES Studie der Zeitaufwand zum Ausfüllen des pCRF und die Verständlichkeit kein grösseres 
Thema mehr. Auf ärztlicher Seite war das Zeitmanagement ein Kritikpunkt. Kurzfristige 
Spitalentlassungen lösten Stress aus. Deshalb müsste die Dienstleistung bei einer Implementierung 
an diese Situation angepasst werden. Nach den Pilotstudien, bei denen ebenfalls Assistenzärzte 
befragt wurden, wurde eine Dokumentation des Studieneinschlusses im Klinikinformationssystem 
eingeführt. Diese wurde nach der Studie ausdrücklich gelobt.  
Bei den Assistenzärzten hat eine stärkere Sensibilisierung stattgefunden als bei den Apothekern. Es 
wurde eine grössere Sensibilisierung angegeben, nachdem die Themen offengelegt wurden. Die 
ersten spontanen Angaben sind deshalb aussagekräftiger. Im Apothekerinterview war die Frage 
nach der Sensibilisierung schwierig verstanden worden, und Hinweise auf Sensibilisierungen 
wurden teilweise zu einem anderen Zeitpunkt während des Interviews angegeben. Ebenfalls wurde 
die Sensibilisierung und ein bemerkter Effekt bei den Apothekern nicht immer klar unterschieden. 
Die grösste Sensibilisierung hat bezüglich der Therapieänderungen (Assistenzärzte) und bezüglich 
der generellen oder speziellen Rezeptkontrolle (Apotheker) stattgefunden. Einige Assistenzärzte 
gaben von sich aus an, die Arbeitsweise der Dienstleistung übernommen zu haben und auch nach 
der Studie selbständig weiterzuführen. Ebenfalls fand bei den Assistenzärzten eine starke 
Sensibilisierung für die Rolle und Dienstleistungen der Offizinapotheker statt. Dies deutet darauf hin, 
dass die bisherigen Kenntnisse über die Betreuung und das Gesundheitssystem bei den Ärzten 
nicht vollständig sind und geschult werden müssen. Bei den Apothekern war die Sensibilisierung für 
die Studieninhalte klein, was auch auf die geringen berichteten Effekte zurückzuführen ist. 
Die Weiterführung der Dienstleistung wurde von beiden Berufsgruppen begrüsst. Die Priorisierung 
der Patienten nach Risiko, und die Integration der Dienstleistung in das Klinikinformationssystem 
müssten bei einer Implementierung geprüft werden. Grundsätzlich wird aber jegliche Art von 
Zusammenarbeit mit der Spitalapotheke begrüsst. 
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Als Limitation muss die kleine Anzahl befragter Personen berücksichtigt werden. Andere in 
Offizinapotheken beschäftige Fachpersonen wie Pharmaassistenten wurden nicht befragt. Die 
Antworten können also nicht auf andere Berufsgruppen übertragen werden. Die angefragten 
Assistenzärzte hatten jeweils viele POMMES Rezepte bearbeitet, bei den Apothekern verteilten sich 
die Rezepte auf die verschiedenen Mitarbeiter. Der Eindruck der Assistenzärzte ist somit 
möglicherweise verlässlicher. Des Weiteren bestanden zwischen dem Interviewer und den befragten 
Personen berufliche Kontakte, welche die Antworten beeinflusst haben können. Die Antworten 
waren möglicherweise stark von den eigenen Erfahrungen mit einzelnen Studienpatienten abhängig. 
Abschliessend kann gemäss den befragten Personen eine positive Bilanz aus der POMMES Studie 
gezogen werden. Obwohl methodische und inhaltliche Änderungen geprüft werden müssten, würde 




6 General discussion 
 
 
Figure 18: Overview of the used approach, adapted for later implementation 
 
In this thesis, we identified challenges at hospital discharge that require optimisation. In the 
following, we will discuss the patients’ and the community pharmacists’ views that were gained as 
evidence to develop the preliminary POMMES study design. Within the feasibility testing, we 
developed the final POMMES RCT design, which led to the results also highlighted here.  
There are some methodical considerations to take into account, some identified thematical hotspots 
and implications from our results, that will be discussed here. 
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6.1 Patients’ views of hospital discharge 
Comprehensibility 
In interviews with 45 hospitalised patients we found that comprehensibility of MCs was insufficient. 
Abbreviations like “Mo” for “morning” in the headings of the columns of the charts were especially 
confusing. The danger of abbreviations has also been demonstrated by other scientists and 
practitioners [115]. The column contents are often shortened due to space limitations. This was also 
remarked by interviewed patients; in order to prevent abbreviations, they preferred the combination 
of several items of information in one column over the presentation of every item in its own separate 
column. In our study, desires regarding the design and content of MCs were very diverse. In a 
recent work, it was seen that patients preferred the dosing instruction in sentences over a tabular “1-
1-1-1” form [176]. We did not have a sentence example in our interview to compare opinions. Our 
interviewed patients were influenced by showing them of possible charts, e.g. with pictograms. 
Especially for patients with low health literacy, pictograms could be favourable for comprehensibility 
[42]. In our population, health literacy correlated only to limited extent with comprehension, which 
may be due to methodical reasons. Other studies, using for example the REALM-tool, showed 
higher correlation of health literacy and understanding [177, 178].  
Swiss patients thought that MCs were very useful after discharge and thought that every discharged 
patient should recieve one [179]. To our knowledge, it is not known how many patients in 
Switzerland receive a MC upon discharge. In Germany, 20% of ambulatory care patients didn’t 
possess one [180]. It is crucial that one health care professional feels responsible to fill in a MC and 
keep it current, as charts contained 50-75% more discrepancies if they were over three months old, 
compared to current ones [12]. The facts, that there are many studies about MCs [179, 181], and 
that charts have been defined for the use in shared electronic health records [182], show what 
implications this document has for current and future health care. 
Instruction, supply and discharge optimisation 
Medication knowledge was reported to be very high in Project A2.1. But the patients’ self-reported 
knowledge should be interpreted with caution, as other studies showed significantly lower 
knowledge [110], and this would lead to nonadherence [52, 120]. As there was a major discrepancy 
between interviewed physicians and patients concerning the perceived rate of actually performed 
instructions, it seemed that patients did judge “instruction” differently to physicians. Handing over the 
prescription with some comments may suffice for physicians, while patients do not classify that as 





A significant portion of our patients did not wish for further information to be given by the community 
pharmacist. Counselling would be needed when a new medication is prescribed. In a study 
performed at the same hospital in 2004, patients from the internal medicine wards (in comparison, 
we analysed internal medicine and surgical wards) had a median of 4 medicines on admission and 6 
at discharge. [134]. Therefore, the majority of patients receive new medicines, and should therefore 
be counselled according to their own opinions. It is an advantage that patients seem to know who to 
ask, as the counselling could therefore be done on demand. This differed from findings in an 
American study, where, after calling the GP, many patients did not to know who to call for further 
information [110]. 
Our findings from Project A2.2 suggest that patients fill their prescriptions quite late and that 
physicians were alarmed about it. However, the late prescription fillings were comparable to findings 
in three other studies; a study of discharged Australian veterans [133], a study of discharged 
patients conducted in the same Swiss region [183], and an American study evaluating filling rates of 
opioid prescriptions after emergency department visits [184]. In contrast, Project C2 showed that the 
filling was done on the day of discharge (median), that is to say, earlier than in Project A2.2, which is 
what physicians would expect. Their concerns are legitimate. Patients who underwent coronary 
stenting had a higher mortality rate if they filled their prescription later than the third day after 
discharge [70]. In the case of newly stented patients, cardiovascular drugs are newly established. 
But chronic patients may still have their long-term medication at home to ensure continuity. 
Therefore, time to prescription filling is a less valid indicator for patient harm than actually 
experienced therapy gaps are. Gaps are very unfavourable, but were seldom observed in our 
sample in Project A2.2, when compared to paediatric patients in Switzerland [126]. Nevertheless, 
community pharmacists reported to be forced to invest a lot for preventing those gaps until the next 
GP visit, as reported in Project B. This is especially so, as in a Swiss study, around 30% of all 
patients did not visit their GP within the first 30 days after discharge [18]. However, we did not aks 
for therapy gaps in patients who did not fill their prescription. There might be some patients that did 
not fill their prescription and have experienced gaps. This may lead to an underestimation of this 
problem.  
Interestingly, neither the interviewed patients, nor the physicians, saw the importance of enhanced 
information transfer to the pharmacy. When patients would ask the pharmacist (as a second source) 
when questions arose, patients risk getting non-useful or even incorrect information if their 
pharmacies were not previously supplied with current information. It may be that interviewed patients 
did not see this correlation. Interestingly, patients with supply gaps were significantly more open to 
information transfer. A small number of Swiss hospitals communicate medication changes to 
community pharmacies [127]. However, this still happens mostly in the context of research projects 
like this one [18, 185]. But improving communication between health care providers now became a 
current political topic as part of the Swiss strategy “Gesundheit 2020” [137]. 
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The more convenient solution to optimise discharge for both patients and physicians would be to 
provide some bridging supply. A recent survey in Swiss hospital pharmacies revealed that 12 of 37 
hospitals already provide supply [127]. But as only 5% of our patients had therapy gaps, it is 
inefficient to supply all discharged patients with the aim of preventing those few gaps. However, as 
an underestimation of gaps have to be kept in mind, there could be a benefit. The large support for 
bridging supply could confirm an underestimation. 
6.2 Community pharmacists’ views of hospital discharge 
Swiss community pharmacists see hospital discharge as an important step during transitions of care. 
Hospitals are perceived as "black boxes”, pharmacists not knowing what happens inside, and having 
to be alert for what comes out. The GPs’ impression was very similar [40]. Existing professional 
relationships with the treating hospital personnel may already enhance collaboration and light some 
aspects of these black boxes [91, 129]. Participants in the focus group and respondents to the 
questionnaire (Project B) complained that missing information impairs patient care in daily practice. 
Community pharmacists called for further essential therapy-related, health-related, care-related, and 
organisation-related information. These challenges are also described in the literature [76, 159]. The 
interviewed pharmacists reported treatment gaps to be a frequent consequence of low availability of 
information in the community pharmacy. They invest a lot of time and effort to protect their patients 
from gaps and associated harms. They seemed to be highly motivated, as there might be a good 
relationship between pharmacists and their patients.  
Pharmacists in both settings insisted on an early transfer of information. They preferred concise and 
clearly structured information. A well-designed form would help hospitals to implement such transfer 
documentation, and help pharmacists to read it efficiently. While questionnaire respondents 
prioritised electronic tools, focus group participants preferred paper-based solutions like handovers, 
because they were afraid of any implementation delay when an electronic tool is introduced. In 
Switzerland, this implementation of the shared electronic health record is now being brought forward 
by law [137]. 
6.3 Optimising hospital discharge by the POMMES strategy  
In Project C2, we succeeded to reduce the number of PIs in the intervention group with a pragmatic 
in-hospital service. There was an odds ratio of 0.33 (0.13-0.78) to have at least one PI in the 
intervention group, and a relative risk of 0.78 (CI 0.62-0.99) for an additional PI if a patient was in the 
intervention group. This was as we hypothesised, based on a similar study [18].  
According to the regression analyses, the profession of the person filling the prescription had an 
influence on the number of PIs. The job role was not important concerning if there was a PI 
performed or not. But the overall number of PIs increased when a more highly educated person filled 
the prescription. This result highlights that clinical skills are important, as more DRPs could be 
detected. It is also possible that pharmacists who filled in the pCRF simply documented more PIs 
than pharmacy technicians, as pharmacists were more sensitised to, or understood better, what 
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DRPs and PIs were. But not only pharmacists, also pharmacy technicians could take an important 
role in the transition of care, if they are educated in the required clinical topics [141]. 
It was concerning to see that a shorter hospital stay was associated with higher PI rates. If patients 
are rapidly discharged, there is no time for in-depth evaluation of their treatment, screening for DRPs 
and precise MedRec at discharge. The length of stay in Swiss acute care settings decreased over 
the recent years [35]. This may be due to new remuneration systems which make early discharges 
economically more attractive. Our results show that this development may not be advantageous for 
patients. Patients should only be discharged, if the medical team evaluated all DRPs. 
In particular, the clinically significant PIs were reduced through our service. Therefore, it can be 
suggested that the quality of the discharge prescriptions increased. There were some details seen in 
the PI pattern that could be directly influenced by the service, e.g. reduced PIs due to interactions, 
less clarifications, but more PIs due to therapy duration. Clarifications were stated by community 
pharmacists (Project B) to be very time consuming, and this was also confirmed by literature [166]. 
The reduction of clarifications is congruent with the increased satisfaction level, but the assumed 
time-saving was not seen in the measured time for filling the prescription.  
However, contacts to the hospital physicians were reduced. Therefore we can estimate that the 
service targeted problems, that are usually discussed with the physicians. Even if physicians stated 
in Project A2 that calls from the pharmacies are justified, this unburdens the physicians in their daily 
practice. 
6.4 Considerations 
In this thesis, qualitative and quantitative methods were used. We applied the MRC framework for 
the development of the POMMES study design [100]. It was very useful that we early defined a list 
of uncertainties that could be encountered during the study and criteria that had to be clarified. In the 
feasibility testing phase, it enabled a structured approach. The different phases of the circular 
framework do not strictly have to follow each other, as illustrated in the graphical approach 
presented throughout the thesis. It may be appropriate to go back one step to revise preliminary 
ideas. The pragmatic in-hospital service is now ready for implementation. 
Recommendations can be drawn from the POMMES study: It was seen that the personal and multi-
channel recruitment of community pharmacies helped to achieve a high participation rate. It is very 
important that procedures that affect physicians are well agreed upon, and that they are asked for 
their opinion. In the case of the POMMES study, patient inclusion had to be more prominently 
documented for the physicians to be aware. Any CRFs that have to be filled out should be easy to 
handle. They should be tested for many cases, which also include some exceptional cases to make 
adaptations in advance. The people filling out the CRFs have to have support, in case they do not 
know how to fill out the CRFs.  
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When the POMMES service will be implemented in daily practice, the MRC approach can continue 
to be used. After implementation, an evaluation should follow after some time. It can assess different 
uncertainties that are similar to the ones assessed in this thesis, or others. This could be, as 
physicians stated in Project C3, that it should be evaluated whether patients with higher risks or 
more complicated medication regimens can be handled as a priority. Furthermore, it could be 
evaluated if the enhanced information transfer service can be opened for discharge summaries and 
what effect this would have on the GPs’ satisfaction. However, firstly, evidence has to be gained on 
these topics.  
Limitations 
The projects within this thesis have strengths and limitations. A major limitation is that the study was 
conducted in one country. Project B has been performed country-wide, but all the others were 
conducted at one study site. It seems that our results are very comparable to other findings from 
projects in the same region [183, 186]. But there may be differences when compared to other 
regions, like the French speaking part of Switzerland, that have a higher baseline PI rate [18]. 
Switzerland has a very distinct and decentralised health care system. Accessible shared electronic 
health records, as in the UK, are not yet available, and self-dispensing is not practiced in other 
countries. If shared electronic health records are implemented (as planned by politics and defined by 
law [137]), the applicability of our findings has to be evaluated.  
In Project A1, we found a limited correlation between the comprehensibility of MCs and health 
literacy. It has to be taken into account that the understanding of MCs does not guarantee the 
correct intake of medication. Therefore, the application, also a main component of health literacy, 
should also be tested to give a valid insight into the topic. Botermann et al. developed a new method 
to evaluate the use of charts with pill boxes, the “Evaluation Tool to test the handling of the 
Medication plan” [11]. We did not test the other components of health literacy, as our focus laid more 
on the design and content of the MCs.  
Within Project B, we conducted one focus group and developed a questionnaire from the findings. 
Further focus groups could have been conducted until data saturation was reached. It is possible 
that one focus group was not enough to get a deep insight in the pharmacists’ views. The online 
questionnaire was filled by 22 pharmacists from the canton AG, which is an above-average 
response rate compared to other cantons. In the study site’s region, we benefitted from highly 
motivated pharmacists. Of 121 pharmacies, 70 participated in the RCT, and there were only 20 of 
172 patients lost due to no-shows of patients or no data transmission by the pharmacy. We 
expected a much higher drop-out rate, and we interpret this success as being partly caused by this 
high pharmacists’ motivation. However, the observation and intrinsic motivation of community 
pharmacists to show their extensive efforts, led to a Hawthorne effect. This may have caused a 
higher number of PIs than in daily practice. However, DRPs that would have needed an action but 
for some reason (time constraints, lack of knowledge) were not followed by a PI, were not assessed. 
These two facts may equalise each other. 
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The conduction of the RCT also needed some motivation from the physicians in charge. It was 
crucial that the head of the internal medicine department enabled the study presentation at a 
morning meeting and designated a senior physician to support the POMMES study. Furthermore, 
the hospital pharmacy regularly participated in ward rounds. This possibly increased the willingness 
of resident physicians to collaborate and accept the clinical pharmacist’s suggestions. Irrespective of 
that, a Hawthorne effect in physicians has to be taken into account, which may have caused 
physicians to prescribe in higher quallity. To conclude, conditions limit the reproducibility of our 
results. Overall, we used a very pragmatic approach for the POMMES RCT, not targeting all DRPs. 
We could have followed a more explanatory approach to better evaluate the efficacy of our service. 
This would have better limited some influencing factors.  
As a last limitation, it was convenient to exclude high-risk patients in our projects, such as those with 
cognitive impairment, or those living in a long-term facility. Our findings therefore may overestimate 
comprehensibility of medication charts, or may under- or overestimate supply problems. In the 
POMMES RCT, age may have been lower than in other studies, and PIs may have been 
underestimated. The comparison of findings from the French speaking part of Switzerland, with a 
higher number of PIs would support that conclusion [18]. However, they included patients with at 
least four medications, possibly leading to a higher baseline rate of PIs than in our patients with at 
least one medication.  
Strengths 
The most important strengths of this thesis are the consideration of different methods, the bottom-up 
development of our discharge optimisation service, and the involvement of different stakeholders. 
The views of the patients have to be taken into account in all health service-related questions and 
research [187]. It is therefore a strength that we performed two projects on the patients’ views. To 
combine these opinions with those of health care professionals gave a valuable opportunity to detect 
differing views (chapter 6.5). Furthermore, the mixed method approach used in Project B showed 
different priorities of pharmacists for optimisation objectives. This would not have been possible if 
only one method had been used.  
Project B was the first to evaluate pharmacists’ opinions about discharge and their information 
needs in Switzerland as a whole. Earlier studies were performed only in other parts of the country or 
abroad [39, 129, 188]. Therefore, this project added new knowledge, and further studies can be 
based on it. 
Project C was a randomised controlled trial with a pragmatic approach. The RCT study design is a 
reliable method to gain good evidence of a studied service. It was advantageous, compared to a 
before-after design, as used in another Swiss study [18]. Frameworks helped to develop, pilot and 
evaluate the service. With the piloting, we automatically adapted ideas to daily practice, and we 
were therefore automatically led towards a pragmatic approach. The pragmatic approach means 
that the findings show the impact of the service under real-life conditions. This can be interpreted as 
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a weakness, as it does not mainly prove efficacy, but we interpret it as a strength. Pragmatic 
approaches show the effectiveness of a service, and are cheaper to conduct. They have good 
potential to be implemented.  
A strength of the POMMES RCT was the use of already available tools. Validated tools in the fitting 
language are important to gain reliable results. The pharmDISC and CLEOde are tools to categorise 
PIs [82, 85]. It was found that pharmDISC categories A and B may be challenging for community 
pharmacists to use if not properly educated. In the validation of the pharmDISC tool, inter-rater 
reliability was higher than was expected, but category A reached lower inter-rater reliability [82]. As 
the focus of the participant education laid more on the study procedure and the categories C, D and 
E, categories A and B were omitted.  
6.5 Identified hotspots 
Differing views 
The difference between findings in different methodologies was already discussed (e.g. different 
goals for optimisation among pharmacists). Furhtermore, we identified differing views between the 
stakeholders, and it can be assumed that with every additional stakeholder, new views would 
emerge. The first difference was shown in Projects A1 and A2. Health care professionals usually 
define how MCs and counselling are delivered. It is controversial as to whether the MC should also 
be used as an information tool for health care professionals. We were able to show that they often 
do not perceive what patients need, and patients are not always satisfied with the care they receive. 
Furthermore, the amount of counselling performed was overestimated by physicians. It should 
therefore be a standard procedure to ask patients what information they need and in what form they 
would like it presented. Standard counselling procedures should also be defined. On the other hand, 
care should also be delivered to balance effort and effect.  
A second difference in views was found between perceived supply problems by pharmacists and 
actual supply problems experienced by patients. Pharmacists stated that gaps are frequent and 
patient care is suboptimal. In fact, supply problems were only encountered by a small proportion of 
patients. Even lower number of patients experienced therapy gaps which lasted up until the second 
day after discharge. Pharmacists seem to overestimate therapy gaps. It may be that they are not 
always aware that the patient still has medication packages at home. Especially when relatives fill 
the prescription for the patient, this knowledge may be lacking. This was supported in Project B, 
where information about supply was desired. 
A third, differing view was observed between the statements of interviewed hospital physicians. In 
project A2.3, where they were asked if they would support an information transfer to the community 
pharmacy, they mostly disagreed. The study team had the impression that the physicians were not 
aware of the processes, roles and problems that occurred when their patients are discharged. But 
after participating in the POMMES study, they seemed to realise that communication, e.g. of therapy 
changes may be useful. We interpret this as a teaching effect. It would be interesting if the same 
  
151 
effect could be seen in patients, who were also not widely supporting of information transfer in 
Project A2.3. In contrast, this was the optimisation strategy that highly met the needs of community 
pharmacists. And also after the RCT, they welcomed further collaboration.  
Roles of community pharmacists 
Throughout our projects, we identified aspects of the community pharmacists’ roles. In Project A2, 
most patients reported usually visiting the same pharmacy. This gives the pharmacist an important 
and continuous role in the dynamic health care setting, where patients encounter changing 
specialists and carers. In case of uncertainties, patients would rather ask the GP than the 
pharmacist for advice. This could mean that the GP is seen as the responsible person to define all 
prescription medicines. But pharmacists were in second place, giving them the position of a second 
opinion, or to re-evaluate previously given advice. 
Pharmacists participating in the focus group of Project B reported that they feel that they are seen 
more as retailers than health care professionals. This brought up the idea of asking the pharmacists 
in the questionnaire if they fulfil their role as defined by the Joint-FIP/WHO Guideline. In fact, they 
fulfil it rather badly. In Project C, a more in-depth look into the work of community pharmacists was 
gained. It was astonishing that a very limited number of clinically significant PIs were performed 
(categories C1-5 compared to the technically caused PIs C6-7). There were almost no inappropriate 
medicines detected. One might say that this is not possible without clinical information. We found 
that pharmacists are not very much interested in receiving clinical information, but that could be 
caused by a lack of education in this field. Other studies also found that community pharmacies lack 
confidence to perform clinical activities [79]. In the latest revision of the law on medical health 
professions (Medizinalberufegesetz), more clinical responsibilities are given to the pharmacists, 
therefore education has to be adapted to these future needs. With that educational background, 
more clinical activities such as medication reviews may be performed, and young pharmacists are 
better prepared to receive and use clinical information after discharge. Therefore in future, they may 
better fulfil their role as therapy managers as suggested by the Joint-FIP/WHO Guideline. 
  
152 
6.6 Implications  
Three implications of our findings on future daily practice can be suggested: on e-health, on 
discharge optimisation, and specifically on a public pharmacy within a hospital.  
E-health 
With the implementation of e-health solutions, new processes are needed. The role of each health 
care professional has to be defined, with access regulations and responsibilities. This 
implementation will change the health care system. In Germany, for example, the GP is responsible 
for the creation of the initial electronic MC [189]. The community pharmacist is allowed and should 
continuously make changes. In Switzerland, an inter-professional work group has recently finished 
its work to define documents and exchange formats in the shared electronic health records relating 
to medication use [182]. They defined a dynamic document, “eCurrentMedication”, which will be 
filled with information from the electronic MC or the prescription.  
Interviewed pharmacists in Project B made clear that the electronic transfer of information would be 
welcome. However, they equally preferred a paper-based method of transfer. This highlights the 
importance of any information transfer, irrespective of its transfer method. It has to be ensured that 
the information is available right at discharge or within a short amount of time. GPs in Switzerland 
are already usually provided with discharge summaries, but the summaries are often provided too 
late [40]. This implicates that existing practice cannot simply be overtaken by electronic systems, 
and that the availability of an e-health system will not automatically make information accessible. 
The content of the system has to be defined, and finally provided by a health care professional. The 
quality and accuracy of this information is of utmost importance. If, for example, stop orders for 
anticoagulants are not correctly documented, patients may be put at risk. Our results show what 
information items would be important. 
A discharge optimisation service 
In Project C3, interviewed health care professionals were positive about a continuation of the 
POMMES service. Both the physicians and the community pharmacists appreciated the enhanced 
collaboration. It seemed that the community pharmacists would prefer any collaboration instead of 
that specific one. Patients were not interviewed about their satisfaction with the POMMES service 
study. Only one fifth of patients had stated that information transfer could be beneficial for them. But 
it has to be kept in mind that a teaching effect would be achievable, as was observed in physicians.  
We think that the POMMES service is ready for implementation. Several considerations are 
important. The MRC framework on the implementation of complex interventions could be helpful for 
implementation [190]. Implementation science could support and evaluate this process. However, if 
needed, the POMMES service could be adapted to future needs. Irrespective of the pragmatic 
approach, which needed six minutes per patient, it may seem too much effort. With more careful 
selection of the patients, the service would be more effective. The service could concentrate on 
patients with a defined number of medicines, such as polypharmacy patients with four or more 
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medicines [18]. Also patients with specific drugs like antibiotics could be selected, as antibiotics 
showed to cause many ADEs after hospitalisation [121]. If the service is to reduce preventable 
readmissions, patient selection should be based on risk factors for readmission. A case-control 
study in Switzerland identified a risk for readmission in patients with a long hospital stay, heart 
failure or hyperkalaemia [191]. Such retrospective case-control studies can deliver evidence for 
more targeted services. Patients could also be selected according to their length of stay. In our 
study, a longer length of stay correlated with lower PI rate. It can be hypothesised that with longer 
hospital stays, discharge therapies and prescriptions were more carefully prepared. Our results 
show that fast hospital discharges should be reviewed. One could analyse if patients with a below-
average length of stay show a very distinct pattern of PI causes compared to “long-stayers”. This 
could give an indication whether a certain type of DRP is solved if the patient stays longer and 
therefore does not cause a PI in the community pharmacy. Then, these DRPs could be targeted in 
patients where a rapid discharge is planned. 
At the study hospital, no standardised MedRec is performed at admission, and therefore no best 
possible medication history is available. In a recent study from the second cantonal hospital in AG, 
researchers showed that the medication history improved with the use of an electronic checklist 
[192]. If no good data basis is available at admission, this impedes MedRec at discharge, to identify, 
for example, medication changes made during the hospital stay. Full MedRec is time consuming and 
costly [193], but the time effort made at admission may be an investment for discharge. This finding 
is supported by a study from the UK, where MedRec on admission had a benefit on discharge 
medication discrepancies [27]. To combine these critical transitions of care can therefore be 
promising. There are several studies combining a service on admission and discharge, but they 
need more extensive ressources [60].  
Hospital physicians in Switzerland said that a pharmacist’s involvement in discharge, especially in 
MedRec, would be helpful, since there are many medication changes which can lead to medication 
errors [194]. However, physicians reported that they want to keep the responsibility for the 
treatment. A study in pharmacy and medicine students showed that their respective roles are not 
clear, and students showed incomplete knowledge about each other’s competencies [195]. The 
pharmacist should not take the physicians’ seat, but support them with complementary activities and 
be present to counsel physicians [194]. Educational activities of pharmacists may be helpful to 
improve physicians’ awareness for DRPs. However, the perceptions of possible educational content 
and formats differ highly between physicians and hospital pharmacists [196]. This is important to 
consider when establishing educational services that replace or complete a discharge service.  
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Another possibility is to educate community pharmacists how to perform good MedRec and 
medication review, as there have been some barriers [79]. Our results show that the more educated 
the staff were, the more PIs were performed. This could mean that education would enable 
pharmacy technicians, as well as pharmacists, to identify more DRPs. Studies investigating an 
advanced role for pharmacy technicians show that there are opportunities to involve them in novel 
tasks [197, 198], especially in transition of care [141]. 
A public pharmacy in a hospital  
Public pharmacies in hospitals are a hot topic in Swiss health care, and are controversially 
discussed. This thesis provides several findings that have implications for a possible public 
pharmacy in the KSB or other hospitals. Firstly, the baseline findings of the health care system: Most 
of the interviewed patients in Project A2 regularly visit the same pharmacy. This was also confirmed 
by national data [8]. Therefore, they profit from continuous care. For example, continuous GP care 
showed to prevent hospital admissions caused by ambulatory care-sensitive conditions [9]. This 
finding is possibly true for pharmacies as well, but this has to be further studied. Secondly, in the 
control group of the POMMES study, around 17.5% of all performed PIs were caused by an error in 
the medication process. If this is calculated per patient, every second patient is affected by a DRP 
caused by an error in the medication process. This proportion was barely reduced in the intervention 
group. We assume that most of these PIs were performed because the pharmacist reconciled the 
prescription with the patient’s pharmacy history. In these cases, the patient hopefully got the brand 
of the medication they already had at home. No reconciliation with the medication at home may lead 
to duplication, and this may lead to patient harm. In a pharmacy other than the patient’s usual 
pharmacy, this can only be assured if the patients bring all their medicine with them to the hospital, 
or if the public pharmacy in the hospital has access to their pre-hospital medication history. In future, 
this would be possible with shared electronic health records.  
Supply problems and gaps were experienced by every fifth and every twentieth of our patients, 
respectively. This stands in contrast to every second patient with a PI due to MedRec with the 
history from their community pharmacy, as discussed before. Therefore, optimisation of supply is not 
a sufficient enough argument for opening a public pharmacy. Already an early transfer of the 
prescription, and good processes for unlicensed medicines could generate equal valuable benefits in 
terms of patient safety. Furthermore, if ward physicians are conscious of the problems, some of the 
supply gaps may be prevented.  
Community pharmacists in Project B reported that it is difficult to reach the prescriber, and 
physicians stated that most calls were justified. In the POMMES study, clarifications and contacts 
established to the hospital physicians were reduced in the intervention group. This indicates, that 
many of these usual calls are caused by problems targeted by the service, namely medication 
changes, formal flaws, or interactions. It was an easy task for the study pharmacist to check the 
prescription and search for information, and make an internal call to physicians and discuss 
interactions. One could suggest that a public pharmacy would overtake the service. The annotation 
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of medication changes are, however, not possible without acess to the electronic patient record in 
the hospital. Depending on health legislation, they may even have access to the hospital patient 
record. But so far, another public hospital pharmacy in AG has no access to the records. Still, 
contact to the prescribing personnel could be easier. This implies that the public pharmacy staff has 
to be in close contact with the physicians. If this is not assured, this contact is equally easy for 
regular community pharmacies.  
Recent data from Switzerland indicated that 13 of 37 hospitals have a public pharmacy in or close to 
the hospital [127]. However, only one of these hospitals communicates medication changes to the 
patient’s usual community pharmacy. But this was a major desire of pharmacists in Project B. If this 
is not the case, there is no optimisation of the system towards seamless care. There would simply 
be an optimisation of the first day’s therapy, even if there is no major problem. It would simply 
smoothen the first transition of care, but also build a new one. In this situation, the studied POMMES 
service would be a better option, as information transfer can be done with fewer staff and 
infrastructure, and no new processes for the patient are created. 
The findings in this thesis lead to the conclusion that public hospital pharmacies are a controversial 
possibility to enhance seamless care. They may pose promising advantages, but pitfalls have to be 
taken into account: Legal restrictions, reconciliation with the patients’ own medicines, transfer of 
information to their usual community pharmacy to enable seamless care. It should be avoided that 
hospitals open “just another pharmacy”. The clear aim has to be defined, e.g. lowering the frequency 




In this thesis, we elaborated insights into patients’ and pharmacists’ challenges at hospital discharge 
and developed a pragmatic in-hospital service to optimise discharge. The following conclusions can 
be drawn from the projects: 
- Hospital discharge is critical for medication safety. A substantial number of patients reported 
not being counselled in the hospital. There should be a focus on the patients’ needs, as well 
as on the actual experienced benefit of given instructions. Written information can be 
delivered as MC. As therapy instructions in MCs may be difficult to understand, their delivery 
should always be accompanied by oral information. The content, the language and the 
content’s presentation should best be adapted to individual needs. However, inputs of health 
care professionals, which may have another focus of medication safety, together with the 
patient’s views, will be useful in the design of basic charts.  
- If the instructions given in the hospital were insufficient, counselling should additionally be 
done in the community pharmacy. However, one should be aware of redundant counselling 
at both sites. Double counselling may, however, be complementary if they have different foci 
or if the second health care professional checks the efficacy of the first counselling activity. 
Community pharmacists may know patients and their needs very well, as most patients 
usually visit the same pharmacy.  
- Patients filled their prescriptions with a delay. Very few therapy gaps were experienced, 
maybe because patients still had medication at home. It is not known what medication led to 
the gaps and if the gaps would be preventable by good, timely information transfer to the 
community pharmacy. In contrast, community pharmacists make a lot of effort to prevent 
therapy gaps but their main obstacle is a lack of information. In Project B, we showed that 
there were several unavailable but desirable information items, which the pharmacists would 
require to provide appropriate pharmaceutical care. 
- The findings were very similar to international findings. The transferred information should 
meet the pharmacists’ needs and be presented in a structured way. One possibility of 
transferring information would be the annotation of information on the existing prescription. 
No new forms or communication systems would be needed. This approach was used for the 
POMMES study. Overall, it increased the quality of prescriptions and enabled better post-
discharge care of patients. Community pharmacists performed less clinically significant PIs, 
but performed more economically significant ones. This may lead to the conclusion that the 
enhanced information transfer may have empowered pharmacists to save health care costs 
through their PIs.  
- The enhanced information transfer on the prescription highly satisfied pharmacists and 
physicians. They wished for the pragmatic in-hospital service to be continued. The service is 




This thesis aimed to develop a pragmatic in-hospital service for the optimisation of hospital 
discharge. With some preparatory steps based on the framework approach, a promising intervention 
was developed and tested. From the answered questions, new questions arise: 
- The availability of information from Project B can be used to compare future findings, and to 
see if shared electronic health records ameliorate the availability of information. 
Researchers may also perform an international or national comparison of results to see if 
there are any substantial differences.  
- We recommend to implement the POMMES service, but to develop and evaluate it 
constantly according to the needs. After some time, the feasibility to conduct the POMMES 
service for a hospital pharmacy team should be evaluated. The service could be limited to 
specific patient groups, if any resource problems arise.  
- We draw the conclusion from the POMMES study that the information used for the 
discharge MedRec was possibly suboptimal. As a future project, one could investigate if a 
combined service at admission and at discharge gives comparable results as our pragmatic 
approach.  
- It should be evaluated what influence the service would have for participating patients. It 
may be interesting to know if patients felt better cared for, or if less ADEs happen. This 
would give an insight of how the health or quality of life of patients is influenced. We 
estimate that solely with information transfer between the hospital and the pharmacy, no 
broad impact to the patient’s satisfaction would be shown. However, we found a 
nonsignificant trend that readmission rates could be lowered. Therefore, this hypothesis 
should be tested in a larger sample of patients.  
- Besides patients, influences on other health care professionals could be evaluated after 
implementation. We hypothesise that annotations on the prescriptions of the POMMES 
intervention group may also be added into the discharge summary for the GPs. It can 
therefore be assumed that an effect can be measured when the patient visits their GP after 
discharge.  
- One might say that with the development and roll-out of shared electronic health records in 
Switzerland, such services might be useless. But only changing the access to information 
databases does not mean automatically that it helps health care professionals in their daily 
work. The availability of information works in parallel with its good quality. If the quality is 
bad, it may be better to not be transferred to health care professionals, as it may lead to 
harmful interpretations. Therefore, the POMMES approach is still, and even more important, 
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9.1 Project A1 























9.1.4 Literature search results: Screening tool for health literacy 
 
Durch die Literaturrecherche konnten 4 unterschiedliche Screening Tools für 
Gesundheitskompetenz (Health Literacy) bestimmt werden. Zu den Instrumenten „Test of Functional 
Health Literacy“ (TOFHLA) und „European Health Literacy Survey Questionnaire“ (HLS-EU-Q47) 
wurden jeweils Kurzversionen identifiziert. Die Gründe, weshalb diese nicht in der späteren 
Probandenbefragung verwendet wurden, sind in der Table 34 dargestellt.  
Table 34: Ausschlussgründe der Screening Tools für Gesundheitskompetenz 
Identifiziertes Screening Tool  Ausgeschlossen aufgrund von: 
Rapid Estimate of Adult Literacy in Medicine 
REALM (Text à 125 Wörter)  
- Keine deutsche Version vorhanden  
- Funktionale Ebene wird nicht untersucht  
Test of Functional Health Literacy in Adults 
TOFHLA (50 items) 
- Keine deutsche Version vorhanden  
- Zu hoher Zeitaufwand (max. 22 Minuten) [199] 
Short Test of Functional Health Literacy in Adults 
S-TOFHLA (37 items) 
- Keine deutsche Version vorhanden  
- Zu hoher Zeitaufwand (max. 12 Minuten) [199] 
Single-item / Two-item Literacy Screener 
SILS / TILS (1 / 2 items)  
- Keine deutsche Version vorhanden 
- Geringe Sensitivität  
New Vital Sign  
NVS (6 Fragen) 
- Keine deutsche Version vorhanden 
- (Rechnerische Fragen)  
European Health Literacy Survey Questionnaire 
HLS-EU-Q47 (47 Fragen) 
- Zu hoher Zeitaufwand 
 
European Health Literacy Survey Questionnaire - 
Kurzform  
HLS-EU-Q16 (16 Fragen) 
- Zu hoher Zeitaufwand 
 
Deshalb wurde die Kurzform des HLS-EU-Q in Betracht gezogen. Das Messinstrument ist auf dem 
konzeptuellen Modell von Sorensen aufgebaut, welches vier Stadien der Bearbeitung 
gesundheitsrelevanter Informationen unterscheidet (Informationen finden, verstehen, beurteilen und 
anwenden). [200] Da die vorliegende Arbeit das Verständnis von Inhaltsangaben von 
Medikationsplänen untersucht, wurden für die spätere Probandenbefragung aus Zeitgründen nur die 
sechs Fragen des HLS-EU-Q16 ausgewählt, welche sich auf das Verstehen von 




9.1.5 Risk analysis for the development of the interview guide 
 
Für die Bestimmung von risikoreichen Formulierungen in Medikationsplänen wurde eine 
Risikoanalyse durchgeführt. In einem Brainstorming mit dem Studienteam wurden 29 
Fehlermöglichkeiten zu den Kategorien Präparat (4), Dosierung (11), Einnahmemodalitäten (10) und 
weitere Fachbegriffe / Abkürzungen (17) identifiziert. Jede Fehlermöglichkeit wurde hinsichtlich ihrer 
Auftretens-, ihrer Entdeckungswahrscheinlichkeit sowie ihres Schadenpotentials mit einem 
ganzzahligen Wert auf einer Skala von 1 bis 5 bewertet (Table 35). Die Multiplikation der drei 
Faktoren ergab eine Risikoprioritätszahl (RPZ). Medikationsanweisungen mit einer hohen RPZ sind 
besonders risikoreich. In der Table 36 sind alle potentiellen Fehler mit einer RPZ ≥ 32 aufgeführt.  




1 Kein Fall bekannt Wird sicher entdeckt Sehr gering 
2 Sehr unwahrscheinlich Wird fast immer entdeckt Gering 
3 Kommt selten vor Wird meist entdeckt Mässig 
4 Kommt häufig vor Wird selten entdeckt Hoch  
5 Praktisch sicherer Fehler Unmöglich zu entdecken Sehr hoch  
Table 36: Fehlermöglichkeiten mit einer Risikoprioritätszahl (RPZ) ≥ 32. Die fett gedruckten 
Fehlermöglichkeiten wurden in der Patientenbefragung verwendet. 
Fehlermöglichkeiten RPZ 
Dosierung: 
 1-0-0-0 48 
3x/d 48 
3 x wöchentlich, pro Woche 36 
nach dem Aufstehen  32 
vor dem Schlafen 32 
"immer wenn", "solange wie", an Tagen X 32 
Einnahmemodalitäten: 
 nüchtern 48 
unabhängig 40 
aufrecht, nicht hinlegen 40 
vor, mit, nach dem Essen 32 
weitere Fachbegriffe, Abkürzungen: 
 Gtt. 60 
Trp. 48 
Supp.  40 
p.o., per os, per oral 40 
ml - ML 36 
IE 32 
topisch  32 
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9.1.6 Script focus group 
  
177 









Interviewleitfaden: Verstehen Patienten unsere Medikationspläne?      Version vom 14.04.2015 / S. 6  
 
 
12. „Sie erhalten nun 6 Kärtchen. Diese sind nach der Art der Information beschriftet.  










Favoritenplan und Wünsche 
 








































Written part of the interview 
 
Ein Medikationsplan enthält folgende Informationen zu einem Medikament:  
-  Medikamentenname mit Stärke und Form 




Medikament Morgen Mittag Abend Nacht 
Fortamet 500 mg Filmtabletten 1 0 1 0 
 
 
Welche Informationen zu einem Medikament hätten Sie gerne zusätzlich? 
 
☐  Wirkstoff  
☐  Einnahmehinweise (z.B. mit einem Glas Milch einnehmen) 
☐  Anwendungshinweise (z.B. nach der Anwendung Mund spülen) 
☐  Grund der Anwendung 
☐  Dauer der Anwendung  
☐  Erkennen des Arztes, der das Medikament verordnet hat  
☐  Information, ob das Medikament ... 
- vom Facharzt verordnet oder  
- vom Hausarzt verordnet oder 
- in der Apotheke gekauft worden ist.   
 
☐  Abbildungen von Tabletten  z.B.  
 
☐  Piktogramme für Form und/oder Hinweisen  z.B.   
 










Medication charts presented during interview 
 
Karton mit vier nummerierten Medikationsplänen und sechsteiligem Raster mit wiederablösbarem Kleber behaftet sowie sechs Kärtchen beschriftet mit 





9.2 Project A2 









































9.3 Project B 































9.4 Project C 
9.4.1 List of uncertainties for the feasibility testing of the preliminary study design 
 
Abbreviations: Screening Pilot (SPS), Community pharmacy pilot study (CPPS), Procedural pilot study (PPS). 









Messindikator  Messmethode Antwort und allfällige Massnahme 
Vorbereitung          




S F Personen vorhanden (j/n) Brainstorming 
Apothekerteam 
Für den Service steht eine Arbeitskollegin (CB) zur Verfügung, als Stellvertretung für die 
Datenerhebung stehen PW und ML verblindet zur Verfügung.  
2 Ist die Unterstützung 
der Offizinapotheker 
für die Studie 
grundsätzlich 
vorhanden? 





Gemäss Brainstorming muss der Benefit (lang- und kurzfristig) für die Apoteker klar 
ersichtlich und der Zeitaufwand im Rahmen sein. Die Offizinapotheker im CPPS geben den 
Zeitaufwand als Barriere an, den langfristigen Benefit als Facilitator für die Teilnahme. 
Wichtig ist, dass die Apotheken richtig motiviert werden.  










Es muss möglich sein, mit der gewählten Schulungsmethode das ganze Team zu erreichen, 
da jeder Mitarbeitende ein Studienrezept entgegennehmen könnte. Mindestens die 
Erkennbarkeit eines Studienrezeptes muss für alle klar sein. Grundsätzlich kann über eine 
Schlüsselplerson intensiv geschult werden. Wie sich im Pilot gezeigt hat, muss intensiv 
geschult werden, was unter einer pharmazeutischen Intervention zu verstehen ist. Ein 
Videotraining wäre möglich, dürfte maximal 5 Minuten dauern. Zu beachten ist, dass nicht 
alle Apotheken Lautsprecher an den Computern installiert haben. Schulungsinhalte könnten 
sein: Hintergrund, Ablauf, Fallbeispiel. Der Benefit der Sudie muss klar erklärt werden. Das 
Video wird von den Pilotpersonen als geeignet angesehen. Es wird vorgeschlagen, dass ein 
Fallbeispiel in einem separaten, ebenfalls kurzen Video erklärt wird.  
4 Können genügend 
Apotheken rekrutiert 
werden?  






Das Feedback der persönlichen Kontakte und der Pilotpersonen ist positiv. Die Rekrutierung 
läuft. 
5 Steht auf den 
ausgewählten Stationen 
ein Arbeitsplatz oder 
Sitzplatz zur Verfügung? 
S F Verfügbarkeit Arbeitsplatz 




Im Assistentenbüro steht kein Arbeitsplatz zur Verfügung und es ist meist voll besetzt. 
Allenfalls kann mit einem Laptop dort gearbeitet werden. Leer ist es während den 
Rapporten. Im Untersuchungszimmer könnte man arbeiten. Somit steht kein sicherer 
Arbeits- oder Sitzplatz zur Verfügung. Es wird davon abgesehen, dass die 
Studienapothekerin auf der Station anwesend sein muss.  
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S F Schreibrechte im 
Produktivsystem im 
Rezept vorhanden (j/n) 
Interview und Auftrag 
Informatik 
Die Berechtigung liegt vor. 





und Rekrutierung) zur 
Verfügung? 
S E Ressourcen gemäss 
Auskunft zur Verfügung 
(j/n) 
Interview Vorgesetzte Ab November 2016 steht eine Praktikantin für 6 Monate zur Verfügung, welche für die 
Studie im ersten Quartal 2017 eingesetzt werden kann.  
8 Steht der generische 








Der generische Exporter ist seit September 2016 installiert, die Bedienung ist allerdings 
noch unklar. Da die Nutzung des Exporters im Spital wieder neu diskutiert wird, wird der 
Exporter für die Studie schlussendlich nicht verwendet. 
9 Sind die Ärzte 
einverstanden mit dem 
Vorgehen und motiviert 
zur Zusammenarbeit? 
S E Meinungen von 
angefragten Ärzten 
(positiv/negativ) 
Brainstorming Ärzte, PPS Die Studie ist gut und interssant. Positiv ist für die Assistenzärzte, dass der Aufwand gering 
ist und mit einem Lerneffekt gerechnet werden kann. Aus chefärztlicher Sicht ist der 
Forschungsgedanke positiv.  
10 Sind Veränderungen im 
Prozess oder in den 
Dokumenten absehbar? 
S, P F, Q Auskunft von IT, 
Unternehmens-




entwicklung, Medizin, Care 
Management 
Es sind bis zum Studienabschluss keine Veränderungen absehbar, welche den Studieninhalt 
oder -ablauf beeinflussen könnten. 
Patientenscreening           
11 Sind die Stationen 121 
und 111 als 
Studienstationen 
geeignet?  






Die Stationen 111 und 121 sind geeigneter als 112 (palliativer Fokus) und 122 (geriatrischer 
Fokus).121 hat viele Dialysepatienten, was auf die Studie einen geringeren Effekt hat. Aus 
dem Pilot SPS ist ersichtlich, dass von der Station 111 sehr viele Patienten (ev. bis 30%) in 
die Rehabilitation übertreten und somit ausgeschlossen werden müssen. Auf beiden 
Stationen zusammen werden 70.9% nach Hause enthalssen. Sie haben ein 
durchschnittliches Alter von 68.5±-16.7 Jahren. Die beiden Stationen 111 und 121 werden 
somit als die geeignetsten Studienstationen angesehen. Alternativ wäre 122 möglich, sofern 
zu wenige Patienten eingeschlossen werden. 
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12 Ist ein serielles 
Screening (z.B. 2 
Wochen) der Stationen 
geeignet, um den 
Lerneffekt des 
Assistenzartes zu 




P Q Eignung der seriellen vs. 
parallelen Bearbeitung der 





Brainstorming Ärzte und 
Studienteam 
Das serielle Bearbeiten der Stationen ist von Vorteil um den Lerneffekt bei den 
Assistenzärzten zu minimieren. Ein 2-Wochen-Rhythmus wäre gemäss Dienstplan geeignet. 
Da ein Arzt schätzungsweise max. 4 Austritte pro Woche bearbeitet, und davon im 
Durchschnitt max. 2 in die Studien eingeschlossen werden können, hielte sich der Lerneffekt 
im Rahmen. Im Brainstorming zeigt sich, dass durch den Unterbruch des Screenings viele 
Patienten verpasst werden. Möglicherweise treten die Patienten auf einer Station erst aus, 
wenn die andere Station bearbeitet wird und wären sie je nach Vorgehensweise verloren. 
Daher ist die Eignung nicht gegeben. Zusammen mit der Power Calculation ergibt sich, dass 
konstant parallel auf beiden Stationen gescreent werden muss. Der tägliche Aufwand wird 
daher grösser, die Studiendauer kann aber wie geplant (3 Monate) kurz gehalten werden. 
Die parallele Bearbeitung der Stationen wird daher als das geeignetstere Schema beurteilt. 
13 Ist das Screening der 
Patienten zeitlich 
machbar? 
P E Zeitdauer bei einem 
Screening einer Station 
SPS Das Screening im SPS dauerte maximal 11 Minuten, mindestens 1 Minute pro Station. Für 
Screenings an 3 Tagen auf 2 Stationen wurden insgesamt 26 Minuten aufgewendet. Anfangs 
Woche oder bei vielen Neueintritten dauert das Screening länger als an Folgetagen. Das 
Screening ist zeitlich machbar.  
14 Zu welchem Zeitpunkt 
wird am besten 
gescreent? 
P F, E Vor- und Nachteile 
verschiedener Zeitpunkte 
PPS, Brainstorming Ärzte Gemäss Aussagen von Ärzten und den Erfahrungen im PPS ist der Zeitpunkt irrelevant. Ein 
möglicher Zeitpunkt ist morgens vor der Visite, da so die Eintritte vom Vortag schnell 
einbezogen werden können. Zwischen 9-11 Uhr wird Zeit für den Service benötigt, der 
Nachmittag eignet sich für die Rekrutierung. Somit eignet sich der frühe Morgen am besten. 
Es soll aus Effizienzgründen nur 1x täglich gescreent werden. 
15 Sind die Daten im KISIM 
verlässlich? 
S E Fehler in der KISIM-
Dokumentation 
SPS, PPS Folgende Fehler in der KISIM-Dokumentation wurden bemerkt: 1. Patienten vom Notfall 
laufen zum Teil noch unter dieser Fachrichtung, obwohl sie bereits medizinisch betreut 
werden. Es darf also nicht nach Fachrichtung gefiltert werden, so dass diese auch gesehen 
werden. 2. Es darf nicht nach "aktuellen" Patienten oder "Neueintritten" gefiltert werden, 
da sons einige Patienten aus unbekannten Gründen nicht angezeigt werden, obwohl sie 
eingeschlossen werden könnten. 3. Das Austrittsmanagement wird nicht immer ganz aktuell 
gepflegt, wird aber bei baldigem Austritt gut gepflegt. Insgesamt können die Fehler mit 
standardisiertem Vorgehen berücksichtigt werden. 
16 Sind alle 
Einschlusskriterien im 
KISIM verfügbar? 
S F Anzahl fehlender 
Einschlusskriterien  
SPS Gemäss Pilotierung sind in der Regel alle Einschlusskriterien verfügbar. Bei fehlenden 
Angaben können diese beim Arzt erfragt werden. 
17 Wie können mehrfache 
Ausschlusskriterien 
dokumentiert werden? 







Gemäss Statistiker können verschiedene Ausschlusskriterien pro Patient erfasst werden, sie 
werden im Bericht jedoch nicht einzeln aufgeführt. Vorteil ist, dass es korrekt erfasst wird, 
Nachteil, dass beim Reporting eine höhere Anzahl Kriterien als Patienten erfasst sind. Im 
SPS wurde versucht, die Kriterien streng chronologisch zu erfassen (ähnlich einem Flow 
chart) und die Patienten, welche beim ersten Kriterium ausgeschlossen wurden, nicht mehr 
auf die anderen Kriterien zu prüfen. Vorteil: ganz klare Vorgehensweise, effizienter. 
Nachteil: nicht alle Kriterien sind für alle Patienten verfügbar. Es wird entschieden, nach der 
zweiten Methode zu arbeiten. 
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18 Welche Austrittsorte 
gibt es, die als 
Ausschluss gelten? 
S Q, F Austrittsarten gemäss 
Controlling und gemäss 
Dokumentation 
SPS, Interview Controlling Folgende Kategorien führt das Controlling: 2=Kranken/Pflegeheim, 3=Altersheim oä, 
4=psychiatrische Klinik, 5=Reha, 6=anderes Krankenhaus, 7=Strafvollzug, 8=andere, 
9=unbekannt (sofern nicht nach Hause), 0=Todesfall. Das Kriterium 1=Zuhause gilt als 
Einschluss. Im SPS wurde betreutes Wohnen als Austrittsart gefunden. In diesen Fällen kann 
mit dem Patienten oder mit dem Arzt geklärt werden, ob der Patient selbständig für die 
Medikamentenbesorgung verantwortlich ist. Je nach Antwort wird der Patient analog 
"Zuhause" oder "Altersheim" behandelt. 
Patientenrekrutierung         
19 Wie ist der Austrittstag 
am verlässlichsten 
herauszufinden? 
P E Empfehlung einer 
Methode 
Brainstorming Ärzte Die telefonische Anfrage bei Assistenzarzt ist die verlässlichste Methode, da diese über den 
Austritt entscheiden. Im Assistentenbüro gibt es keine Tafel, und jede im Stationsbüro ist 
möglicherweise nicht sofort nachgepflegt. Das Austrittsmanagement im KISIM wird von der 
Pflege nachgeführt und ist meist gegen Ende des Aufenthalts nachgeführt. Es wird 
telefonisch bei den Assistenten nachgefragt.  
20 Ist das 
Rekrutierungsgespräch 
zeitlich machbar? 
P E Zeitdauer für 
Rekrutierungsgespräch 
PPS Das Rekrutierungsgespräch dauert meist nicht mehr als 5 Minuten. Für ein effizienteres 
Rekrutieren, kann die Patienteninformation und die Einverständniserklärung dem Patienten 
nach dem Gespräch abgegeben werden, damit dieser es in Ruhe lesen kann. Die 
Rekrutierung ist somit machbar. 
21 Wann kann das 
Rekrutierungsgespräch 
stattfinden? An 
welchem Spitaltag, um 
welche Tageszeit 
idealerweise?  
P F, E Vor- und Nachteile 
verschiedener 
Rekrutierungs-zeitpunkte 
PPS Im PPS wurden verschiedene Rekrutierungszeitpunkte ausprobiert. 16 von 59 Patienten 
wurden wegen Besuch, Abwesenheiten oder Schlaf verpasst. Diese Rate war nachmittags 
besonders hoch und ist daher ein Nachteil. Ein Vorteil für den Nachmittag ist die lange 
Zeitspanne ohne Visite. Morgens muss auf die Visite und die Pflegevorgänge Rücksicht 
genommen werden. Kurze Zeitfenster, die genutzt werden können, sind jedoch von Vorteil. 
Ebenfalls ist positiv aufgefallen, pro Tag 2-3x zu rekrutieren. So können einmalig verpasste 
Patienten noch einmal aufgesucht werden.  
22 Wieviele Patienten 
werden nicht verpasst? 
P F, E Anzahl verpasster 
Patienten 
PPS, Interview Ärzte Wie unter Punkt 21 erwähnt, wurden 16 von 59 Patienten (27%) für die Rekrutierung 
verpasst. Mit besseren Rekrutierungszeitpunkten und der längeren Studiendauer als im 
Pilot kann diese Zahl verbessert werden. Für die Intervention wurden 5 von 21 Patienten 
(23%) verpasst. Gemäss Interview mit den Ärzten kann dies verbessert werden, wenn sie 
wissen, welche Patienten eingeschlossen sind. Darum wird eine einmalige Mitteilung und 
eine fortbestehende im Prozedere im KISIM vorgesehen. 




für die EKNZ 
ausreichend? 
P F unverbindliche Auskunft 
von EKNZ (j/n), später 
definitive Verfügung (j/n) 
Interview mit 
Ethikkommission EKNZ 
Gemäss schriftlicher, unverbindlicher Auskunft der EKNZ wird ein Forschungsprojekt zu 
Rezepturprozessen nicht als Humanforschung angesehen. Es muss kein Ethikvotum 
eingeholt werden, eine Unbedenklichskeitserklärung reicht. Weil aber gesundheitsbezogene 
Daten (gemäss Gesetz „Informationen über eine bestimmte oder bestimmbare Person, die 
sich auf deren Gesundheit oder Krankheit beziehen, einschliesslich ihrer genetischen 
Daten“) gesammelt werden, könnte es als Humanforschung gelten. Insbesondere wenn 
Krankheitsbilder fesetgelegt werden. Im Falle einer Unbedenklichskeitserklärung wäre keine 
Einverständniserklärung notwendig.  
Gemäss definitvem Beschluss fällt das Projekt unter das Humanforschungsgesetz und eine 
schriftliche Einverständniserklärung ist nötig. Die mündliche, und schriftlich dokumentierte 
Einverständniserklärung reicht nicht aus. 
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24 Wieviele Patienten 
lehnen die Teilnahme 
ab? 




11 von 59 (18%) Patienten lehnten die Teilnhame im Pilot ab. In der Masterarbeit waren es 
bei einer ähnlichen Population ca. 30%. Dieses Spektrum wird angenommen. 
25 Wie viele Patienten 
müssen ausgeschlossen 
werden? 
S E Anzahl Ausschlüsse im 
Pilot 
PPS Von 66 Patienten erfüllten 7 (10%) die Einschlusskriterien nicht, und von den verbleibenden 
59 Patienten mussten 22 (37%) aufgrund eines Ausschlusskriteriums ausgeschlossen 
werden.  
Randomisierung           
26 Ist die Randomisierung 
mit random.org 
machbar? 




Die Randomisierung wurde ausprobiert und scheint machbar. Es wird in 5-10 er Gruppen 
block-randomisiert, damit die Gruppen während dem Verlauf der Studie gleich gross 
bleiben. 
27 Muss für die Apotheke 
stratifiziert werden? 
P Q Empfehlung PCRG Brainstorming 
Forschungsgruppe 
Eine Stratifizierung pro Apotheke wäre zu kompliziert, da jede Apotheke nur wenige 
Rezepte bearbeiten wird.  
Service: Rezeptcheck           
28 Wieviel Zeit benötigt 
man für die 
Rezeptvalidierung 
(Check)? 






In dieser Diplomarbeit wurde eine ausgedehnte, retrospektive Rezeptvalidierung 
durchgeführt. Die Ein- und Ausschlusskriterien wichen etwas von der POMMES-Studie ab. 
Pro Rezept war im Durchschnitt 9.69 ± 4.51 Minuten (ohne Dokumentation) nötig. Die 
Dokumentation nimmmt zustätzlich 5-15 Minuten pro Patient in Anspruch, bei 3.28 ± 2.33 
Interventionen pro Rezept. Hier wurden Schwierigkeiten mit dem Tool festgestellt, welche 
gelöst werden mussten. Beim Pilotieren dauerte die reine Validierung nie mehr als 10 
Minuten.  
29 Steht das Rezept 
rechtzeitig zur 
Verfügung? 
S F Erfahrungen im Pilot (j/n) PPS, Interview Ärzte Im Pilot hat sich gezeigt, dass das Rezept spätestens 30 Minuten vor dem Austritt zur 
Verfügung stehen sollte, um die Validierung in der Interventionsgruppe durchzuführen. Bei 
aussergewöhnlich vielen Medikamenten muss mehr Zeit einberechnet werden. In den 
meisten Fällen stand das Rezept genügend früh zur Verfügung. Gemäss Aussage der Ärzte 
könnte das Rezept in vielen Fällen am Vorabend vorbereitet werden. Dann müssten sie 
jedoch daran erinnert werden.  
30 Ist das hospital Case 
Report Form (hCRF) 
geeignet? 
S Q Handhabbarkeit des hCRFs 
(gut/schlecht) 
Test, PPS hCRF wurde mit mehreren Rezepten getestet und optimiert. Im PPS wurden erneut 
Optimierungen vorgenommen, so dass das hCRF gut handbar ist.  
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31 Werden relevante 
Validierungskriterien 
bearbeitet? 






Diplomarbeiten Iris Grimm 
und Cristina Belenda 
Bei der Diplomarbeit von Cristina Belenda waren die häufigsten Interventionsgründe 
Kategorie C: C4.2 Ungeeignete Anwendungsweise 21.80% (das sind halt alle diese 
Einnahmehinweise), C7.1 Unvollständige / unklare Verordnung 14.36%. Interaktionen: 
5.36% (Stufe 1-3 sind gut), potentiell nötige BTM-Rezepte : 3.81%, Fehler in der 
Rücksubstitution: 7.27% . In der Kategorie der technischen/formalen Probleme waren 
0.73/Rx, Unvollständige/unklare Verordnung waren 0.32/Rx, Interaktionen 0.12/Rx. Fehler 
in der Rücksubstitution 0.16/Rx.  
Bei der Diplomarbeit von Iris Grimm waren in Kategorie C (Interventionsgründe) die 
unklaren Verordnungen sehr wenig relevant, eher die Verfügbarkeit und die finanzielle 
Belastung, sowie die unangemessene Therapiedauer. Die Unterschiede zwischen den 
Arbeiten sind vor allem auf die verschiedenen Dokumentationsmethoden und Sichtweisen 
zurückzuführen. 
Therapiedauer, Änderungen (Substitutionen) und Interaktionen sind sehr relevant gemäss 
Aussagen der Offizinapotheker. Unklar ist weiterhin, ob die Zufriedenheit der Apotheker 
gesteigert werden kann, wenn z.B. Substitutionen vorbearbeitet werden. Neue 
Medikamente zu dokumentieren ist sicher sehr relevant. 













Firmennamen wurden in der Diplomarbeit nicht umgestellt, da es ineffizient schien. 
Ausserdem war nicht sicher, dass die Anamnese korrekt war. Therapeutische Umstellungen 
wurden aufgenommen. Ebenfalls generische Umstellungen, bei denen der 
Medikamentennamen wesentlicher als nur beim Firmennamen änderte. Insgesamt waren 
so 7.27% aller Interventionen Substitutionen, diese wurden als Unterpunkt "Fehler in der 
Rücksubstitution" definiert. Es wird entschieden, auch die Firmennamen einzubeziehen, 
und die Fehlerhaften Anamnesen in Kauf zu nehmen. Dies hat sich im PPS bewährt. 
33 Welche formalen Fehler 
sollen korrigiert 
werden? 







formale Fehler können sein: fehlendes Betäubungsmittelrezept, fehlende Hilfsmittel, 
fehlende oder falsche Einheiten, falsche galenische Form zur Dosierung, fehlende 
Therapiedauer. Gemäss Diplomarbeit sind alle diese Fehler selten vorgekommen. Fehlende 
Hilfsmittel werden in dieser Studie nicht berücksichtigt, da die Eruierung von z.B. den 
richtigen Lanzetten oder Teststreifen den Aufwand sehr steigern würden. Einfach und 
effektiv umzusetzen sind Betäubungsmittelrezept, Einheiten, galenische Form oder 
Therapiedauer bei Antibiotika.  
34 Wann ist der 
Assistenzarzt 
erreichbar?  
S E ideale Zeitpunkte PPS, Interview Ärzte Ideale Zeitpunkte sind vor der Morgenvisite um 9.30 Uhr (ausser bei der Chefarztvisite, die 
früher beginnt und während der Morgenfortbildung), und den ganzen Nachmittag (ausser 
während den Mittagsfortbildungen).  
35 Wieviele Interventionen 
im Service werden nicht 
akzeptiert?  




Visiten im KSB 
Daten der klinischen Visiten: 72% werden vollständig akzeptiert und umgesetzt. Es wird eine 
höhere Rate erwartet, da es um weniger klinische Interventionen geht, sondern häufig um 
formale Probleme. Problematisch könnte sein, dass der Arzt Interventionen ablehnt und es 
dadurch zu einem höheren Aufwand kommt. Gemäss Pilot werden alle Interventionen 
akzeptiert oder teilweise akzeptiert, wenn eine andere als die vorgeschlagene Lösung 
implementiert wird. z.B. Monitoring bei Interaktion vorgeschlagen, aber Arzt setzt 
Medikament ab.  
36 Wie wird vorgegangen, 
wenn Interventionen im 
Service nicht akzeptiert 
P Q Vorgehensweise 
definieren 
Brainstorming Ärzte Da dieser Fall im Pilot nicht eingetreten ist, ist dieses Element hinfällig. Es wird definiert, 




37 Werden die 
Interventionen 
rechtzeitig an den Arzt 
übermittelt, sodass eine 
Entscheidung und 
Umsetzung möglich ist? 
P F Rechtzeitige 
Optimierungen  
PPS Durch das sofortige Verändern des Rezeptes und die Rücksprache mit dem Assistenzarzt 
wurden die Interventionen bisher rechtzeitig umgesetzt. 
Service: Rezeptoptimierung           
38 Wer implementiert die 
Interventionen im 
Rezept?  
P Q, F, E Vor- und Nachteile 
verschiedener Optionen  
PPS Die Optimierungen sollen direkt durch das Studienteam eingefügt werden, damit den 
Assistenzärzten kein Zusatzaufwand entsteht. Ausserdem werden so die Optimierungen wie 
besprochen und schnell eingefügt. 




P Q Vor- und Nachteile 
verschiedener Optionen  
PPS, Brainstorming Ärzte Das Studienteam soll den Standardsatz (zum Studieneinschluss des Patienten) einfügen. 
Dies hat den Vorteil, dass für die Assistenzärzte kein Zusatzaufwand entsteht. Nachteilig 
gibt es für das Studienteam mehr Aufwand, wobei dieses die Optimierungen sowieso 
einfügt. Von Vorteil ist, dass der Satz exakt standardisiert eingefügt wird. 




P Q Probleme bei der 
Implementierung (j/n) 
PPS Im PPS sind keine Schwierigkeiten mit der Implementierung aufgetreten. Da diese durch das 
Studienteam gemacht werden, ist auch weiterhin nicht mit Schwierigkeiten zu rechnen. Es 
muss aber darauf geachtet werden, dass die Rezepte nicht schon vorgängig ausgedruckt 
und so ohne Optimierungen abgegeben werden. 
41 Wieviele 
Optimierungen werden 
nicht akzeptiert? Was 
sind die Gründe? 





PPS Es sind nur vereinzelte Optimierungen abgelehnt worden. Gründe waren meistens 
Unwissen des Studienteams im Bezug auf ein Detail in der Patientengeschichte. Dies kann 
bei der Rücksprache mit dem Arzt geklärt werden.  
42 Wie häufig sind 
handschriftliche, 
ärztliche Änderungen 
auf dem Rezept? Wie 
kann damit 
umgegangen werden? 
P Q Häufigkeit handschriftliche 
Änderung auf dem Rezept.  
Interview Offizinapotheker Alle befragten Apotheker geben an, dass handschriftliche Änderungen sehr selten sind.  
43 Können alle 
Interventionen mittels 
PharmDISC 
dokumentiert werden?  
S F Erfahrungen (j/n) PPS, Interview und 
Literaturrecherche 
Diplomoarbeiten Iris 






Grundsätzlich können alle Interventionen im pharmDISC dokumentiert werden. Die 
Dokumentation ist jedoch sehr subjektiv. Standardfälle können helfen, wiederkehrende 
Interventionen zu dokumentieren. Es wird entschieden, Standarddokumentationen zu 
verwenden. 
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Rezepteinlösung allgemein           
44 Wie kann vorgegangen 
werden, wenn der 
Patient das Rezept nicht 
innerhalb einer Frist am 
vorgegebenen Ort 
einlöst?  
P E Lösungsvorschläge PPS, Brainstorming 
Offizinapotheker 
Es wird keine standardisierte Frist festgelegt. Patienten, die ihr Rezept in einer anderen 
Apotheke einlösen, werden anhand eines Blanco-Bogens erfasst, sofern diese Apotheke 
teilnimmt. Das Rezept ist erkennbar durch den Standardsatz. Die Blanco-Bögen werden zu 
Studienbeginn an alle teilnehmenden Apotheken verteilt. Patienten, deren Rezepteinlösung 
nicht nachvollzogen werden kann, werden als Drop out ausgeschlossen. 
45 Wie hoch ist die 
Dropoutrate?  




im PPS wurden 2 von 11 Outcomebögen nicht zurückgefaxt. Dies ist eine relativ hohe 
Anzahl, welche aber bereits mittels gezielter Rückfragen vermindert werden konnte. Dies ist 
auch der vorteilhafteste Lösungsansatz für die Studie. 
Dokumentation von Interventionen         




S F, Q Aussagen Apotheken (j/n) CPPS, Interview Iris 
Grimm, Brainstorming 
Offizinapotheker 
Die Kapazität sollte vorhanden sein, auch wenn dies ein limitierender Faktor ist. Deshalb 
muss die Dokumentationsart möglichst einfach und schnell möglich sein. Besonders die 
Kategorien A-C sind abstrakt und deshalb schwierig auszufüllen. Die Kategorien D-F sind 
jedoch möglich. Die Apotheker haben weniger Kapazität als die Personen, welche das 
Rezept ausgeführt haben. Die Berufsgruppe ist ein limitierender Faktor.  
Bezüglich Kompetenz ist sicher wichtig zu beachten, dass Apotheker nicht alle 
Interventionen als solche erkennen und deshalb nicht dokumentieren. Es gibt 
Unsicherheiten mit dem pCRF, und fehlende Vertrautheit. Es wäre möglich einen "Power 
user" pro Apotheke festzulegen. Die Schulungs muss offene Fragen klären. Insgesamt darf 
das hCRF die Kapazitäten nicht überschreiten und nicht auf die Berufsgruppe Apotheker 
beschränkt sein. Bezüglich Kompetenz muss gute Hilfestellung geboten werden. Siehe 
Schulungsmöglichkeiten 
47 Soll der pharmDISC von 




P Q, F, E Vor- und Nachteile der 
verschiedenen Methoden 




Wenn der pharmDISC von der Offizin selber ausgefüllt wird, kann die Kategorisierung in 
einem Schritt erfolgen, es ist kaum nachträglicher Aufwand nötig. Nachteilig ist der 
Zeitaufwand und dass die Apotheker für das Tool spezifisch geschult werden müssen. 
Kategorisiert das Studienteam, kann eine Standardisierung garantiert werden und der 
pharmDISC muss nicht geschult werden. Ausserdem ist durch Übung ein Effizienzgewinn zu 
erwarten. Nachteilig ist, dass für Rückfragen ein Telefonanruf nötig ist, dafür können aber 
ganz gezielte Nachfragen gestellt werden und nicht-dokumentierte Interventionen noch 
nacherfasst werden. Für die Offizin müsste das pCRF sehr einfach und intuitiv sein. Es wird 
entschieden, dass die Offizin eine pharmDISC-artige Vorerfassung mittels pCRFmacht und 
das Studienteam es erfasst. 




P E Zeitmessung einer 
pharmDISC-
Dokumentation 
CPPS, Interview Cristina 
Belenda, Iris Grimm 
Nicht zutreffend, da der pharmDISC wie in Element 47 besprochen durch das Studienteam 
kategorisiert wird. 
49 Ist die Zeitdauer zum 
Ausfüllen des pCRF 
angemessen? 
P E Erfahrungen im Pilot (j/n) CPPS Das pCRF ist zeitlich gut auszufüllen. Der Zeitfaktor ist zwar eine Hauptbarriere zur 
Teilnahme an der Studie, der Aufwand wird aber als angemessen beurteilt.  
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50 Ist das pCRF geeignet? S Q, E Erfahrungen im Pilot (j/n) CPPS Die Länge des pCRF ist angemessen und darf nicht länger werden. Es steht jedoch zu wenig 
Platz zur Verfügung und es bestehen Verständnisfragen. Diese werden einerseits auf dem 
Bogen geklärt, andererseits für das Trainingsvideo vorgemerkt. Die Dokumentation der 
Interventionen wird aufgrund der Rückmeldungen angepasst. Das pCRF ist mit Änderungen 
geeignet.  
51 Wie kann die 










Bei einer Likert-Skala (analog Studie Vevey) wäre die Dokumentation sehr einfach, aber die 
Daten wären vorkategorisiert. Bei einer Freitextangaben könnten die Apotheken die Zeit 
genau erfassen und die gesamte Datentiefe bleibt vorhanden. Die Kategorisierung kann 
später erfolgen.  
Datenmanagement         
52 Welches Tool wird für 
die Datensammlung 
verwendet? 




Nachteilig bei Access ist der Aufbau der Datenbank, da dieser für nur 150 Datensätze 
verhältnismässig zu hoch ist. Vorteilig wäre, dass Access für Datenbanken und Abfragen gut 
geeignet ist. Excel hat den Vorteil, dass es dem Studienteam gut bekannt ist und einfach in 
der Handhabung. Nachteil ist die fragliche Datensicherheit. Aufgrund der bestehenden 
Kenntnisse und der Effizienz wird Excel verwendet.  
53 Ist die Studie so 








Die Power Analyse basiert auf Daten aus verschiedenen Quellen. Es wurden zwei 
konservative Annahmen gemacht: die höchste berechnete Pateientenzahl wurde verwendet 
und zur Sicherheit von 126 auf 150 Patienten aufgerundet. Die Studie hat gute Chancen, 
statistisch signifikant zu werden.  
Outcomes         
54 Beeinflussen die Visiten 
auf der Medizin den 
Outcome? Wie kann 
dies kontrolliert 
werden? 





Anhand der bisher durchgeführten Interventionen wird ein Effekt vermutet. Es wird deshalb 
definiert, dass die klinischen Visiten auf den Studienstationen keine Interventionen zum 
Austrittsrezept oder zur Austrittsmedikation vornehmen dürfen, welche in der Studie 
behandelt werden. 
55 Outcomes genügend 
nützlich für KSB? 
S Q Aussagen Geschäftsleitung Brainstorming 
Geschäftsleitung KSB 
Das geplante Studiendesign mit den Endpunkten wurden der Geschäftsleitung präsentiert. 
Es soll zusätzlich geprüft werden, inwiefern sich die Resultate auf eine öffentliche Apotheke 
im KSB übertragen lassen. 
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9.4.13 Summary of answers by community pharmacists 
Was ist Ihre generelle 
Meinung zur POMMES-
Studie in 1-2 Sätzen? 
 Ich finde es eine sehr gute Idee. Ich schätze, dass man wirklich in Zukunft die 
Synergien nutzen will, die Zusammenarbeit haben. Was ein bisschen mühsam 
war im Alltag, mit dieser Struktur, wie die Fragebögen aufgebaut sind. 
 Ich habe es eine sehr gute Studie gefunden, die Dosierungen haben mir sehr gut 
gefallen. 
 Ich habe die Studie sehr begrüsst, weil es eine Schnittstelle ist, die nicht 
unproblematisch ist. Beim Spitalaustritt kann wirklich einiges schief gehen. 
 Der Aufwand war eigentlich noch im Rahmen. 
 Die Bemühungen, das Ganze zu verbessern und zu strukturieren, finde ich 
super. 
 Mich hat es überzeugt, dass man realisiert hat, ob ein Rezept vorbearbeitet 








 Ich habe vor allem an der GV aktiv davon gehört, und ich denke, das ist der 
beste Weg, wirklich sehr persönlich, dass du auf uns zugekommen bist und uns 
überzeugen konntest. 
 Es sind wirklich alle informiert gewesen. Und es ist auch etwas gewesen, was vor 
allem bei den Apothekern auf grosses Interesse gestossen ist, weil man sich 
dieser Schnittstelle bewusst ist. 
 Den Kommunikationsweg über den AAV finde ich super, weil dort haben wir die 
Gewähr, dass alle Apotheken informiert werden 
 Die Youtube-Videos waren instruktiv. 
 Ich war an der GV und habe es dort gehört. Es war klar, was wir machen 
müssen. 




 Grundsätzlich finde ich gut per Fax, weil er immer noch sehr zentral ist bei uns.  
 Ich hätte es geschätzt, man hätte irgendwie eine Online-Variante dieses 
Fragebogens gehabt, mit der Möglichkeit, Bemerkungen reinzuschreiben. 
Anklicken und Bemerkungen, wo es einem auch durchgeführt hätte. 
 Man hatte den Outcomebogen immer genug früh. Ich glaube, was weniger gut 
war, dass die Patienten jeweils nicht genau gewusst haben; wir haben von Studie 
gesprochen, ihr von Projekt, dann sind sie jeweils gerade wieder verwirrt 
gewesen.  
 Das mit dem Faxen hat gut geklappt, und den Outcomebogen habe ich auch gut 
gefunden. Ich habe es jeweils schwierig gefunden den Fehler zuzuordnen. Ihr 
habt ja ein Email geschrieben, man soll etwas härter, etwas kritischer sein. Ich 
habe das gut gefunden, das hätte man vielleicht von Anfang an sagen sollen. Ich 
habe die Erfahrung gemacht, dass die Pharmas meistens zu lieb waren. Weil als 
Apotheker füllt man anders aus und schaut das Rezept anders an. 
 Im Tagesbetrieb kommt dann vielleicht das Telefon zu einer Zeit, in der es 
gerade hektisch ist, oder diese Mitarbeiterin ist gerade besetzt.  
 Ich fand es gut, dass relativ zeitnah nachgefragt worden ist und man das 
Formular auch schnell zurückschicken können, dann war das schon 
abgeschlossen. Aber es hat manchmal zu einer Hektik geführt. 
 Das [Faxen des Outcomebogens] war super, da wir dann meistens gerade einen 
Eintrag beim Kunden gemacht haben, damit wir es nicht verpassen: „Achtung 
POMMES“. Man war dann vorgewarnt, jetzt kommt dann einer.  
 Vielleicht ist das mit den Interventionen auch nicht ganz klar, wie das heute 
definiert ist, ich mache einfach.  
 Das wäre vielleicht gut, wenn man in einer nächsten Studie, dass die Rückfragen 
von jemandem kommen, der den Alltag kennt. 
 Die Nachfragen waren konzis.  
 Was Schwierigkeiten gemacht hat, dass wir manchmal trotz aller Instruktion nicht 
ganz begriffen hatten, wie man den Fragebogen korrekt ausfüllt. 
Wie beurteilen Sie das 
Rezept als 
Kommunikationsmittel 
zwischen Spital und 
öffentlicher Apotheke? 
 Ich hätte mir aber gewünscht, dass wir immer auch die Medikationsliste dazu 
haben. Weil wir doch oft merken, dass unsere Kunden vom Arzt, der sie 
entlassen hat, doch noch hier und da Instruktionen erhalten hat, die uns gefehlt 
haben. Das habe ich mir wirklich gewünscht, dass man auch den 
Medikationsplan hätte. Wir müssen uns voll auf den Kunden verlassen, wenn er 
sagt ich muss das Medikament 6 Wochen nehmen oder spritzen.  
 Das Rezept dient als Kommunikationsmittel, es reicht aber nicht. Es erschwert es 
gerade dann, wenn der Patient nicht persönlich da ist sondern eine Drittperson 
es für ihn abholt. Die wissen häufig gerade gar nichts. 
 Am Schluss muss man sagen, was ist die Alternative. Patienten, wo wir 
Dosettebetreuung machen. Wo es enorm wichtig ist, dass man die aktuelle 
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Medikationsliste hat.  
 Das Rezept ist nach wie vor ein gutes Instrument. Der Apotheker braucht ein 
Rezept, eine Vorgabe. Wir getrauen uns nicht so leicht, etwas zu ändern, das 
finde ich auch gut so. Wenn es noch mehr Partner hat, wird es schwierig. Ich 
möchte die Verantwortung übernehmen könnten, für was ich abgebe. 
 Das wäre grundsätzlich cool, wenn wir das [dass die Interaktionen geprüft 
wurden] schon wüssten.  
 Rezept als Kommunikationsmittel finde ich super. Wenn man es als 
Kommunikationsmittel verwendet wird, muss sich der, der es schreibt bereits 
überlegen, was der damit macht, der es bekommt. Und das erledigt bereits viele 
der Punkte, die nicht funktionieren. 
 Für mich sind eigentlich alle Kommunikationswege gut, solange sie [die 
Kommunikation] stattfindet.   
 Das Rezept ist sicher ein guter [Weg], dann hat man alles beieinander. 
Haben Sie selber 






 Manchmal war es so sonnenklar, dass alles perfekt gestimmt hat, und gut 
dokumentiert war. 
Bitte geben Sie an, ob 
durch die Studie 
irgendeine 
Sensibilisierung 
stattgefunden hat.  
 Ich würde behaupten, wir sind schon relativ gut. Aber es ist sicher eine 
Sensibilisierung da gewesen, dass man wirklich schaut, welche Medikamenten 
waren schon vorher in der Therapie, was sind neue, dann auch nicht immer nur 
die kleinste OP mitgeben. 
 Das was für mich das grösste Problem ist, wie lange muss jemand etwas 
nehmen. Dass man aufhören sollte, Einzelrezept oder Dauerrezept zu schreiben, 
sondern man sollte doch schreiben: Einnahme bis zur nächste Kontrolle, und 
dann nächste Kontrolle dann und dann. 
 Ich denke eigentlich auch nicht, dass das die Arbeit beeinfluss hat.  
 Wir haben intern im Team mehr darüber gesprochen. 
 Mir ist bei den Betäubungsmitteln wirklich nur die Schmerzmedikation in Reserve 
(aufgefallen). Das wird selten sauber gemacht, und dort war es wirklich sauber 
gemacht. Ich habe nachgerechnet, es war derselbe Wirkstoff, bei 
Durchbruchschmerzen, es hat gestimmt, es war 1/10 der Tagesdosis. Es hat 
wirklich aufs Komma gestimmt, das musste ein Apotheker berechnet haben. 
 Das mit den Interaktionen hat mich speziell gedünkt, aber korrekt. Ich musste mir 
dann sagen, das sind ja auch Pharmazeuten, die haben das für korrekt 
befunden. Jetzt braucht es mich nicht auch noch einmal. Ich musste mich wirklich 
bewusst zurücknehmen. Es ist einfach schwierig loszulassen. 
 Wenn ich da so lese, hier bei den POMMES-Rezepten stand es [Therapiedauer] 
drauf. Im Nachhinein gesehen. Weil normalerweise steht es nicht drauf. Ich 
merke es erst jetzt, wo sie es sagen. 






 Bei den Therapieänderungen sind wir relativ grosszügig, mit Ausnahme der 
Psychopharmaka. Da haben wir in der History ganz klar, was der Patient hatte, 
dann bekommt er das auch wieder. 
 Wir haben jetzt einfach in der POMMES-Studie profitieren können, wenn wir ein 
Rezept erwischt haben, wo das schon gemacht worden ist. Wir haben das schon 
immer gemacht. 
Stellen Sie sich vor, die 
Spitalapotheke könnte 
die Rezepte weiterhin 
wie in der Studie 
bearbeiten. Welche 
Kommentare oder 
Wünsche hätten Sie 
diesbezüglich?   
 Ich denke, wir das akademische Personal, haben eher noch den Plausch daran, 
aber zum Teil ist es schon harzig, wenn eine PA das ausfüllen muss.. Dass man 
zum Beispiel die galenischen Formen berücksichtigt, dass wenn die [Patienten] 
zu uns kommen, dass wir schon wissen, ah das wurde abgeklärt, dass die Frau 
Mühe hat mit Schlucken. Oder Mühe hat zu spritzen. Das wäre sicher ideal, das 
würde uns die Arbeit vereinfachen.Also sicher Arzneiformen ist ein grosses 
Thema.. Auch wenn es ein off-label use oder eine Dosierung, dass man das 
sauber rezeptiert, dass man immer noch weiss, wenn es unterstrichen ist, oder 
ein Ausrufezeichen oder ein Sic, dass wir wissen, dass es wirklich bewusst so ist. 
Dass wir nicht immer nachfragen müssten. Also wieder, damit es eine 
Vereinfachung gibt, und ich finde auch, gegenüber dem Patienten wirken wir 
beide viel kompetenter. Das Spital wie auch die Offizinapotheke.. Dass man die 
Kostengutsprachen schon weiss und bekommen hat. Auch dokumentiert hat. 
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Wenn man das nur schon auf das Rezept draufschreiben würde, dass der 
verschreibende Arzt sagt, „Kostengutsprache ok“, das reicht. Das ist auch 
angenehm für den Patienten.  
 Wirklich den Plan dazu.  
 Wie gesagt, mit dem KSB arbeiten wir eigentlich gut zusammen, wir schätzen die 
übersichtliche Rezeptierung. 
 Die Indikation wäre immer schön. Und es wäre nicht schlecht, wenn das Visum 
des Apothekers drauf wäre. Dann kann man unter Umständen schnell den 
Apotheker fragen, weil die Person das dann schon angeschaut hat. Das würde 
es viel einfacher machen.  
 Es gibt ja Präparate, die vom KSB selber sind. Man könnte einen Kommentar 
machen, dass man einen Ersatz suchen muss. Oder dass man schreiben könnte, 
"KSB-Herstellung, bei Bedarf Rezeptur beantragen" oder so. 
 Weil die Leute verstehen nicht, dass es dafür [für BTM] ein spezielles Rezept 
braucht.. Das steht "Per Post unterwegs".  
 Kalium, Magnesium oder Eisenwert, finde ich immer sehr hilfreich, wenn so 
etwas auf dem Rezept steht. 
 Und wenn die Spitalapotheke beim Austritt des Patienten ein zusätzliches Auge 
darauf [auf das Rezept] wirft, ist es weniger Arbeit für uns. Und das ist eine 
qualitative Verbesserung.. Es ist eine Erleichterung, es ist ein Anfang, aber es ist 
für mich keine Auslagerung, dass ich sage: ich muss nichts mehr studieren, ich 
bekomme das Rezept vorpräpariert von der Spitalapotheke. Wir kennen den 
Patienten, die Situation wie er lebt, und wir können und müssen dort gewisse 
Sachen adaptieren. Hier ist es wichtig, mit dem Spital in Kommunikation zu 
bleiben, um zu wissen, welche Materialien verwendet werden. Diese 
Kommunikation funktioniert jetzt besser. 
 Wenn ihr das mit den Interaktionen drauf tun würdet, das wäre natürlich sehr 
cool. Wenn schon draufsteht, dass die Interaktionen zwischen diesen 
Medikamenten, die vom Spitalrezept kommen, dass die schon geprüft sind und in 
Ordnung sind, dann ist das für uns schon eine grosse Erleichterung. Und wenn 
daraufsteht, bei Antiinfektiva und so, wie lange die Therapie geplant ist, oder 
wenn man zum Beispiel bei Antikoagulantien schon weiss, der muss das Xarelto 
jetzt 1 Jahr nehmen, da gibt es normalerweise keinen Wechsel, dann kann man 
eine grosse Packung abgeben, kostengünstiger, und weiss, im Spital hat er das 
schon eine Zeit gehabt, er hat es vertragen.  
 Dann habt ihr diese Interaktionen geprüft und abgeklärt intern? Aha, das ist 
natürlich cool.  
 Für mich wäre von grossem Vorteil, wenn die Kommunikation, die stattgefunden 
hätte via Rezeptformular, wenn das fortgesetzt werden würde. 
 Was ich etwas sehr Gutes finde, ist die Dosierungskarte, die man den Patienten 
mitgibt im Spital.. Dort gibt es immer wieder leichte Dosisanpassungen. Wenn 
das jeweils auch auf einem Blatt sauber dokumentiert wird und klar kommuniziert 
wird, dass jetzt das die Dosisänderung ist. Das könnte man vielleicht noch 
verbessern. 
Stellen Sie sich vor, die 
Spitalapotheke würde 
andere Formen der 
Zusammenarbeit mit den 
öffentlichen Apotheken 
anbieten. Welche 
Wünsche hätten Sie 
diesbezüglich? 
 Ich möchte weiterhin Magistralrezepturen machen. Ich wünsche mir, dass wir die 
Vorgaben erhalten, das bekommen wir auch und das schätzen wir sehr, dass wir 
Zugang haben zu den Magistralrezepturen, . Und schön wäre es wenn wir das 
ausweiten könnten, ist eben schon da, dass wir auch anrufen dürfen und blöde 
Fragen stellen. Wenn wir unsicher sind einfach um uns abzusichern. 
 Schulungen im Bereich psychologische Betreuung (dass wir wissen, wie wir mit 
diesen Patienten umgehen sollen, wir wissen ja nicht was die haben), der ganze 
palliative Bereich, ein grosses Thema ist Wundversorgung.  
 Die deutschen Assistenzärzte schreiben Medis auf, die es hier gar nicht gibt. Die 
schreiben einfach einen Wirkstoff auf und wir dürfen uns dann darum kümmern. 
Das stört mich manchmal. Ich finde super, dass sie zu uns arbeiten kommen, 
aber dann müssen sie sich auch an die Spitalliste halten.  
 Off-label use. Eben mit einem Ausrufezeichen vermerken. Dass man weiss, das 
waren sie sich bewusst, dass ist ok so.  
 Dass ihr aktiv auf uns zukommt, dass Peter wirklich auch an die GVs kommt, und 
immer offen ist wenn du ein Problem hast, das hat natürlich viel bewirkt 
 dass man mit dem Apotheker selber sprechen kann. Es wäre nicht schlecht, 
wenn gewisse Produkte, die ihr herstellt, dass man dort schauen könnte, dass 
man die sicher einmal beziehen kann. Weil gewisse Sachen können wir nicht ad 
hoc herstellen und es wäre wichtig, dass der Patient diese hat.  
 Und bei den Wundmaterialien. Ich habe jetzt eine Liste erhalten um zu wissen, 
was das KSB alles an Lager hat, dass wir wissen, was sie verschreiben.  
 Was ich ganz gut finde, ist das Spitalgeflüster, das wir auch bekommen. Das 
finde ich gut. Ihr habt einmal über den Magenbypass etwas gebracht, das finde 
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ich super. Wenn man solche Eingriffe dokumentiert und dann auch Rezepte 
aufzeigt und zeigt, warum man so verschreibt, das finde ich gut. Oder wenn ihr 
ein spezielles Produkt herstellt.  
 wenn man solche Events hat, z.B. im Aargau, wo man zusammensitzen kann 
 Wir haben eigentlich eine gute Beziehung zum Spital.Es ist auch wichtig, dass 
der Patient auch an dieses Ort geht, wo er vertraut ist, wo man ihn kennt. 
 Ich finde das etwas ganz wichtiges, dass man diese Kommunikation verbessern 
kann.  
 wenn ein Austritt auch auf ein Wochenende zugeht, oder gerade Antibiotika die 
nicht so geläufig sind. Ich denke, wenn man da schon ein Rezept im Haus hätte, 
dann halt im Spital fragen: wer ist ihre Apotheke, können wir die kontaktieren.  
 Verbandssachen. Wir können das meiste innerhalb von 12 oder 24h auftreiben, 
aber wir brauchen die Zeit teilweise. 
 Ich finde das etwas ganz wichtiges, dass man diese Kommunikation verbessern 
kann.. Die Ärzte haben ein anderes Denken als wir, und wir ein anderes als die 
Ärzte. Wenn man sich einmal verstehen würde, lernen würde zu verstehen, 
verstehen will, dann würde es viel einfacher.. Aber es steht und fällt mit dem 
aktuellen Medikationsplan. 
 Je früher die Patienten entlassen werden nach Operationen, dann kommen die 
Rezepte mit dem Verbandmaterial, Kathetersäcken und und und schon, aber 
was dort schwierig ist, zu wissen, bei diesen Sachen Stoma, Katheter, was passt 
jetzt auf was. Dort wäre es noch cool, aber das können wir nicht von euch 
erwarten, aber es wäre cool, grundsätzlich mal zu überdenken, wie machen wir 
das.. Oder wenn ihr das schon quasi in der Spitalapotheke bearbeitet, was sehr 
luxuriös wäre, dass man schon einen Pharmacode hätte, dass man genau weiss, 
welches Produkt. t. Aber das wäre super-schön, dass wir genau wüssten, 
welches Produkt. 
 Hier können wir noch viel voneinander profitieren. Das Paradebeispiel sind die 
Quetiapinkapseln, die 5mg. Das waren so Sachen, die irgendwann irgendwo 
aufkamen. Dann wird es nicht weiterverfolgt. Das ist auch eine Frage der 
Kommunikation. Was machen wir jetzt konkret damit. Und dann könnte man ja 
auch einmal in einer gemeinsamen Fortbildung oder in einer Kommunikation an 
die Offizinapotheker bringen.  
 Diesbezüglich ist jede Kommunikation vom KSB nach aussen gut. Ein grosses 
Thema ist natürlich auch die Wundversorgung.. Hier ist die Frage; ist es an uns, 
jedes Mal Rückfrage zu halten, wenn genau dieser Katheter oder dieser 
Urinbeutel, der hier genau aufgeschrieben wurde, nicht zur Verfügung steht, wie 




9.4.14 Summary of answers by resident physicians 
Was ist Ihre generelle 
Meinung zur 
POMMES-Studie in 1-2 
Sätzen? 
 Dass du auch noch einmal über das Rezept geschaut hast, ist als Kontrolle im 
Vieraugenprinzip sicher gut gewesen.  
 Da habe ich gemerkt, dass einige Sachen […] geändert haben, sei dies Dosisänderung oder 
Stoppverordnung, was die Ärzte nicht immer aufschreiben. Das hat dem Patienten sicher 
geholfen. 
 Eine gute Intervention. 
 Etwas mit dem Vieraugenprinzip, es passieren doch häufig Fehler. 
 Dass ihr auch gefragt habt; ist das jetzt wirklich [so] gewünscht, dass Insulin so und so, und 
das Antihypertensivum so, dass man sich wirklich kritisch gefragt hat, ob das so stimmt. 
 Sicher etwas Gutes, dass wir eine dritte Kontrolle hatten. 
Wie beurteilen Sie das 
Prozedere im 
Nachhinein? 
 Dass es im KISIM gerade erschienen ist, dass man sich gar nicht darum kümmern musste, zu 
wissen welche Patienten eingeschlossen sind war gut. 
 Die telefonische Rückmeldung war sicher gut, manchmal habe ich im Stress etwas verpasst, 
oder nicht überlegt. 
 Manchmal war das ein bisschen ein Stress. 
 Dass es im KISIM gerade erschienen ist, dass man sich gar nicht darum kümmern musste, zu 
wissen welche Patienten eingeschlossen sind, war gut 
 Es war gut dokumentiert. 
Wie beurteilen Sie das 
Rezept als 
Kommunikationsmittel 
zwischen Spital und 
öffentlicher 
Apotheke? 
 Ich denke, sehr gut. Es ist knapp, aber klar und deutlich. 
 Ich muss ehrlich sagen; mir war nicht bewusst, dass die Apotheke sich hier aktiv darum 
kümmert, im Sinne von: was hatte der Patient vorher für Medikamente. […] ich habe das 
deutlich unterschätzt 
 Mir war das auch gar nicht bewusst, dass man eine Art Stammapotheke hat. 
 zum Beispiel die Wichtigkeit zu kommunizieren, etwas ist gestoppt worden oder […] eine neue 
Dosierung. 
 Ich dachte, ich muss es einfach dem Patienten sagen, aber nicht, dass es für die Apotheke 
wichtig ist. Also das Verständnis für die Rolle der Apotheke, dass man dort auch mal 
nachfragen kann, das wusste ich vorher nicht, das mit der Stammapotheke. 
 Ich glaube es ist gut, dass es auf dem gleichen Blatt steht. 
Haben Sie selber 






Bitte geben Sie an, ob 
durch die Studie 
irgendeine 
Sensibilisierung 
stattgefunden hat.  
 Seither habe ich mehr auf die Unterschiede zwischen Ein- und Austrittsmedikamente 
geachtet. 
 Ja, vor allem dass die Eintrittsmedikamente und und Austrittsmedikamente verglichen worden 
sind. Und dass es dort möglichst keine Abweichungen gab, die nicht irgendwie begründet 
waren. 
 Etwas was ich früher nicht gemacht habe, was ich jetzt doch noch denke, das es wichtig ist: 
Dass der Patient dies merkt, und dass man schriftlich festhält, welche Änderungen gemacht 
worden sind. Das ist sicher auch hilfreich für den Hausarzt, wenn er es sieht. 
 Jetzt schreibe ich wirklich brav bei jedem Medikament, das anders ist, hin warum, was es 
ersetzt. Was ich noch nicht immer konsequent mache, ist, wenn ein Medikament wegfällt 
 Auf jeden Fall. Ich habe vorher einfach die Medikamente aufgeschrieben, ohne Kommentar. 
 Dashabe ich bei dir gesehen und für gut befunden, und in dem Sinne kopiert. 
 Vor allem im Verlauf der Studie habe ich mehr darauf geachtet, dass ich wieder die 
Eintrittsmedikamente verordne, und schon selber draufschreibe, was neu ist. Da hat es sicher 
etwas sensibilisiert. Und wenn die Studie noch länger gelaufen wäre, dann umso mehr.  
 Dass ich sicher die Medikamente auf das richtige Generikum zurückverordnet habe und was 
neu ist. 
 Was ich gelernt habe, dass jetzt Vitamin D nicht mehr in Tropfen sondern in Milliliter gegeben 
werden. Dass ist für mich neu gewesen.  
 Das mit den Therapieänderungen, das ist mir ganz fest aufgefallen 
 Wenn ich eine Therapie pausiere oder umstelle, oder etwas neues dazu verordne, dann 
werde ich das dem Patienten klar kommunizieren, und auch beim Ausführungsgespräch 
ausführlich erklären, auf dem Rezept mache ich dann so mit Farbstift „neu“ oder ein Stern, 
dass ich sage, diese sind neu, diese müssen sie unbedingt neu holen, die anderen haben sie 





 Weil jemand, der das wirklich 1:1 oder immer gleich anschaut, weil es sonst manchmal sehr 
zufällig ist, wie genau oder systematisch man etwas anschaut. 
 Dass jemand, der nichts mit dem Patienten zu tun hat, das anschaut, der etwas von Medis 
versteht. 
 Sicher ein erhöhtes Bewusstsein, dass die [öffentliche] Apotheke überhaupt solche Sachen 
anschaut, was ich auch gemerkt habe, weil sie zum Teil angerufen haben.  
 Das Bewusstwerden, die Sensibilisierung, und eben eine bessere Kommunikation. 
 Ich denke schon dass es (bei Therapieänderungen) einen Effekt gegeben hat, dass unsere 
Rezepte besser wurden. Das mache ich jetzt häufiger. 
 Ja, doch, ich habe subjektiv einen Effekt gemerkt. Nicht einen riesigen, ich schaue selber 
schon gut, dass ich die Rezepte gut ausstelle. Ich gebe mir sehr Mühe.  
 Bezogen auf die Assistenzärzte kann ich mir schon vorstellen, dass sie sich Gedanken 
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gemacht haben „stimmen jetzt meine Rezepte“ oder nicht. 
 Dass man bessere und für Patienten klarere Rezepte abgibt, kann ich mir schon vorstellen. 
 Ich mache es jetzt wirklich konsequent so. Weil es ja eigentlich das Wichtigste ist, dass es 
nicht nur während der Hospitalisation klappt, sondern dass es auch nachher klappt. Sonst ist 
die Rehospitalisation ja vorprogrammiert, wenn sie die Änderungen gar nicht warhnehmen. 
Stellen Sie sich vor, 
die Spitalapotheke 
könnte die Rezepte 
weiterhin wie in der 
Studie bearbeiten. 
Welche Kommentare 
oder Wünsche hätten 
Sie diesbezüglich?   
 Ich finde es gut, wenn es weiterhin so wäre. 
 Wenn es last moment Änderungen gegeben hat, dass man das auch noch kommunizieren 
könnte. 
 Dass man es auch herumschicken könntet, mit KISIM-Mail zum Beispiel, dass ich gerade 
sehe: Ah, ihr habt‘s angeschaut, es ist quasi von euch freigegeben. 
 Ich persönlich fände es sicher ein Gewinn, wenn auch jemand von der Apotheke 
daraufschauen würde. 
 Die Rezepte hier auf der Inneren sind schon ausführlicher und klarer. 
 Dass man etwas abstuft zwischen kleineren Sachen und Relevantem. 
 Ich persönlich würde es wertvoll finden, wenn jemand draufschauen würde. Weil du dann 
sicher vier Augen hast. Sicher schaut manchmal der Kader drauf, manchmal halt auch nicht. 
Aber wenn es der Assistent und der Pharmakologe ist, dann sind es schon vier Augen, das 
wäre schön. 
 Es würde die Sicherheit gut erhöhen. 
 Vielleicht könnte man einen Cut-off setzen: ab 5 oder 8 Medis [..] muss der Apotheker das 
Rezept gegenvisieren. 
 Wenn das irgendwie machbar wäre, würde ich das unterstützen 
 Den Arbeitsprozess könnte man noch optimieren, aber die Idee finde ich sehr gut. 
Stellen Sie sich vor, 
die Spitalapotheke 
würde andere Formen 
der Zusammenarbeit 





 Ich finde es gut wenn die [öffentliche] Apotheke nachfragt, […] das ist wieder das 
Vieraugenprinzip, wenn auf dem alten Rezept etwas war, und jetzt nicht mehr. 
 Ich finde gut, das sie [die öffentlichen Apotheken] nachfragen. Aber es ist schwierig für die 
Apotheke nachzuvollziehen, was während dem Spitalaufenthalt passiert ist.  
 Es ist unnötig, wenn man etwas auf das Rezept schreibt, was gestoppt ist. 
 Die Patienten aktualisieren z.T. ihre alte Dosierungskarte. Wenn die Apotheke das mit dem 
Patienten selber noch anschaut; das kommt von der ärztlichen Seite manchmal etwas zu 
kurz. 
 Ich fände es allgemein wirklich cool, wenn ihr präsenter wärt. 
 Weil ihr einfach mehr über die Medikamente wisst als wir.  
 Von mir aus dürfte die Apotheke auf jeden Fall anrufen, wenn sie eine Frage hat. Weisst du, 
ich bin froh, wenn sie anruft, wenn etwas komisch vorkommt, […] das dürfen sie unbedingt 
machen. 
 Auch wenn ich manchmal denke, mein Gott, was ist das für eine Frage, bin ich insgesamt 
mega froh wenn sie anrufen, weil ich merke, es schaut noch jemand, es macht sich noch 
jemand Gedanken. Also ich finde dass ist unbedingt, dass sie schauen, und selber überlegen, 
und wenn sie das Gefühl haben etwas macht keinen Sinn, dass sie nachfragen. Das finde ich 
wichtig, und ich hoffe, das machen sie immer. 
 Ich sehe es nicht selten, dass Patienten mit alten Dosierungskarten und alten Rezepten 
vorbei kommen und hundert mal streichen. 
 Man könnte es ausdehenen, dass man vorher [während der Hospitalisation] schauen würde. 
Dass man es anfordern kann, wenn jemand diese und jene Medikamente hat, […] oder die 
und die Laborkonstellation, dass ihr dann automatisch einmal draufschaut auf die Therapie.  
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